Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,24966,0.199859938050723,0.00462217461273609,0.19080047580976,0.208919400291686,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,29786,-0.197280820386174,0.00355178491586492,-0.20424231882127,-0.190319321951079,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,24951,0.0782350016690527,0.00170799854505545,0.074887324520744,0.0815826788173614,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,29545,0.0863656728188481,0.00189620879267517,0.0826491035852048,0.0900822420524915,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,29218,-0.0947954724119931,0.00202550684108427,-0.0987654658205182,-0.0908254790034679,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,29301,-0.211259377198658,0.00518579731811267,-0.221423539942159,-0.201095214455158,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,29383,-0.0818179122488728,0.00205504555908271,-0.0858458015446749,-0.0777900229530707,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.145528341006599,0.00215463527649781,0.141305255864663,0.149751426148535,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,28797,-0.521174252082332,0.00824425945064348,-0.537333000605594,-0.505015503559071,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,28916,-0.196297146872577,0.00452937448092585,-0.205174720855191,-0.187419572889962,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29761,0.335457965204807,0.00838296289918618,0.319027357922402,0.351888572487212,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,24922,-0.275679019063647,0.00561484277079185,-0.286684110894399,-0.264673927232895,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,29500,-0.20044096404776,0.00353367174155986,-0.207366960661217,-0.193514967434302,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,29478,0.142128439114077,0.0032151214023025,0.135826801165564,0.14843007706259,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,29443,-0.207255788581754,0.0028476048934959,-0.212837094173006,-0.201674482990502,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,29725,-0.238881421414287,0.00443237822942629,-0.247568882743963,-0.230193960084612,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.128407364869012,0.00211779284748207,0.124256490887947,0.132558238850077,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,29581,0.107752364642393,0.00190146395116161,0.104025495298117,0.11147923398667,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,24938,-0.156036986601773,0.00272172858990847,-0.161371574637993,-0.150702398565552,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,29347,-0.145116235064996,0.00277020925738529,-0.150545845209471,-0.13968662492052,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PYY,Peptide YY,24111,-0.319021645031184,0.0065811544618753,-0.33192070777646,-0.306122582285908,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,29349,-0.284395868348496,0.00616015860365008,-0.29646977921165,-0.272321957485342,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,-0.0892693005511238,0.0022583670578914,-0.093695699984591,-0.0848429011176567,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,29454,-0.145008061667217,0.00376262543632416,-0.152382807522412,-0.137633315812021,1.11253693163792e-308
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C9,Complement component C9,24951,0.141758412769054,0.00367179541104946,0.134561693763397,0.148955131774711,1.11253693388931e-308
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,29489,-0.212033140636624,0.00556443638058345,-0.222939435942567,-0.20112684533068,1.13046081630001e-308
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,29725,-0.0881990456608996,0.00233070098450265,-0.0927672195905248,-0.0836308717312744,4.28867798052431e-306
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29628,-0.122576754471121,0.00325847622553454,-0.128963367873169,-0.116190141069073,1.46990654409674e-302
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,29694,-0.35687640429387,0.00958553806303142,-0.375664058897411,-0.338088749690328,1.45991288865673e-296
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29725,-0.0835815559979089,0.00226496683683316,-0.0880208909981019,-0.0791422209977159,1.6611606878964e-291
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29379,-0.137031885154441,0.00372389466326828,-0.144330718694447,-0.129733051614435,7.69071941964055e-290
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,28931,-0.20164428407657,0.00549015439064111,-0.212404986682227,-0.190883581470914,1.11749114238917e-288
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",28774,-0.133550467842428,0.00364706341395873,-0.140698712133787,-0.126402223551068,5.67529122496029e-287
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,29702,0.0895605568952774,0.00247955977852174,0.0847006197293748,0.09442049406118,1.27756526951576e-279
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,-0.169523489288216,0.00470162146902964,-0.178738667367514,-0.160308311208918,1.3353591312266e-278
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,24195,-0.20048257352811,0.00560598711462746,-0.21147030827278,-0.18949483878344,5.45677823940237e-273
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,29478,-0.151143667682155,0.00426390768417489,-0.159500926743138,-0.142786408621172,1.48581197227401e-269
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,24793,-0.135235175566099,0.00384694912785375,-0.142775195856692,-0.127695155275506,3.11791219620795e-264
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,29400,-0.246765188650371,0.00703429499790197,-0.260552406846259,-0.232977970454484,3.81996485483514e-264
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FURIN,Furin,29566,-0.0810730429858384,0.00231615672216792,-0.0856127101612875,-0.0765333758103893,4.77308134315129e-263
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,29820,-0.107379116092554,0.00307826814402482,-0.113412521654842,-0.101345710530265,2.45132127751441e-261
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,29820,-0.124260857390793,0.00362072300418296,-0.131357474478992,-0.117164240302594,3.45615579775774e-253
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,24381,0.0729384830052679,0.00212535793897032,0.0687727814448861,0.0771041845656497,4.18450356982809e-252
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,28916,-0.122398899941178,0.00357761602692051,-0.129411027353942,-0.115386772528413,1.65680242369824e-251
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,23825,-0.0763470106798717,0.00222833578939732,-0.0807145488270905,-0.071979472532653,3.60685714967299e-251
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,29786,-0.0618735696739209,0.00181724134418632,-0.065435362708526,-0.0583117766393157,2.64591001882201e-249
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,24922,-0.215275071509789,0.00634564580348517,-0.22771253728462,-0.202837605734958,1.17201251459443e-246
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,27442,-0.095225445115583,0.00281589389211864,-0.100744597144136,-0.0897062930870305,1.22897804524368e-245
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,-0.110412773663078,0.00327983712152799,-0.116841254421273,-0.103984292904883,9.31014996907349e-244
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,29443,-0.0960742686988761,0.00285898438606659,-0.101677878095567,-0.0904706593021856,5.7175861063463e-243
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,-0.127865356861721,0.00382109488099417,-0.135354702828469,-0.120376010894972,6.59719799742958e-241
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,-0.193474966617965,0.00579414206090176,-0.204831485057332,-0.182118448178597,6.64434698289469e-240
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,28774,-0.118933910665869,0.00356745182072254,-0.125926116234485,-0.111941705097252,3.82379113329126e-239
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,-0.146358515194744,0.00439615894757634,-0.154974986731993,-0.137742043657494,1.6746695008135e-238
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,29478,-0.141344531934027,0.00424929528024566,-0.149673150683308,-0.133015913184745,3.39204841474706e-238
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,29694,0.0497999469611624,0.00150157766341257,0.0468568547408738,0.0527430391814511,7.29326992737286e-237
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,29036,-0.336553799376078,0.0102116830359872,-0.356568698126613,-0.316538900625543,6.76951823001234e-234
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,29434,-0.120690093839013,0.0036966855967741,-0.12793559760869,-0.113444590069336,1.07535684335209e-229
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,29435,0.102044181262421,0.00313051744119741,0.0959083670776745,0.108179995447168,5.46595341771987e-229
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,29786,-0.0640297091626652,0.00196710946199088,-0.0678852437081673,-0.0601741746171631,2.11643821541241e-228
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,-0.0717948430905622,0.00220551616343797,-0.0761176547709006,-0.0674720314102238,2.25521170151893e-228
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,29786,-0.0774276840741747,0.00238615376781265,-0.0821045454590875,-0.0727508226892619,5.1192845152045e-227
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28967,-0.0984223479029439,0.00304473619352436,-0.104390030842252,-0.0924546649636362,3.12010985768501e-225
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,23787,0.097096589566055,0.00302416664059136,0.091169222950496,0.103023956181614,1.88249592231749e-221
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,29478,-0.0677021516966149,0.00211514725662059,-0.0718478403195913,-0.0635564630736386,5.1387001379479e-221
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,-0.0796262815632924,0.00248956502905428,-0.0845058290202388,-0.074746734106346,1.06068117219658e-220
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.0767239617127712,0.00242237660274328,-0.0814718198541481,-0.0719761035713944,1.53517110498209e-216
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,29536,-0.0730492643187098,0.00231109661276489,-0.077579013679729,-0.0685195149576906,1.13228025216696e-215
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29559,-0.0512766846169044,0.0016246491700316,-0.0544609969901663,-0.0480923722436424,4.64445564709338e-215
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,29683,-0.0440336694578078,0.00139628101677325,-0.0467703802506834,-0.0412969586649322,9.72936252293668e-215
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,29674,-0.258823560604504,0.00822191706162661,-0.274938518045292,-0.242708603163716,5.50097492025216e-214
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,29725,0.0776432774999474,0.00247257068740457,0.0727970389526344,0.0824895160472603,5.81502589282567e-213
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,24240,-0.111790456036608,0.00356359088523638,-0.118775094171671,-0.104805817901544,8.8684070640294e-212
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,-0.0841460976609768,0.00269841196792571,-0.0894349851181112,-0.0788572102038424,4.29065228609133e-210
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,29426,-0.182065700210065,0.0058503874475934,-0.193532459607348,-0.170598940812782,3.1818546464977e-209
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,29584,-0.0738326752347235,0.00237719331918107,-0.0784919741403184,-0.0691733763291286,1.95040663364023e-208
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29349,-0.149146429437425,0.00480450980930028,-0.158563268663653,-0.139729590211196,3.32875367122009e-208
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,29694,-0.130702338505395,0.00422085815051774,-0.13897522048041,-0.12242945653038,3.10221320982872e-207
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,29349,-0.12038642694009,0.00390049437079048,-0.128031395906839,-0.11274145797334,7.07530572493382e-206
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24804,-0.182182969980027,0.00593094916472539,-0.193807630342888,-0.170558309617165,2.16236969804412e-203
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,-0.161724562269194,0.00531119222803024,-0.172134499036133,-0.151314625502255,5.71988913916002e-200
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,28935,-0.166681421388885,0.0054850148364218,-0.177432050468272,-0.155930792309498,1.07989001743927e-199
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29349,-0.171358594769249,0.00565136140844206,-0.182435263129795,-0.160281926408702,7.00567365197813e-199
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,29820,-0.0921136850328355,0.00306489704527782,-0.09812088324158,-0.086106486824091,1.58942603520986e-195
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29694,-0.0723935157662094,0.00241065911228903,-0.0771184076262959,-0.0676686239061229,3.27634042700256e-195
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,-0.117024233578695,0.00390691596489867,-0.124681788869896,-0.109366678287493,3.48630897764874e-194
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,29559,-0.0679238445642604,0.00226798634868047,-0.0723690978076741,-0.0634785913208467,3.64192218920852e-194
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,29581,-0.0864853543899843,0.00289160289442561,-0.0921528960630585,-0.0808178127169101,1.15400396434867e-193
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,-0.12257835810895,0.00412115736659547,-0.130655826547477,-0.114500889670422,1.66221646116871e-191
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,29443,0.0769106274964902,0.00261057511843915,0.0717939002643495,0.082027354728631,4.88694055992346e-188
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,-0.0893381407605617,0.00305186342103012,-0.0953197930657807,-0.0833564884553426,1.16385760246093e-185
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,-0.148192826016301,0.00505873513777416,-0.158107946886338,-0.138277705146264,1.70708623989049e-185
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,29594,0.067836044909414,0.00231886653415734,0.0632910665024656,0.0723810233163624,1.75986488230218e-185
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,-0.0693818282964368,0.00238027553330861,-0.0740471683417217,-0.0647164882511519,3.41878394845939e-184
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,29786,-0.0615033975197017,0.00211200769332592,-0.0656429325986205,-0.0573638624407829,7.43824770350315e-184
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29545,0.0594711151811305,0.00205185386744728,0.0554494816009338,0.0634927487613272,3.72703557543956e-182
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29655,-0.0631462489953929,0.00218757354069988,-0.0674338931351647,-0.0588586048556211,1.0183206044339e-180
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24381,-0.0756154528524281,0.00262190777376847,-0.0807543920890143,-0.0704765136158419,7.13261565588224e-180
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MENT,Protein MENT,24381,0.0456959299365412,0.00158566803573753,0.0425880205864957,0.0488038392865868,1.30947102450201e-179
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,-0.0759891487122871,0.00264612617136664,-0.0811755560081657,-0.0708027414164085,6.44041888310504e-179
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MME,Neprilysin,29349,-0.158782806131162,0.00559181209306659,-0.169742757833572,-0.147822854428751,5.36035533429218e-175
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,29426,-0.0916370166297855,0.00323380542405061,-0.0979752752609247,-0.0852987579986463,2.65493437126928e-174
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,29034,0.105536918207004,0.00373402703191232,0.0982182252244561,0.112855611189552,2.17292189611133e-173
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,29218,-0.0713225097324139,0.0025256872305718,-0.0762728567043346,-0.0663721627604932,4.14966841927465e-173
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,29577,-0.127848597982834,0.00454411501533904,-0.136755063412899,-0.11894213255277,6.7613681391112e-172
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,29697,-0.0519940734797022,0.00185250936367581,-0.0556249918325068,-0.0483631551268976,4.28736000855554e-171
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,-0.155467994663059,0.00554181952115493,-0.166329960924523,-0.144606028401595,6.53884828638045e-171
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,29545,-0.0355093116307489,0.00126812545448079,-0.0379948375215313,-0.0330237857399666,2.63196162842754e-170
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,24579,-0.0510734271164115,0.0018271708021194,-0.0546546818885655,-0.0474921723442574,2.76375783981724e-169
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,29349,-0.0888815500767678,0.00318815956205386,-0.0951303428183934,-0.0826327573351422,7.726149073437e-169
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,24938,-0.0637895979751522,0.00229631444823878,-0.0682903742937002,-0.0592888216566041,2.74104921564486e-167
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,24329,-0.0729666063957208,0.00263120766036928,-0.0781237734100445,-0.067809439381397,1.15023570461273e-166
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,24914,0.0723659622501081,0.00261873099213922,0.0672332495055152,0.077498674994701,1.37006212863092e-165
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,-0.176573740962053,0.00639804662191082,-0.189113912340998,-0.164033569583107,1.64781928703413e-165
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,-0.105355803959582,0.00383180886300306,-0.112866149331068,-0.0978454585880957,2.62626889013235e-164
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,24381,-0.0775558553960456,0.00282158653436613,-0.0830861650034033,-0.072025545788688,8.00015249661558e-164
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,29632,-0.0925196687348982,0.00337499550715516,-0.0991346599289223,-0.0859046775408741,2.09529617133366e-163
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,29530,-0.0542159162056859,0.00197879564177793,-0.0580943556635707,-0.0503374767478012,3.16624960097412e-163
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,29349,-0.0681452276103428,0.00248842564253029,-0.0730225418697022,-0.0632679133509835,4.68277537897084e-163
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,29433,-0.0569383488926302,0.00208136111941581,-0.0610178166866852,-0.0528588810985752,9.91682514543965e-163
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,28797,-0.145870750714096,0.005344559334701,-0.15634608701011,-0.135395414418082,5.89105771938723e-162
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29349,-0.165210939726064,0.00605757774898231,-0.17708379211407,-0.153338087338059,9.16416376027092e-162
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,29786,-0.0622971313912614,0.00228717859215494,-0.0667800014318851,-0.0578142613506377,2.22814799146502e-161
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,29443,0.0510447743662854,0.00188151153576462,0.0473570117561868,0.0547325369763841,4.11856187021742e-160
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28797,-0.155519688557072,0.00573503918801072,-0.166760365365573,-0.144279011748571,6.28957583034534e-160
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,24805,-0.134675100794241,0.0050424819053671,-0.144558365328761,-0.124791836259722,5.90792097219843e-155
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,29604,-0.110574437532653,0.00416649032252061,-0.118740758564793,-0.102408116500512,2.15611007323598e-153
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29478,0.0499944724319877,0.00189579610040389,0.046278712075196,0.0537102327887793,1.68514456685527e-151
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,29750,0.0992784250965897,0.00376898573538287,0.0918912130552392,0.10666563713794,3.55346683395903e-151
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OCLN,Occludin,24867,-0.0811407175711193,0.00307712701691179,-0.0871718865242664,-0.0751095486179721,3.73415220919944e-151
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29581,-0.0533176606169717,0.00202865959372164,-0.0572938334206661,-0.0493414878132773,1.64627060661229e-150
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,-0.193963855507314,0.00738050116912377,-0.208429637798797,-0.179498073215832,1.7708801197959e-150
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,-0.0547746873137426,0.0020842957656848,-0.0588599070144848,-0.0506894676130004,1.78827086748041e-150
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24609,-0.058675575679911,0.00223330530151769,-0.0630528540708857,-0.0542982972889363,4.5979862880574e-150
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,29478,-0.0480469462966557,0.00184020623766117,-0.0516537505224716,-0.0444401420708398,1.39612452099812e-148
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,-0.0617603879219429,0.00237083424531862,-0.0664072230427674,-0.0571135528011185,6.37326704673524e-148
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,29566,-0.0400533016820778,0.00153987320021338,-0.043071453154496,-0.0370351502096595,1.71498081852918e-147
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,29434,-0.0867278954249846,0.00333773144773442,-0.093269849062544,-0.0801859417874251,3.44085254817368e-147
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29434,-0.092760006415985,0.00358008822461292,-0.0997769793362263,-0.0857430334957436,2.26085810040863e-146
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,29604,-0.107852445526283,0.004169716446517,-0.116025089761456,-0.0996798012911097,6.80743572415826e-146
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,29725,-0.0666269666488215,0.00257841908741865,-0.071680668060162,-0.0615732652374809,1.27633892395758e-145
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,-0.0896017621157807,0.00346844748026873,-0.0963999191771074,-0.0828036050544539,3.37034981374943e-145
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,24922,-0.0512840509504145,0.00198569484037929,-0.055176012837558,-0.0473920890632711,3.61901007172144e-145
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,-0.0549236751647992,0.00213445659560926,-0.0591072100921934,-0.0507401402374051,2.02420745493896e-144
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,29683,-0.0617449235357084,0.00240112647621121,-0.0664511314290824,-0.0570387156423344,3.03263744519813e-144
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,29453,-0.0572858827544975,0.00222765895014934,-0.0616520942967902,-0.0529196712122048,3.06039563732156e-144
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29674,-0.0754636904644488,0.00294082498686364,-0.0812277074387015,-0.0696996734901961,1.18945551004261e-143
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,29115,-0.0647800836022389,0.002525286798107,-0.0697296457265286,-0.0598305214779491,1.56331080638806e-143
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,29169,-0.0549669690555408,0.00214716795426666,-0.0591754182459035,-0.0507585198651782,5.84545492154986e-143
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELE,E-selectin,29820,-0.0898958876179617,0.00351770644744052,-0.0967905922549451,-0.0830011829809783,1.64890447907906e-142
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,-0.0693042688817289,0.00271760480962213,-0.0746307743085882,-0.0639777634548695,6.71718322912665e-142
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,-0.0844979525615672,0.00331415116365598,-0.090993688842333,-0.0780022162808015,1.56623255268373e-141
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,29725,0.029479764567129,0.00116033751116717,0.0272055030452413,0.0317540260890166,6.89813874474292e-141
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,29349,-0.063681582233424,0.00250838566276839,-0.06859801813245,-0.0587651463343979,1.14845115201621e-140
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,29443,-0.0415466077320792,0.00164148020125121,-0.0447639089265316,-0.0383293065376269,7.699091856861e-140
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGRN,Agrin,29581,-0.0608148990695424,0.00240532481466397,-0.0655293357062837,-0.056100462432801,1.48057803583896e-139
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REN,Renin,29478,-0.13408174655719,0.0053206270347205,-0.144510175545243,-0.123653317569138,1.17062934053424e-138
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,29725,-0.050282185645867,0.00199723024117558,-0.0541967569185712,-0.0463676143731629,2.08061508807847e-138
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,29163,-0.12771034691042,0.00507690224925976,-0.137661075318969,-0.117759618501871,3.70250569510375e-138
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29434,-0.0661880248183518,0.0026408770161577,-0.0713641437700209,-0.0610119058666827,3.48169559906842e-137
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,24381,-0.0505389876729705,0.00201606789005162,-0.0544904807374716,-0.0465874946084693,6.02771492271602e-137
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29443,-0.0747971479931872,0.00298998930026071,-0.0806575270216982,-0.0689367689646762,1.10405284906543e-136
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,29507,0.0345863255461916,0.00138451947997873,0.0318726673654333,0.0372999837269499,2.59326095401338e-136
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,28764,-0.10377245949404,0.00416124761095122,-0.111928504811504,-0.0956164141765752,8.05512045741798e-136
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,24951,0.0901670883324917,0.00362349320055726,0.0830650416593995,0.0972691350055839,4.92240369848334e-135
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,28762,-0.0551765621026983,0.00222274723013982,-0.0595331466737723,-0.0508199775316242,1.30759602313109e-134
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,-0.067898216954208,0.00273320382054367,-0.0732552964424736,-0.0625411374659424,1.52657013881105e-134
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,29544,-0.0529725970827656,0.00214264349648874,-0.0571721783358836,-0.0487730158296477,1.38427491036001e-133
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29820,0.0588909160663406,0.00238441251385239,0.0542174675391899,0.0635643645934913,2.45003979987297e-133
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,29434,-0.0692213526345423,0.00280560393347712,-0.0747203363441574,-0.0637223689249271,4.75927022467172e-133
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,29693,-0.0979001697509808,0.00397187651867492,-0.105685047727584,-0.090115291774378,8.32102494753656e-133
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,29725,-0.220320433147263,0.00894224936275315,-0.237847241898259,-0.202793624396266,1.06140175940273e-132
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,-0.0981924008593337,0.00399709572351966,-0.106026708477432,-0.0903580932412352,1.099743397721e-131
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,28553,-0.172942606431261,0.00705904294884681,-0.186778330611001,-0.159106882251522,3.4007498036329e-131
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,24240,-0.0924116489315188,0.00378906496061752,-0.0998382162543291,-0.0849850816087085,8.21959480450185e-130
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,29581,-0.0460077721705706,0.00189054437720025,-0.0497132391498831,-0.0423023051912581,1.54763155185792e-129
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,-0.0979666320501523,0.00402289593603378,-0.105851508084778,-0.0900817560155261,1.97410161308953e-129
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,24888,0.0833481022472877,0.00343232918208426,0.0766207370504025,0.0900754674441728,9.30323450335006e-129
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,29820,-0.0999414528361422,0.00412962672319095,-0.108035521213596,-0.0918473844586879,3.74539543484216e-128
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,29443,-0.0947752119863982,0.00392259922205485,-0.102463506461626,-0.0870869175111707,9.98222204051253e-128
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,29434,0.0578920788386555,0.00239653149613638,0.0531948771062282,0.0625892805710828,1.11745574220047e-127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,29786,-0.0765316807941773,0.00317116043317915,-0.0827471552432085,-0.0703162063451462,1.86311041655744e-127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,24240,-0.108145580496136,0.00450036580079542,-0.116966297465695,-0.0993248635265766,4.00706869217237e-126
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELN,Elastin,24922,-0.0591867574612054,0.00246431825645678,-0.0640168212438607,-0.0543566936785501,4.95213897611596e-126
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29760,-0.0641813594988122,0.00267889552686917,-0.0694319947314758,-0.0589307242661486,1.18111469895167e-125
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,-0.114575090028577,0.0047780624253878,-0.123940092382337,-0.105210087674817,1.35116009884499e-125
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,29435,0.0529551512105371,0.0022165152205267,0.0486107813783047,0.0572995210427694,5.8750787740382e-125
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,-0.0478543082126813,0.00200674871056543,-0.0517875356853895,-0.043921080739973,1.66681925461646e-124
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,-0.0913901718578933,0.00385103530480086,-0.098938201055303,-0.0838421426604836,2.66253035538556e-123
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,29333,0.104516658989691,0.00440866991583858,0.0958756659546469,0.113157652024734,4.3970820289873e-123
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,29820,0.0272118892522581,0.00114815475520401,0.0249615059320583,0.029462272572458,4.90423546124209e-123
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.0679794542208607,0.00287146037094982,-0.0736075165479224,-0.0623513918937991,9.40667810433689e-123
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,-0.0561466988085641,0.00237320186817602,-0.0607981744701891,-0.0514952231469391,1.33857143200003e-122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,24805,-0.184477481638163,0.00779332663454217,-0.199752401841866,-0.16920256143446,1.63363438970667e-122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,-0.136514978038023,0.00578083894480116,-0.147845422369833,-0.125184533706213,3.9209227917514e-122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,29173,-0.0469188508055394,0.00198805662471997,-0.0508154417899905,-0.0430222598210882,5.33279594301497e-122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,24867,-0.073350197453355,0.00310908636448509,-0.0794440067277458,-0.0672563881789643,1.0098974716448e-121
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,29545,-0.0543762505656668,0.00231272053788382,-0.0589091828199191,-0.0498433183114145,4.01297577296766e-121
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,29434,-0.0763706250094696,0.00326895707514589,-0.0827777808767556,-0.0699634691421837,1.26891519443413e-119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,24381,-0.0442372663316475,0.00191640984581858,-0.0479934296294519,-0.0404811030338431,1.21323164528048e-116
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,-0.0445802951460317,0.00193397003396422,-0.0483708764126016,-0.0407897138794618,2.39588453529549e-116
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,29487,-0.0509262300205897,0.00221343335930157,-0.0552645594048208,-0.0465879006363586,4.1152251086793e-116
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,24828,-0.0497812257818368,0.00216333217682259,-0.054021356848409,-0.0455410947152645,5.87503250059973e-116
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24922,-0.106484498240447,0.00462881129554908,-0.115556968379723,-0.0974120281011704,6.75535806936362e-116
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,29594,-0.0858669202859229,0.00375133107606185,-0.0932195291950042,-0.0785143113768417,5.87713331712263e-115
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29434,-0.101708628008046,0.00446159049194702,-0.110453345372262,-0.09296391064383,4.84180319437211e-114
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,29434,-0.0864795878640115,0.00379952152883346,-0.0939266500605251,-0.079032525667498,1.0817228826771e-113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29378,-0.107787261365384,0.00474699762956047,-0.117091376719323,-0.0984831460114458,3.6583256130492e-113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,29786,-0.0654877968006276,0.00289219858712821,-0.0711565060313989,-0.0598190875698563,1.46526856615245e-112
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,24951,0.0421124556880704,0.00186212579432849,0.0384626891311866,0.0457622222449543,4.11838851341155e-112
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,-0.0634928234710474,0.00281223046901378,-0.0690047951903144,-0.0579808517517804,9.64540857403729e-112
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PXN,Paxillin,28774,-0.0812056300195807,0.00360476874684492,-0.0882709767633967,-0.0741402832757646,2.06828572995825e-111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,28916,-0.0844371660416636,0.00375216075675579,-0.091791401124905,-0.0770829309584223,3.45790466701918e-111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,29433,-0.0472924964645392,0.00210348057651992,-0.0514153183945182,-0.0431696745345601,5.25765529941878e-111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,0.0615276804014365,0.00273970082037977,0.0561578667934921,0.0668974940093808,9.17595403475932e-111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,29820,-0.0550405293670588,0.00245282340177196,-0.0598480632345319,-0.0502329954995858,1.33366201039383e-110
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,29725,-0.0871182112601708,0.0038841904463705,-0.094731224535057,-0.0795051979852846,1.7022954000866e-110
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24793,-0.0826054016796392,0.00368329488700276,-0.0898246596581646,-0.0753861437011138,2.68760463678103e-110
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,24381,-0.100311582130605,0.00448161377284344,-0.109095545125378,-0.0915276191358316,7.39939828269885e-110
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29478,-0.0565620651043266,0.00252953042277303,-0.0615199447329617,-0.0516041854756915,7.80544248546217e-110
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,-0.0572172152627227,0.00255958480216813,-0.0622340014749722,-0.0522004290504732,9.04873753266724e-110
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,-0.0609505495170378,0.00272977502078225,-0.066300908557771,-0.0556001904763045,1.60435426162201e-109
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,29478,-0.0552846992142883,0.00248061762909147,-0.0601467097673076,-0.050422688661269,3.97741849157427e-109
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,29434,-0.118362072221777,0.00531521771504766,-0.128779898943271,-0.107944245500284,5.94116355318153e-109
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,24240,0.0953351519575422,0.00428212138684623,0.0869421940393235,0.103728109875761,1.02775013158561e-108
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,29349,-0.121001396761328,0.00544185078703892,-0.131667424303924,-0.110335369218732,1.23735759922102e-108
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,29566,-0.0645001233897208,0.00291517924703027,-0.0702138747139002,-0.0587863720655415,1.34201357064478e-107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AFM,Afamin,24966,-0.0302573393209027,0.001369201937605,-0.0329409751186085,-0.0275737035231969,3.48781087784107e-107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,29652,-0.0575835390684121,0.00260799541619059,-0.0626952100841456,-0.0524718680526785,3.63478932450937e-107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,29786,-0.05350835531116,0.00242787584659289,-0.058266991970482,-0.0487497186518379,8.68398602803482e-107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,24194,-0.0426391986394199,0.0019385188529593,-0.0464386955912202,-0.0388397016876197,3.47913082646703e-106
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29390,-0.0773091822085156,0.00351848612759662,-0.084205415018605,-0.0704129493984263,3.80366485135418e-106
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,29725,-0.0408642485391985,0.00186129018364401,-0.0445123772991408,-0.0372161197792562,5.43434091018248e-106
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,-0.0608066939431523,0.00277446418858897,-0.0662446437527867,-0.0553687441335179,1.27359085502648e-105
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,29786,-0.117802004458581,0.0053797324822488,-0.128346280123789,-0.107257728793373,1.87363432177375e-105
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,-0.0775934409701033,0.00357590780892522,-0.0846022202755967,-0.0705846616646098,1.42166809407429e-103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,29701,-0.0362722092269422,0.00167315617038336,-0.0395515953208936,-0.0329928231329909,2.06028628557409e-103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,29434,-0.0849830389185384,0.00392044323069346,-0.0926671076506975,-0.0772989701863792,2.18716787218066e-103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,29786,-0.0825394408092655,0.00381617665795783,-0.0900191470588628,-0.0750597345596681,5.97489791405067e-103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,-0.078841263197525,0.00365222481016038,-0.0859996238254394,-0.0716829025696107,1.45989839734857e-102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,29581,0.0652344053768075,0.00302581361337368,0.0593038106945951,0.0711650000590199,2.6616499049842e-102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,29566,-0.0400781459069351,0.00185922346685512,-0.0437222239019712,-0.0364340679118991,2.83382789381803e-102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,29192,-0.0558433432931404,0.0025963030516936,-0.0609320972744598,-0.0507545893118209,7.97003114061025e-102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,24966,0.041587174252331,0.00193336308543143,0.0377977826048854,0.0453765658997766,1.04771248002864e-101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29370,-0.030453740444112,0.0014181713826434,-0.033233356354093,-0.0276741245341309,1.6503402029789e-101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,29683,-0.0866082386172921,0.00404318520294049,-0.0945328816150555,-0.0786835956195288,4.98905793877287e-101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POSTN,Periostin,24938,0.0570007838539177,0.00266400571522105,0.0517793326520845,0.062222235055751,1.15621775507356e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,29478,0.055864484749225,0.00261710796440086,0.0507349531389994,0.0609940163594507,2.45366309726035e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28797,-0.0535830536146485,0.0025132126244859,-0.0585089503586409,-0.0486571568706562,4.35789824728452e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,29351,-0.0476968976419939,0.00223891712012394,-0.0520851751974368,-0.043308620086551,6.02482054740675e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,24914,-0.0422600608746584,0.00198357447630951,-0.046147866848225,-0.0383722549010917,7.946875097225e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HLA_E,,29434,-0.0432489811460587,0.00203304745796229,-0.0472337541636648,-0.0392642081284526,1.13980012054284e-99
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,29349,-0.088350510798433,0.00417175675288463,-0.0965271540340869,-0.0801738675627792,8.33528024370025e-99
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,29478,-0.0942756757287448,0.00445328891262744,-0.103004121997495,-0.085547229459995,9.85215028683546e-99
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,29694,-0.0987422875910923,0.00466949415897516,-0.107894496142684,-0.089590079039501,1.59509541276804e-98
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,29291,-0.0452412360626282,0.00214115958674204,-0.0494379088526426,-0.0410445632726138,2.3235824702711e-98
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29454,-0.0411204341389578,0.00195052858068698,-0.0449434701571043,-0.0372973981208114,6.21068404456949e-98
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,-0.0893293100181318,0.00424646941834195,-0.0976523900780821,-0.0810062299581816,1.61073439747443e-97
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,-0.0648865554372587,0.00308925082578147,-0.0709414870557904,-0.058831623818727,3.13973526852097e-97
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,29434,0.0514353865112261,0.00245021648096455,0.0466329622085356,0.0562378108139166,3.9909605964715e-97
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,29725,-0.0677819978846332,0.00322938419225521,-0.0741115909014534,-0.061452404867813,4.18345609212817e-97
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,-0.0830657445402584,0.00395516917677199,-0.0908178761267315,-0.0753136129537853,4.67889848987405e-97
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,29527,0.0572063896295331,0.00273019402819188,0.051855209334277,0.0625575699247892,8.8958558816791e-97
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,-0.153540052403778,0.00734528409072917,-0.167936809221607,-0.139143295585948,2.53140489210631e-96
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAST,Gastrin,24845,-0.191355680542245,0.00916511200214805,-0.209319300066455,-0.173392061018034,5.58995357688316e-96
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,-0.0403728100514507,0.00193538037697981,-0.0441661555903311,-0.0365794645125703,6.0312784744237e-96
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,29694,-0.0633044615319394,0.00304266769815168,-0.0692680902203167,-0.0573408328435621,1.85261615046114e-95
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,29278,-0.040054652199895,0.00193052226824394,-0.0438384758456531,-0.0362708285541368,6.1623519177099e-95
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,29434,-0.0893335362846419,0.00430999627915118,-0.0977811289917782,-0.0808859435775056,9.40374536649482e-95
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,-0.0982832740913898,0.0047583194297302,-0.107609580173661,-0.0889569680091186,4.23934129901909e-94
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,24381,-0.0666610973956317,0.0032264143104083,-0.0729848694440319,-0.0603373253472314,4.9724540895175e-94
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,29581,-0.0966650743767211,0.00468453612509599,-0.105846765181909,-0.087483383571533,6.13071347610314e-94
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,-0.0648793997030613,0.00314791604485273,-0.0710493151509727,-0.0587094842551499,1.41193558571347e-93
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,-0.0646262159671206,0.00314180175637266,-0.070784147409611,-0.0584682845246302,2.2853180193175e-93
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,24240,-0.0463209804408851,0.00225132660427271,-0.0507335805852596,-0.0419083802965106,2.88693316916051e-93
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,28477,-0.0577881824189915,0.00281811511487595,-0.0633116880441484,-0.0522646767938347,8.92966767716096e-93
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,24229,-0.0644606759581395,0.00314771021537154,-0.0706301879802678,-0.0582911639360113,2.02897931954571e-92
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29820,-0.0715817864326757,0.00350387074548508,-0.0784493730938265,-0.064714199771525,3.92773406760847e-92
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,29594,-0.0441830157428186,0.00216980391906988,-0.0484358314241956,-0.0399302000614416,1.5228997093889e-91
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.0364480692229328,0.00179186084522577,0.0329360219662903,0.0399601164795753,2.38444156997473e-91
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MLN,Promotilin,29434,-0.126712194966651,0.00623545217850928,-0.138933681236529,-0.114490708696773,3.53029514107395e-91
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,24381,-0.0613743658806657,0.00301968455302801,-0.0672929476046006,-0.0554557841567308,4.42347766727012e-91
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,29163,-0.0882947925137759,0.00435257656626485,-0.096825842583655,-0.0797637424438968,7.31109858298004e-91
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,29595,-0.0967327593414422,0.00476983978555174,-0.106081645321124,-0.0873838733617608,8.00297581507455e-91
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",29454,-0.133644146755826,0.00659965589231786,-0.146579472304769,-0.120708821206883,1.4672010054375e-90
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,24922,-0.0376193331181731,0.00186064719242278,-0.0412662016153217,-0.0339724646210244,3.57137884061417e-90
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28797,-0.155884734702763,0.00773116856204782,-0.171037825084376,-0.140731644321149,8.61441898673334e-90
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,29434,-0.0854629874095327,0.00424013625304602,-0.0937736544655029,-0.0771523203535625,9.68902183519807e-90
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,-0.0845706442872025,0.00419666779176583,-0.0927961131590635,-0.0763451754153415,1.3540737344725e-89
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,29349,-0.0736150433701386,0.00366698070087604,-0.0808023255438556,-0.0664277611964215,4.83424543021598e-89
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,29478,-0.108343630602543,0.00541247654858638,-0.118952084637773,-0.097735176567314,1.50920813979586e-88
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,29674,-0.0396957533673637,0.00198336741958543,-0.0435831535097512,-0.0358083532249763,1.58940865202148e-88
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,29443,-0.0524943751425961,0.00262519786395216,-0.0576397629559423,-0.0473489873292498,2.29200845562749e-88
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSN,Gelsolin,24845,0.0268770225521145,0.00134558007058075,0.0242396856137762,0.0295143594904527,4.53586110358443e-88
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,29443,0.037706262840386,0.00189096339642749,0.0339999745833881,0.0414125510973839,6.94235280576234e-88
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,0.0276486086103673,0.00138749467205376,0.0249291190531419,0.0303680981675926,9.0511441197488e-88
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,24653,-0.0383593112215164,0.00192380107589103,-0.0421299613302628,-0.03458866111277,9.14103716909114e-88
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29757,0.0868635561205001,0.00436377008330269,0.0783105667572268,0.0954165454837734,1.35441311780753e-87
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,-0.102631928705216,0.0051596307380831,-0.112744804951859,-0.0925190524585735,1.83795885875746e-87
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,29820,-0.0848630563414587,0.0042667582839782,-0.093225902578056,-0.0765002101048614,1.86060659980445e-87
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28774,-0.0389957322456796,0.00196142748728559,-0.0428401301207593,-0.0351513343705998,2.28491510518806e-87
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,-0.0386124425409207,0.00194243970020448,-0.0424196243533215,-0.0348052607285199,2.35008058035081e-87
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,24938,-0.0352898096743089,0.00178203990606035,-0.0387826078901872,-0.0317970114584306,1.29995299075328e-86
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,29218,-0.0530055609335658,0.00267874477103793,-0.0582559006848001,-0.0477552211823314,1.41131567261724e-86
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,29581,-0.0563393529880468,0.00285118766741773,-0.0619276808161856,-0.0507510251599081,2.37906714526712e-86
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,-0.0604957790660577,0.00306361878298661,-0.0665004718807114,-0.0544910862514039,3.12561054936209e-86
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,24229,-0.11849923540932,0.00601533989429674,-0.130289301602142,-0.106709169216499,1.02205646184326e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,29349,-0.0934064453731204,0.00474931718521134,-0.102715107056135,-0.0840977836901062,1.46340013681411e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,29497,-0.0682792786298255,0.00349189460906595,-0.0751233920635947,-0.0614351651960562,1.3210570268153e-84
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEP,Leptin,29478,-0.0919091544798308,0.00471584452961852,-0.101152209757883,-0.0826660992017785,4.57199180942679e-84
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFI,Complement factor I,24966,-0.0273462134005727,0.00140319356640558,-0.0300964727907276,-0.0245959540104178,5.78561095967551e-84
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27939,-0.0546585868497015,0.00280641166836293,-0.0601591537196929,-0.0491580199797102,6.29198645901529e-84
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29443,-0.0479998990938666,0.0024690464849474,-0.0528392302043635,-0.0431605679833697,1.17186284593442e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,29443,-0.0724574656545123,0.00373112055499619,-0.0797704619423048,-0.0651444693667197,1.75180163658711e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,24938,-0.0509018909074429,0.00262279503637042,-0.0560425691787289,-0.0457612126361569,2.74910035115962e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29434,-0.0377564191470905,0.00194674891863146,-0.0415720470276082,-0.0339407912665729,2.84160853218082e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29542,0.0420302582769261,0.00217539206402892,0.0377664898314294,0.0462940267224228,1.16462948547272e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,29736,-0.0680841108276573,0.00352473001794873,-0.0749925816628368,-0.0611756399924778,1.26339465505984e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,29434,0.0627044050890904,0.00324941902540531,0.056335543799296,0.0690732663788848,1.83867378584117e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,24922,-0.0610011991923543,0.00315989086602556,-0.0671945852897644,-0.0548078130949443,1.9588283926279e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,29349,-0.168009895042323,0.00870835510659347,-0.185078271051246,-0.1509415190334,1.99744090674532e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,29566,-0.0443686083658049,0.00230005390324826,-0.0488767140161715,-0.0398605027154383,2.08548829857767e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EZR,Ezrin,29694,-0.0324314215031528,0.00168391769753837,-0.035731900190328,-0.0291309428159776,3.73145764734343e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,-0.10159884900907,0.00528714383370241,-0.111961650923126,-0.0912360470950128,1.05803356392758e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.0495489393270585,0.00258298802946961,-0.0546115958648189,-0.044486282789298,1.6231389621051e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,24229,-0.113122500814948,0.00589388493991044,-0.124674515297172,-0.101570486332723,1.7013730042178e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29683,-0.0844605029717472,0.00441707298023773,-0.0931179660130131,-0.0758030399304812,5.15523312361586e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,24845,-0.0636635862338409,0.00333104223888169,-0.070192429022049,-0.0571347434456328,7.61285972923949e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,-0.057034527804849,0.00298650061165363,-0.0628880690036901,-0.0511809866060078,8.13603481199152e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,29725,-0.0511126822537997,0.00267738060583426,-0.0563603482412349,-0.0458650162663646,9.22292120219401e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24867,-0.0839850936421382,0.00441025812595225,-0.0926291995690046,-0.0753409877152718,2.79727086118164e-80
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,29581,-0.0885352180514597,0.00466945995936561,-0.0976873595718163,-0.0793830765311031,1.07613579990138e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24793,-0.0926696085468815,0.00488618776981543,-0.10224653657572,-0.0830926805180432,1.2039470392786e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,-0.0769642912963417,0.00406255236696785,-0.0849268939355986,-0.0690016886570847,1.44310735600493e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,29335,-0.0610950344406895,0.00322703460187541,-0.0674200222603653,-0.0547700466210137,1.84469278656448e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,29694,-0.0491493036789804,0.00259768740296831,-0.0542407709887983,-0.0440578363691625,2.27352835457349e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,-0.0560116386942171,0.00296038508666405,-0.0618139934640786,-0.0502092839243556,2.28251791276514e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,29495,-0.0618274822007555,0.00326844213354765,-0.0682336287825089,-0.0554213356190021,2.46403253356647e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,24229,-0.10620142726792,0.0056130645634052,-0.117203033812194,-0.0951998207236453,2.89252220244532e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,29434,-0.0757099251434133,0.00400625261949455,-0.0835621802776226,-0.067857670009204,3.4961439900903e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,24240,-0.0800699955878355,0.0042463763670709,-0.0883928932672944,-0.0717470979083765,9.60428517862042e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,29786,-0.0553900580614404,0.00294626222197725,-0.0611647320165158,-0.049615384106365,2.1462841945547e-78
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,23389,-0.0323286982276144,0.00171973075484631,-0.0356993705071131,-0.0289580259481156,2.9258537053999e-78
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,24793,-0.0589359745748826,0.0031362027753202,-0.0650829320145102,-0.052789017135255,3.06708116889624e-78
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29434,-0.0863230240222252,0.00460118345931655,-0.0953413436024856,-0.0773047044419647,4.49581498001124e-78
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,24240,-0.0797685016501507,0.00425165800702861,-0.0881017513439268,-0.0714352519563747,5.54757419909165e-78
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29434,-0.0741103394818839,0.00395327683641351,-0.0818587620812544,-0.0663619168825134,5.88502861630689e-78
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,-0.0555196075708732,0.00296927154016264,-0.061339379789592,-0.0496998353521545,1.44693925020128e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.0674108824180537,0.00360575647748126,-0.074478165113917,-0.0603435997221905,1.51610462763866e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,24381,-0.0301611162795154,0.00161250817322629,-0.0333216322990389,-0.0270006002599919,1.59045565740182e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,24381,-0.099404531521647,0.00533494361333652,-0.109861021003787,-0.0889480420395074,5.97965317341847e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,29301,-0.0337726331536266,0.00181452697311679,-0.0373291060209355,-0.0302161602863177,7.09098315412294e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,-0.0557084053540744,0.00299380987901475,-0.0615762727169433,-0.0498405379912054,7.65774159797703e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,29349,-0.0945280992446451,0.00509150606115632,-0.104507451124511,-0.0845487473647787,1.66817510233659e-76
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,29081,-0.0470821521795316,0.00254131045576458,-0.0520631206728302,-0.042101183686233,3.45596355307855e-76
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,24922,-0.106258128863471,0.00575412088247799,-0.117536205793128,-0.094980051933814,1.23112975134174e-75
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,24966,-0.040376379776221,0.00219385635446934,-0.0446763382309809,-0.0360764213214611,3.81704573560786e-75
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,29293,-0.0916181398228019,0.00498752107741369,-0.101393681134533,-0.081842598511071,6.08736879196593e-75
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,-0.109404970407414,0.00596451167732132,-0.121095413294964,-0.0977145275198643,1.21071763759089e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,29566,-0.117408950373582,0.00640693603099831,-0.129966544994339,-0.104851355752826,1.34805570692412e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,24845,-0.0489139610694475,0.00266967549322068,-0.0541465250361601,-0.043681397102735,1.71024892934309e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,24240,-0.0398904517803541,0.00217837020139066,-0.0441600573750798,-0.0356208461856284,2.10818822534914e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,29349,-0.146054012667808,0.00798604627364458,-0.161706663364151,-0.130401361971465,2.63996894056818e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,29192,0.0362898640979516,0.00199072236214078,0.0323880482681557,0.0401916799277476,7.74430487879844e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,24922,-0.117342944192314,0.00643496203644969,-0.129955469783756,-0.104730418600873,8.2005078325601e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,-0.0345039329894983,0.00189361736963059,-0.0382154230339743,-0.0307924429450224,8.89509267958343e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,24922,-0.0878791594553296,0.00482461451553937,-0.0973354039057868,-0.0784229150048725,1.18626686172184e-73
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,29409,-0.0589608182258217,0.0032455523210135,-0.0653221007750082,-0.0525995356766352,2.3910669792518e-73
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,24938,0.0757665811934379,0.00416959530067754,0.0675941744041099,0.0839389879827659,2.59682707157772e-73
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,29218,0.0433724819551481,0.00238834931906127,0.038691317289788,0.0480536466205081,2.71049156003072e-73
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,-0.0432820373301579,0.00238673036907515,-0.0479600288535452,-0.0386040458067706,4.2662991107282e-73
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,24922,-0.0722559040947656,0.00398252186166269,-0.0800616469436244,-0.0644501612459067,4.29490377706471e-73
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD248,Endosialin,24938,0.0512713763085197,0.00283476935787923,0.0457152283670764,0.056827524249963,1.1852200899382e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,29372,0.0801853954468904,0.00443912672766221,0.0714847070606725,0.0888860838331084,1.53259256935481e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29453,-0.0633245243716382,0.00350618764688587,-0.0701966521595345,-0.0564523965837419,1.599849405432e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,28765,-0.0502081153948052,0.00278059085472273,-0.0556580734700617,-0.0447581573195486,1.76082483252829e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,29642,-0.051649346527595,0.00286223103528381,-0.0572593193567512,-0.0460393736984387,2.10562585932889e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,29218,-0.111708444247494,0.00621458159697994,-0.123889024177574,-0.0995278643174128,7.43904150899892e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,29468,0.0486978594479325,0.00271339248162536,0.0433796101839468,0.0540161087119182,1.21592480417639e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,-0.0882435796002575,0.00491910942252857,-0.0978850340684135,-0.0786021251321015,1.701288275246e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,-0.0479128050537415,0.00267595480451362,-0.0531576764705882,-0.0426679336368948,2.5578040808069e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,24951,-0.0308691072621924,0.0017233981229915,-0.0342469675832558,-0.0274912469411291,2.672536293635e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,28931,-0.106747302228893,0.00597438443577049,-0.118457095723003,-0.0950375087347824,5.09417886497503e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,24938,-0.141830657485314,0.00794989327772566,-0.157412448309656,-0.126248866660971,9.43132401545264e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0325758802650331,0.00182700244587089,0.0289949554711261,0.0361568050589401,9.61322850396051e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,24805,-0.134328078058117,0.00753914492058461,-0.149104802102462,-0.119551354013771,1.42729316734824e-70
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29349,-0.105517028989297,0.00593740133244181,-0.117154335600883,-0.0938797223777107,2.74337079453268e-70
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,29454,-0.0328587972610839,0.00185406915701478,-0.0364927728088329,-0.0292248217133349,6.48987944824054e-70
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,29628,0.0345591745313311,0.00195437757308306,0.0307285944880883,0.0383897545745739,1.29459444778643e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,29725,-0.0804841441376665,0.00455472202288965,-0.0894113993025302,-0.0715568889728028,1.60704607187562e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,29218,-0.0826673487195666,0.0046896291590257,-0.091859021871257,-0.0734756755678762,3.44923243158192e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,29218,-0.0423778372701802,0.00240477858193239,-0.0470912032907677,-0.0376644712495927,3.78763394600494e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29581,-0.0505148247161856,0.00286775201964575,-0.0561356186746913,-0.0448940307576799,4.28010371761043e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,-0.110468967144085,0.00627126333579207,-0.122760643282238,-0.0981772910059327,4.30475484660437e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,-0.0347130257658199,0.00197375254478916,-0.0385815807536067,-0.0308444707780332,6.93500938630517e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,29480,0.064744183476117,0.00368873619240063,0.0575142605390117,0.0719741064132222,1.28730017311355e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29478,-0.0394957303435578,0.00225352948654442,-0.0439126481371849,-0.0350788125499308,2.01386406309315e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,28774,-0.0755632043214882,0.00431448096143462,-0.0840195870059001,-0.0671068216370764,2.54353234841478e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,29349,-0.0375651449932258,0.0021469750649104,-0.0417732161204501,-0.0333570738660014,3.36861011148738e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,29443,-0.0395756406978364,0.0022642469433503,-0.044013564706803,-0.0351377166888698,4.61510373380527e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,29786,-0.0927401111543186,0.0053118370177866,-0.10315131170918,-0.0823289105994569,6.39878279695219e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,-0.0369265093550862,0.00211525254958551,-0.0410724043522738,-0.0327806143578986,7.72253110019923e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,24922,-0.0420559919685557,0.00241337907432423,-0.0467862149542312,-0.0373257689828803,1.31569125841463e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,-0.0595689189498416,0.00342201267339023,-0.0662760637896864,-0.0528617741099967,1.59915919322323e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,-0.0341713458606763,0.00196389203913484,-0.0380205742573806,-0.030322117463972,1.80749145779117e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,-0.0730767963952264,0.00419989933143698,-0.0813085990848429,-0.0648449937056099,2.08973012044351e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,-0.0354031312757329,0.00203598705626632,-0.0393936659060149,-0.0314125966454509,2.56421590579302e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,28868,-0.0467064022206837,0.0026878971913768,-0.0519746807157822,-0.0414381237255851,2.73538828577867e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TTR,Transthyretin,24707,-0.0310983818017413,0.00178916166948069,-0.0346051386739234,-0.0275916249295591,2.86476291427625e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,29030,-0.051857644495333,0.00299044789285505,-0.0577189223653289,-0.0459963666253371,5.01863117957486e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,29536,-0.0701797135810075,0.0040579366998763,-0.078133269512765,-0.06222615764925,1.1051038473959e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,29491,-0.0483079448135883,0.00279634299453543,-0.0537887770828778,-0.0428271125442989,1.5339465717908e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,28347,-0.038235944597932,0.00221834597938298,-0.0425839027175227,-0.0338879864783414,3.09278284098869e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDK,Midkine,29455,-0.0615367948390407,0.0035714516365423,-0.0685368400466636,-0.0545367496314178,3.33180595332026e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,29725,-0.0485271599861897,0.00281672634493205,-0.0540479436222565,-0.0430063763501228,3.42337387192966e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,28795,-0.0601295066552233,0.0034946959100092,-0.0669791106388413,-0.0532799026716053,5.13127104059133e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,24820,-0.132538454126058,0.00770166546174128,-0.147633718431071,-0.117443189821045,5.49021483645607e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RETN,Resistin,29362,-0.0510034151397619,0.00296648756642029,-0.0568177307699457,-0.0451890995095781,6.28582742296767e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,24867,-0.0702733430739936,0.00408716947223625,-0.0782841952395766,-0.0622624909084105,7.12984690499983e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,29694,-0.0417042842474081,0.00242914839999425,-0.0464654151113969,-0.0369431533834194,9.54002364400734e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,29434,-0.0408400186537136,0.00238899654233562,-0.0455224518766914,-0.0361575854307358,3.33865026901567e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,-0.0858738652306155,0.00502553826559888,-0.0957239202311893,-0.0760238102300417,3.8566220087243e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,-0.0367259635302843,0.00215027590082625,-0.0409405042959037,-0.0325114227646648,4.31306333263151e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29443,0.0629288621527241,0.00368563933946848,0.0557050090473659,0.0701527152580823,4.76596542377089e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,24381,-0.0630298256748936,0.00369325838878101,-0.0702686121169044,-0.0557910392328828,6.32058587095358e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,28797,-0.0565003043879293,0.00331334868486383,-0.0629944678102624,-0.0500061409655962,7.00159322362055e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,28797,-0.0888514734877708,0.00522803585556297,-0.0990984237646743,-0.0786045232108674,1.84007046915667e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,-0.0493770493333894,0.00290546363268283,-0.0550717580534478,-0.0436823406133311,1.85459556059835e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,-0.0602775895284064,0.00354525364414738,-0.0672262866709353,-0.0533288923858775,1.87438824577419e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,-0.116218718834165,0.00684098990303056,-0.129627059044105,-0.102810378624225,2.02963748745833e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,24229,-0.111728978826596,0.0065735959392656,-0.124613226867557,-0.0988447307856357,2.05694005878977e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,29400,-0.109468735045652,0.00644953672825283,-0.122109827033028,-0.0968276430582764,2.63163284198804e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28797,-0.0588295016801654,0.00347984409248805,-0.065649996101442,-0.0520090072588889,8.29354872225186e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,29434,-0.0695983152460071,0.00412146152605648,-0.0776763798370778,-0.0615202506549364,1.12341474590198e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,-0.0448903045452364,0.00265854905173885,-0.0501010606866446,-0.0396795484038283,1.16667564291414e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,29678,-0.0322496798821098,0.00191074225234261,-0.0359947346967013,-0.0285046250675183,1.29298161971359e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,29694,-0.0267445496011614,0.00158634167482466,-0.0298537792838177,-0.0236353199185051,1.7722934566889e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24793,-0.0946101992760847,0.00561382000291035,-0.105613286481789,-0.0836071120703804,2.24610024911728e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,29694,0.0442304182795745,0.00262614774861758,0.039083168692284,0.0493776678668649,2.35385993908596e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,0.0399601515081701,0.00237340958430048,0.0353082687229412,0.0446120342933991,2.60193631873922e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,-0.0823790406485002,0.00489908185982232,-0.0919812410937519,-0.0727768402032484,4.30707411682303e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29536,-0.061338239607047,0.00365593899770576,-0.0685038800425503,-0.0541725991715437,6.95478248953188e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,29218,-0.0611456020351083,0.00365667896682423,-0.0683126928100838,-0.0539785112601328,1.7819744631703e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,-0.0240815572755045,0.0014403491274515,-0.0269046415653094,-0.0212584729856995,1.83224874148456e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,-0.0959816641366648,0.00573937364070118,-0.107230836472439,-0.0847324918008905,1.94851018871337e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29704,-0.0960516253251745,0.00574665494238786,-0.107315069012255,-0.0847881816380943,1.98897533407866e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,24805,-0.115192868593024,0.00690274976499252,-0.12872225813241,-0.101663479053639,3.50418823168104e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,-0.0937787071412125,0.00562150320829639,-0.104796853429473,-0.0827605608529516,3.85436694410529e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28862,-0.0615468832393081,0.00369364078803022,-0.0687864191838473,-0.0543073472947689,4.75736065521252e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,29820,0.0319457373535617,0.00191852288843104,0.0281854324922368,0.0357060422148865,5.65413342157765e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29581,-0.0309873892135595,0.00186116592210951,-0.0346352744208942,-0.0273395040062249,5.85204377610081e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29394,-0.0351834961586264,0.00211456527230852,-0.0393280440923511,-0.0310389482249017,7.02687071292902e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,28797,-0.0747737244930664,0.00449813369935151,-0.0835900665437954,-0.0659573824423375,9.18168989436637e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANG,Angiogenin,29435,-0.0394132058200323,0.00237247273407735,-0.0440632523788239,-0.0347631592612407,1.0777690852565e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,29566,-0.0623861598563002,0.00376696335538983,-0.0697694080328643,-0.0550029116797362,2.50543257326289e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,-0.0600839383173244,0.00363052975424972,-0.0671997766356539,-0.052968099998995,3.09389716009749e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,24111,-0.0726902100967774,0.00440148275368927,-0.0813171162940083,-0.0640633038995464,6.19682399361259e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,28797,-0.0731811118618809,0.00443356763402075,-0.0818709044245616,-0.0644913192992003,6.31872222719685e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,29820,-0.0473953185457654,0.00287180924087808,-0.0530240646578864,-0.0417665724336444,6.44015303437474e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASPN,Asporin,24922,0.0321034147385858,0.00194468087086564,0.0282918402316891,0.0359149892454824,6.73660850961012e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,29286,-0.0532822832276761,0.00323028827787009,-0.0596136482523015,-0.0469509182030507,7.55635065736959e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,29820,-0.0652544540068973,0.00396706719178661,-0.0730299057027991,-0.0574790023109956,1.57579358957176e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,24381,-0.0359132991396742,0.00218510472784041,-0.0401961044062414,-0.0316304938731069,2.25228210361814e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,29319,-0.091073999146303,0.00555171601168211,-0.1019553625292,-0.0801926357634061,3.2880925779635e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,29265,-0.0265044001668982,0.00161987102151009,-0.029679347369058,-0.0233294529647384,6.59169708534384e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,29478,0.059233315045836,0.00362132601287007,0.0521355160606106,0.0663311140310613,7.14693566603974e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24867,-0.0445295532530616,0.00272170259864044,-0.0498640903463969,-0.0391950161597264,7.4773005588461e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28931,-0.0806229019757027,0.00493104717031586,-0.0902877544295218,-0.0709580495218836,8.06738541376992e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28586,-0.0441951961926492,0.00270390280659541,-0.0494948456935762,-0.0388955466917222,8.82891216883015e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,29082,-0.0540422981373789,0.00330780477168149,-0.0605255954898746,-0.0475590007848831,9.812454888297e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,29694,-0.0663383250580001,0.00406262424068705,-0.0743010685697467,-0.0583755815462534,1.11936370749414e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,24905,0.0396795729243575,0.00243275320655998,0.0349113766394999,0.044447769209215,1.69061635641536e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,29343,-0.0353603434049242,0.00216958546867388,-0.039612730923525,-0.0311079558863234,1.85630325914653e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,29443,0.0460819492025333,0.00282857336849313,0.0405379454002868,0.0516259530047798,2.06222806625941e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,-0.0587836788816316,0.00361064813282343,-0.0658605492219655,-0.0517068085412977,2.75139033976307e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,-0.0990133156802544,0.006086550301384,-0.110942954270967,-0.0870836770895418,3.09715940919708e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,-0.0476549539005652,0.00293798080826014,-0.0534133962847551,-0.0418965115163753,6.56009836974688e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,28931,-0.0540230515182357,0.003333239000202,-0.0605561999586317,-0.0474899030778398,8.12922329437863e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,29581,-0.0484378812054395,0.00298903398361719,-0.0542963878133292,-0.0425793745975498,8.31058875946526e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,24445,-0.147102325898545,0.00909274432214329,-0.164924104769946,-0.129280547027144,1.45404075424485e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,-0.124481763330274,0.00770333156895932,-0.139580293205434,-0.109383233455114,1.94149130381987e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,-0.0377583683082274,0.00234081570420426,-0.0423463670884677,-0.033170369527987,2.77924760983752e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,29434,-0.0569712727458823,0.00354088053322582,-0.0639113985910049,-0.0500311469007597,5.3410355274729e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28797,-0.0725186780211453,0.00450728384472197,-0.0813529543568004,-0.0636844016854902,5.43962408965241e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,28774,-0.0729064098016548,0.00453379266025185,-0.0817926434157484,-0.0640201761875612,6.24033068823659e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,29511,0.0418536629196278,0.00260483850531024,0.0367481794492198,0.0469591463900359,7.57311449378198e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,28774,-0.0641625909353592,0.00399668990716683,-0.0719961031534062,-0.0563290787173122,9.56771929003774e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,29694,-0.0887965825000658,0.00553309475222133,-0.0996414482144196,-0.0779517167857119,1.02889686034123e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,28774,-0.0957494476718033,0.00597475179661885,-0.107459961193176,-0.0840389341504303,1.50189329893116e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,29135,-0.038720893422888,0.00241732882056519,-0.0434588579111957,-0.0339829289345802,1.68415494323574e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,-0.0592994658526916,0.00370491739689409,-0.0665611039506041,-0.0520378277547792,2.30028006058523e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29375,-0.0416583613211529,0.00260474641881892,-0.0467636643020379,-0.0365530583402678,2.48851397495728e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,-0.0688447816558635,0.00430853955096733,-0.0772895191757594,-0.0604000441359675,3.13461930491938e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,24240,-0.0818338107428644,0.00512611297491372,-0.0918809921736953,-0.0717866293120335,4.44508401707626e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,28797,-0.0682434076584474,0.00428161783550331,-0.0766353786160339,-0.0598514367008609,5.98673171340901e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,24919,-0.0630208911383754,0.00396429108350954,-0.0707909016620541,-0.0552508806146967,1.26013946085096e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,-0.0863738362759885,0.00543641732365311,-0.0970292142303486,-0.0757184583216284,1.45557879847121e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,24793,-0.111220364471473,0.00700684577325453,-0.124953782187052,-0.0974869467558938,1.84777163240016e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,-0.156701904607011,0.00988037272034028,-0.176067435138878,-0.137336374075144,2.27398594710092e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,-0.0492685035385608,0.00310887467809288,-0.0553618979076228,-0.0431751091694987,2.78387701523471e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29820,-0.0745870205811334,0.00471131827767341,-0.0838212044053733,-0.0653528367568935,3.20170277593961e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,28797,-0.052488591703403,0.0033155263648249,-0.0589870233784598,-0.0459901600283462,3.27775584621487e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,29218,-0.0588611066924323,0.00371863704758428,-0.0661496353056975,-0.0515725780791671,3.38131498338322e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,24644,-0.0355743721151258,0.00224912899548335,-0.0399826649462731,-0.0311660792839784,4.49046970440217e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,29434,-0.0817654122475792,0.00517338522881122,-0.0919052472960492,-0.0716255771991093,4.88892659532297e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,-0.0357960179907424,0.00226715493530453,-0.0402396416639393,-0.0313523943175455,6.26044277253222e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,-0.108470581898796,0.00687217476070811,-0.121940044429784,-0.0950011193678084,7.61053247838943e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,-0.0827690388701788,0.00524919498333879,-0.0930574610375229,-0.0724806167028348,9.82542560326029e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,-0.0661408501220111,0.00419816846057853,-0.074369260304745,-0.0579124399392772,1.08759915193223e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,29434,-0.0474810911165587,0.00301562511696674,-0.0533917163458136,-0.0415704658873039,1.25418517134271e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,24752,-0.0483326402046006,0.0030694768677938,-0.0543488148654764,-0.0423164655437247,1.35837721065606e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,-0.0636959783112408,0.00404950316836266,-0.0716330045212316,-0.0557589521012499,1.60254218707226e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,29786,-0.0416318091239106,0.00264792720087776,-0.046821746437631,-0.0364418718101902,1.77632815542664e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,-0.0485808699299107,0.00309659961095179,-0.0546502051673762,-0.0425115346924452,3.05101729895504e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,-0.114549322142428,0.00730469509776339,-0.128866524534045,-0.100232119750812,3.7221558985429e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29673,-0.0467406693069297,0.00298182849086381,-0.0525850531490228,-0.0408962854648366,3.72484028935155e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,29478,-0.0397719063462259,0.00253898290713129,-0.0447483128442032,-0.0347954998482486,4.41416498286623e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,24229,-0.0508873388843619,0.00324761615902496,-0.0572526665560508,-0.044522011212673,4.58579944250248e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,29694,-0.0649866474312463,0.00416538702847047,-0.0731508060070484,-0.0568224888554441,1.17120156902826e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29820,-0.0349107564962836,0.00224140899784829,-0.0393039181320663,-0.030517594860501,1.75607432024356e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,-0.0949963945363564,0.00610201845361039,-0.106956350705433,-0.0830364383672801,2.17097458852699e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,24938,-0.0256060141696104,0.00164539376094184,-0.0288309859410564,-0.0223810423981644,2.36920642166906e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,29434,-0.0915598990531388,0.00588752454568242,-0.103099447162676,-0.0800203509436012,2.55800917740511e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,24229,-0.135248091780991,0.00870252270395221,-0.152305036280738,-0.118191147281245,3.33416133247163e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COCH,Cochlin,24922,-0.0507666448902095,0.00326716500094934,-0.0571702882920702,-0.0443630014883487,3.42465436082331e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFH,Complement factor H,23693,-0.0256902428251537,0.00165536970264505,-0.028934767442338,-0.0224457182079694,4.74005764315878e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,29694,-0.0571842438115368,0.00368982840477491,-0.0644163074848956,-0.049952180138178,5.84344347478134e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAYN,Layilin,29163,-0.0380208845437779,0.0024584954386805,-0.0428395356035917,-0.0332022334839641,9.76093588491393e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,29624,-0.0738097538302392,0.00477512688612417,-0.0831690025270425,-0.0644505051334358,1.09524915956035e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,0.0414492863836303,0.00268429568244252,0.036188066846043,0.0467105059212177,1.39586624362101e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,29443,-0.0486205792700801,0.00314868784491461,-0.0547920074461127,-0.0424491510940474,1.39638645094563e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24867,-0.0574977661031102,0.00372454757860383,-0.0647978793571737,-0.0501976528490467,1.622950736393e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,-0.025413127287368,0.00164841926754079,-0.0286440290517479,-0.022182225522988,2.04653302965277e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,-0.107089969835725,0.00695347837494108,-0.120718787450609,-0.0934611522208404,2.59169672175837e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,29349,-0.0754637838069838,0.00490743258443408,-0.0850823516724746,-0.065845215941493,3.74037814523418e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,29435,-0.0428572600158271,0.00279033808250714,-0.0483263226575411,-0.0373881973741131,4.94168996532676e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,-0.0483292569732,0.00314754610882787,-0.0544984473465026,-0.0421600665998974,5.30779540644845e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,29434,0.0469974308051562,0.00306265529598771,0.0409946264250203,0.0530002351852921,6.10696850379532e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,29786,-0.0529886043254043,0.00345871511125136,-0.059767685943457,-0.0462095227073516,8.89863671758504e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,29478,-0.0262610996280949,0.0017141972475735,-0.029620926233339,-0.0229012730228509,9.01698586375246e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28774,-0.0659521450062814,0.00430507627636045,-0.0743900945079479,-0.0575141955046149,9.14035791865811e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,28424,-0.0987467338679717,0.00645096448035893,-0.111390624249475,-0.0861028434864682,1.10984710279926e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,24195,-0.130626151986162,0.00854483589467282,-0.147374030339721,-0.113878273632603,1.64017148534229e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,29786,-0.101218992976534,0.0066264204847478,-0.11420677712664,-0.0882312088264287,1.7736975704463e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,-0.0338988231763875,0.00221930000767388,-0.0382486511914283,-0.0295489951613466,1.95712081950408e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,-0.0365143152906182,0.00239321880693558,-0.041205024152212,-0.0318236064290245,2.33053349267747e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,-0.0924949425402816,0.0060666536078882,-0.104385583611742,-0.0806043014688207,2.75107008985184e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,28705,-0.0745989988418696,0.00489569395329268,-0.0841945589903232,-0.0650034386934159,3.18505461160226e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,28990,0.0322071303174764,0.00211379063558157,0.0280641006717365,0.0363501599632163,3.21919936315385e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,24938,-0.0302900201483483,0.00198811434123466,-0.0341867242571682,-0.0263933160395284,3.53055052184853e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,24922,-0.0336826806169017,0.00221100963109579,-0.0380162594938495,-0.029349101739954,3.61190423795522e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,24111,-0.0392781204208289,0.002578663055678,-0.0443323000099578,-0.0342239408317,3.79695264726826e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,24381,-0.0322977503830595,0.00212269689459876,-0.036458236296473,-0.0281372644696459,4.84773698408392e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,29218,0.0275320451916809,0.00181094634076356,0.0239825903637843,0.0310815000195775,5.33451275673031e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,-0.0677721166353947,0.0044563014383164,-0.0765064674544948,-0.0590377658162945,5.35720852633091e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29566,-0.0358915271033668,0.00236142042981752,-0.0405199111458091,-0.0312631430609245,5.63732104644101e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,-0.10486105555005,0.00689744288333812,-0.118380043601393,-0.0913420674987072,5.79866336376876e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NADK,NAD kinase,29478,-0.0578283920730535,0.00380683524997232,-0.0652897891629992,-0.0503669949831077,6.41563832290654e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,-0.0209185765266433,0.00137869685321401,-0.0236208223589428,-0.0182163306943438,8.53583117601317e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,29349,-0.0348637991254039,0.00229975757005124,-0.0393713239627043,-0.0303562742881034,1.02576195540591e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,29218,-0.055530244886901,0.00366307236951129,-0.0627098667311431,-0.0483506230426589,1.0324833184898e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,29594,0.0322669018814959,0.00212991761764929,0.0280922633509033,0.0364415404120885,1.19585568862006e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,29169,-0.054619921608644,0.00360621279201208,-0.0616880986809876,-0.0475517445363003,1.26518492798344e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,-0.036849039885708,0.00243525114332148,-0.0416221321266181,-0.0320759476447979,1.57130754609303e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,28797,-0.0595075075526127,0.00393664817694732,-0.0672233379794295,-0.051791677125796,1.99357950238858e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,24111,-0.0722154995829363,0.0047782533532882,-0.0815808761553812,-0.0628501230104914,2.27456270804298e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,29466,-0.0564186029909399,0.00373516969876609,-0.0637395356005215,-0.0490976703813584,2.34952941463656e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29581,-0.041046458604465,0.0027235241098147,-0.0463845658597019,-0.0357083513492282,3.88826125042444e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29736,-0.0345157884844296,0.00229577274555795,-0.0390155030657232,-0.030016073903136,6.71698796570962e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,24240,-0.0544981021997946,0.00362453145003155,-0.0616021838418565,-0.0473940205577328,7.24902507491185e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,-0.0404304667679092,0.00269141434643605,-0.0457056388869238,-0.0351552946488945,8.13262391745148e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,29169,-0.048460859238674,0.00322595375801092,-0.0547837286043754,-0.0421379898729726,8.14551789341008e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,29169,-0.0545558154454402,0.00363357126078993,-0.0616776151165884,-0.0474340157742919,9.1544950499959e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28774,-0.0537916925494273,0.00358404377576668,-0.06081641834993,-0.0467669667489246,1.00320472068797e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,29443,-0.0586874824987557,0.00391363901789704,-0.0663582149738339,-0.0510167500236775,1.20686794818154e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,-0.056964786963105,0.0038073618767395,-0.0644272162415144,-0.0495023576846956,2.00429281765674e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,-0.0605304553708182,0.00404590061972936,-0.0684604205854877,-0.0526004901561487,2.0326172611857e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,24804,-0.062150208299704,0.00415585028135539,-0.0702956748511606,-0.0540047417482475,2.40078984408026e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,29725,-0.040399141968501,0.00270424890556434,-0.0456994698234071,-0.0350988141135949,2.79242294251396e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,29581,-0.049816037726972,0.00333629265809995,-0.0563551713368479,-0.0432769041170961,3.13247063113919e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,24557,-0.0251859465430064,0.00168784190035777,-0.0284941166677077,-0.0218777764183052,3.93501788039761e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,29349,-0.0774449450980852,0.00519516898170306,-0.0876274763022232,-0.0672624138939472,4.52104037684836e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,-0.0282423543810627,0.00189700304129338,-0.0319604803419978,-0.0245242284201277,5.99557811908936e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,29566,0.0443022175609062,0.00297662193844685,0.0384680385615504,0.050136396560262,6.41034138035406e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,24938,-0.0428962595366385,0.00288188857149926,-0.0485447611367771,-0.0372477579365,6.78219946252716e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,24381,0.0545888147515669,0.00366995728659674,0.0473956984698373,0.0617819310332965,7.9849136352674e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",24101,-0.0766703659363598,0.00515756376352251,-0.086779190912864,-0.0665615409598557,9.16137336314152e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29443,0.0458386357599631,0.0030851164437332,0.039791807530246,0.0518854639896801,9.35728526276282e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0386864736266459,0.00260444891370365,0.0335817537557868,0.0437911934975051,1.07164766240931e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,29694,-0.099969416320628,0.00673731043343481,-0.11317454477016,-0.0867642878710957,1.25032865705962e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,24381,-0.0434646017506535,0.00292887359922425,-0.0492051940051331,-0.037724009496174,1.32945849330185e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,-0.072550463329362,0.00489332198055091,-0.0821413744112418,-0.0629595522474822,1.61060241407326e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,29443,-0.0532765788509784,0.00359723398936588,-0.0603271574701355,-0.0462260002318213,1.890889839972e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,0.0256692488804407,0.00173481548352473,0.0222690105327322,0.0290694872281492,2.30957195404972e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,29786,-0.0481896390581036,0.00326434543580411,-0.0545877561122797,-0.0417915220039276,3.81996189734107e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,-0.0866029844773442,0.00587231944364401,-0.0981127305868864,-0.0750932383678019,5.18288603917655e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,-0.0476335262795213,0.00323797513414634,-0.0539799575424481,-0.0412870950165944,8.18258748894791e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,-0.0794074341204339,0.00539856469956709,-0.0899886209315854,-0.0688262473092824,8.42573804977054e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBIN,Erbin,29349,-0.10595778147003,0.00720466351605648,-0.120078921961501,-0.0918366409785594,8.69659285636918e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GH1,Somatotropin,29433,0.183543316759471,0.0124909384180283,0.159061077460135,0.208025556058806,1.0466732467728e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,24892,0.0761218717680935,0.00518047953465255,0.0659681318801745,0.0862756116560125,1.1272882305628e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,29786,-0.048478060466176,0.00330243416636349,-0.0549508314322484,-0.0420052895001036,1.29063961498186e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,-0.0299159543921676,0.0020404173338888,-0.0339151723665897,-0.0259167364177456,1.67806434804303e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,-0.0432096827963356,0.00294737330774334,-0.0489865344795125,-0.0374328311131586,1.84326517131267e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,28797,-0.0575434271263182,0.00392743492033267,-0.0652411995701703,-0.0498456546824662,1.96523549198052e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,-0.0498067853145019,0.0033995947232623,-0.056469990972096,-0.0431435796569078,2.1197584252434e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.0606933230156554,0.00414921763830658,-0.0688257895867364,-0.0525608564445746,2.7739563049203e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,28797,-0.0418190967656109,0.00285959701845135,-0.0474239069217756,-0.0362142866094463,2.93739836339152e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29694,-0.069653712198077,0.00476431071042266,-0.0789917611905054,-0.0603156632056486,3.08702876078955e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,29395,-0.0852395731341073,0.00583884882329003,-0.0966837168277558,-0.0737954294404588,4.22071160747628e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,29478,-0.0892833600063714,0.00611642826591083,-0.101271559407557,-0.0772951606051862,4.30241170791355e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,-0.0512333697875036,0.00350964599985305,-0.0581122759472156,-0.0443544636277916,4.68471600713844e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,24966,-0.0313067932047276,0.00214626033507242,-0.0355134634614695,-0.0271001229479857,5.3833685297645e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,-0.098090069306419,0.00674244546621053,-0.111305262420192,-0.0848748761926464,8.85640695732556e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24788,-0.0443051142104467,0.00305069924959349,-0.05028448473965,-0.0383257436812435,1.3607649360854e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28774,-0.0806034973913817,0.00555614648326332,-0.0914935444985779,-0.0697134502841856,1.60861679728809e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,29566,-0.0579372482187662,0.00400609574092375,-0.0657891958709767,-0.0500853005665556,3.04238268557969e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,29694,-0.0290590337489487,0.00200939949365236,-0.0329974567565074,-0.0251206107413901,3.0693056327183e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,29536,-0.0305110224750757,0.00211143861251302,-0.0346494421556012,-0.0263726027945502,3.61467730152476e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29517,-0.0273856487726302,0.00189562761144108,-0.0311010788910548,-0.0236702186542057,3.80827321193682e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,-0.0644722303056166,0.00446420021485421,-0.0732220627267308,-0.0557223978845023,4.07648528417921e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,-0.115149680977134,0.00797412942923783,-0.130778974658441,-0.0995203872958283,4.50383219836693e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,29786,-0.0571712710866679,0.00396343815758797,-0.0649396098755403,-0.0494029322977955,5.21666173752158e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,29639,-0.058641084114207,0.00406534639962797,-0.0666091630574778,-0.0506730051709362,5.22940160157799e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29434,-0.107427999319391,0.00745848128974157,-0.122046622647285,-0.0928093759914977,7.10681565887352e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28916,-0.038202456912949,0.00265237720622765,-0.0434011162371552,-0.0330037975887428,7.19141611648096e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,24381,-0.118009533499424,0.00819772104424932,-0.134077066746153,-0.101942000252695,8.60622261666719e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,29434,-0.0959564871459758,0.00668518854507916,-0.109059456694331,-0.0828535175976206,1.45351702456065e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,29383,-0.0291204477094065,0.00203289940617398,-0.0331049305455075,-0.0251359648733055,2.20258593983926e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,-0.0730823165497544,0.00510033021085651,-0.0830789637630332,-0.0630856693364756,2.21198792224044e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,24867,-0.106070078265572,0.00740439621563261,-0.120582694848212,-0.0915574616829325,2.32752121342124e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,29349,-0.0849516103885339,0.00593690960926938,-0.0965879532227019,-0.0733152675543659,2.75070532856474e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,-0.0516739242316951,0.00361515106743659,-0.0587596203238708,-0.0445882281395194,3.40765196950157e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,29391,-0.0290147426753929,0.00203247247221778,-0.0329983887209398,-0.0250310966298461,4.43156438140553e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,-0.0297936783207253,0.00208721623965385,-0.0338846221504468,-0.0257027344910037,4.80484981857277e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,24813,-0.0748751185765674,0.00526164539465803,-0.0851879435500971,-0.0645622936030377,8.99334077278968e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,24793,-0.0362322742401841,0.0025473102783756,-0.0412250023858003,-0.0312395460945679,9.88234529723742e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,-0.0974007594955977,0.00685112971595267,-0.110828973738865,-0.0839725452523305,1.02253813313043e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,28835,-0.0386793737994226,0.00272180944113924,-0.0440141203040555,-0.0333446272947897,1.11889399226252e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,29218,-0.041796096270243,0.00294269313174252,-0.0475637748084584,-0.0360284177320277,1.23965295490666e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,23907,-0.0714185210971565,0.00502781821793785,-0.0812730448043147,-0.0615639973899983,1.31452948468031e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,-0.108330485280636,0.00762938835911434,-0.1232840864645,-0.0933768840967718,1.39969224760105e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,-0.0944465555890053,0.00665570261300797,-0.107491732710501,-0.0814013784675097,1.49095745932494e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,29694,-0.0458176301148892,0.00322938964262044,-0.0521472338144253,-0.0394880264153532,1.53861671391638e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,29594,-0.10025030236385,0.00707135540567917,-0.114110158958981,-0.0863904457687188,1.79354755983866e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,24240,-0.0403947464154588,0.00285037043943209,-0.0459814724767457,-0.0348080203541719,2.08163613209232e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24922,-0.0253305344138045,0.00178834307105041,-0.0288356868330633,-0.0218253819945456,2.2882209276196e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,29566,-0.0399569456811461,0.00282282423316598,-0.0454896811781514,-0.0344242101841407,2.44892049318957e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,29566,-0.0823180174820096,0.00582160638418673,-0.0937283659950156,-0.0709076689690036,3.02102913477251e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,-0.0531203114135832,0.0037597336050959,-0.0604893892795712,-0.0457512335475952,3.55963505024059e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,-0.0373313207323377,0.00264390418665017,-0.042513372938172,-0.0321492685265033,4.02955550094632e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,29786,0.00883099064656822,0.000626139476385148,0.00760375727285333,0.0100582240202831,5.0210717463075e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0391882863594225,0.00277982426507237,0.0337398307998806,0.0446367419189644,5.55444168565343e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,24845,-0.0628518921034047,0.00446071699347477,-0.0715948974106153,-0.0541088867961942,6.51108601223083e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,29434,-0.0849268034945606,0.00603585618820056,-0.0967570816234337,-0.0730965253656875,8.07333444742226e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,24805,-0.0996532212412549,0.0070878664270048,-0.113545439438184,-0.0857610030443255,9.98099159945974e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,0.0236685225485685,0.0016858477987533,0.020364260863012,0.026972784234125,1.24271672320456e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,24888,-0.0440984691360242,0.00314281328057702,-0.0502583831659551,-0.0379385551060932,1.47881393359557e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,24381,-0.0400641816023025,0.00286244165223043,-0.0456745672406741,-0.0344537959639308,2.43186170279648e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NBN,Nibrin,28931,-0.0516449702581487,0.00369204916254473,-0.0588813866167364,-0.044408553899561,2.56838928067003e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,29820,-0.0219342695012231,0.00156829198244252,-0.0250081217868104,-0.0188604172156357,2.61775590241562e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,-0.0789656355884235,0.00564829022891687,-0.0900362844371005,-0.0678949867397464,3.05074825569781e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,24805,-0.0757485717142536,0.00541844600460226,-0.086368725883274,-0.0651284175452331,3.05115280462788e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,29443,-0.0245998037817087,0.00176044958848551,-0.0280502849751403,-0.0211493225882771,3.12944481918972e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,24805,-0.0839180474749166,0.00603325628284755,-0.0957432297892978,-0.0720928651605354,8.13442368715696e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,29434,-0.0895665940433549,0.0064416296630224,-0.102192188182879,-0.076940999903831,8.20576427377858e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,29345,-0.0421727260186581,0.00303519570327296,-0.0481217095970731,-0.0362237424402431,9.40677569004824e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29632,-0.0707084360365545,0.00510692483113205,-0.0807180087055733,-0.0606988633675357,1.84783581038288e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELP,P-selectin,29594,-0.0553710857617183,0.00400159335360185,-0.0632142087347779,-0.0475279627886587,2.07446131597438e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,29566,-0.0291350365077056,0.00210570049147948,-0.0332622094710054,-0.0250078635444058,2.1036966991749e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,29434,-0.0890712778252331,0.00643840001597216,-0.101690541856538,-0.0764520137939276,2.1622853138405e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24845,-0.0291232151616263,0.00210576446818891,-0.0332505135192766,-0.0249959168039761,2.42531930689571e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,29434,-0.0381524032458082,0.00276405699782735,-0.0435699549615498,-0.0327348515300666,3.33216894129077e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,29820,-0.0242672573717862,0.00175837926698679,-0.0277136807350803,-0.0208208340084921,3.41736880001603e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24396,-0.0634709947600655,0.00460392180772793,-0.0724946815032123,-0.0544473080169188,4.47260999852608e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BSG,Basigin,29760,-0.0199322140110265,0.00144646874388118,-0.0227672927490336,-0.0170971352730194,4.56710134052231e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29349,-0.133202610021293,0.00966953830553285,-0.152154905100137,-0.114250314942449,4.87454401772527e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,29434,-0.0317681239033771,0.00230927271291662,-0.0362942984206936,-0.0272419493860605,6.30006318860648e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29786,-0.0537679145266526,0.00391159981286245,-0.0614346501598629,-0.0461011788934422,7.30180635360154e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.0234648575021693,0.00170705523294764,0.0201190292455919,0.0268106857587467,7.31113442731644e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,24805,-0.0821868132441222,0.00598558857543868,-0.093918566851982,-0.0704550596362624,9.52311290282148e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,-0.0644872794646027,0.00469990917418455,-0.0736991014460045,-0.055275457483201,1.0366258348778e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,-0.0561936143875364,0.00410618922144173,-0.0642417452615622,-0.0481454835135106,1.69452461621832e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,28870,-0.0481283925949472,0.00351795030339458,-0.0550235751896006,-0.0412332100002938,1.79447658530008e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,29443,-0.0374545376275596,0.00273916838127048,-0.0428233076548497,-0.0320857676002694,1.96602268067096e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,0.0406794002160958,0.00297643495511748,0.0348455877040655,0.046513212728126,2.15154860352679e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,29404,-0.019153801827979,0.00140191239804981,-0.0219015501281566,-0.0164060535278013,2.28757679824987e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGN,Mimecan,29443,-0.0405082345111703,0.00296557333556739,-0.0463207582488824,-0.0346957107734582,2.38642785571064e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,24845,-0.027051066272697,0.00198013646736875,-0.0309321337487398,-0.0231699987966543,2.46261110421178e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,-0.0719477292036251,0.00527092919828601,-0.0822787504322657,-0.0616167079749846,2.89769846957e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24381,-0.0375644869207767,0.00275284785151993,-0.0429600687097558,-0.0321689051317977,3.06320332799261e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,24801,-0.0310261644925985,0.00227442247684444,-0.0354840325472136,-0.0265682964379834,3.23031131279791e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,29434,-0.0818744756762183,0.00601027750055782,-0.0936546195773116,-0.0700943317751249,3.95599692892886e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,24101,-0.0383932586658463,0.00281829459005567,-0.0439171160623555,-0.0328694012693372,4.1950167665179e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24805,-0.0801880117888501,0.00588742913238179,-0.0917273728883184,-0.0686486506893818,4.30555926730216e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,29736,-0.0265125450489293,0.00194804443274138,-0.0303307121371024,-0.0226943779607562,4.68082694516991e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,29498,-0.0625008239789732,0.00459357259908515,-0.0715042262731801,-0.0534974216847663,4.93238284557171e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28797,-0.0321148417810217,0.00236122520232209,-0.036742843177573,-0.0274868403844704,5.33295932958386e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24845,-0.0305579403885978,0.00224885400877138,-0.0349656942457897,-0.0261501865314059,6.64264143282642e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,29581,0.0617350007442419,0.00454582958486245,0.0528251747579115,0.0706448267305723,6.97436621813595e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,28774,-0.0333287004887101,0.00245428226681216,-0.038139093731662,-0.0285183072457583,7.10427522105495e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,-0.0908369751324031,0.00668983924156301,-0.103949060045867,-0.0777248902189396,7.18967583464449e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,23906,-0.051382516600468,0.00378401750381078,-0.0587991909079371,-0.0439658422929989,7.64776669834426e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,29694,-0.0576890715133741,0.00426308241762692,-0.0660447130519228,-0.0493334299748253,1.34083138347253e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,29443,0.0245991197765756,0.00181835309440425,0.0210351477115433,0.0281630918416079,1.41880700449954e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,-0.0677128475060392,0.00500692960316716,-0.0775264295282468,-0.0578992654838315,1.50935121863016e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,29478,-0.0543408765702992,0.00401940216528694,-0.0622189048142616,-0.0464628483263368,1.59311328164477e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,28797,-0.0583943507072868,0.00432067827614634,-0.0668628801285336,-0.04992582128604,1.70556741094082e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,24381,-0.0484861971405209,0.00358860831735739,-0.0555198694425414,-0.0414525248385004,1.89596170875965e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,-0.0611920356899699,0.00453226399026699,-0.0700752731108932,-0.0523087982690466,2.16548984638722e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,29489,0.0261320493742075,0.00193780431603795,0.0223339529147732,0.0299301458336419,2.52868734714448e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,29786,-0.0833020264117885,0.00617952074312279,-0.0954138870683092,-0.0711901657552679,2.69928185582311e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,24240,-0.0703777891869185,0.00522079701373131,-0.0806105513338319,-0.0601450270400051,2.87888862780904e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,-0.0606965546604688,0.00450294396239709,-0.0695223248267671,-0.0518707844941705,2.8896668139046e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,28774,-0.054875078851201,0.00407267613304235,-0.062857524071964,-0.046892633630438,2.97022106395496e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,29227,-0.068635229247765,0.00509778627557031,-0.0786268903478828,-0.0586435681476471,3.39344834391828e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,-0.0422616668631728,0.00313905806207168,-0.0484142206648333,-0.0361091130615123,3.61312077508015e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,24966,-0.0162726101458316,0.00120892427045522,-0.0186421017159238,-0.0139031185757394,3.7235482234919e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,28916,-0.054863450616598,0.00407881102088008,-0.062857920217523,-0.0468689810156731,4.04783752103391e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,29694,-0.0342584046689214,0.00254863311866098,-0.0392537255814969,-0.0292630837563459,4.53253848305122e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,-0.038668830515929,0.00287593781497864,-0.0443056686332872,-0.0330319923985709,4.54726787481174e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,0.0251249308075489,0.00187042498237025,0.0214588978421032,0.0287909637729946,5.39999472477054e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29434,-0.0451452839265301,0.00336184548652693,-0.0517345010801229,-0.0385560667729373,5.42121634134075e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,24922,-0.0709281985133806,0.00528117771212049,-0.0812793068291368,-0.0605770901976245,5.57505760551993e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,29434,0.0496995141903895,0.00370467598820482,0.0424383492535081,0.056960679127271,6.48640159872058e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,29433,-0.0703882617420015,0.00525148739540006,-0.0806811770369856,-0.0600953464470174,7.6035076625142e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,29478,0.029337252824264,0.00218942285462788,0.0250459840291934,0.0336285216193347,8.0136039690936e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,28797,-0.0374210486646501,0.00279354692283452,-0.0428964006334058,-0.0319456966958944,8.51001748925286e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,29581,-0.117800527193835,0.00880861163115054,-0.13506540599089,-0.10053564839678,1.1367172364863e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,24793,-0.0201139787535347,0.00150422179447061,-0.0230622534706971,-0.0171657040363723,1.2245608892644e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,24867,-0.0500718682954103,0.00374579355228956,-0.0574136236578979,-0.0427301129329228,1.2937761047508e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,-0.0652349834387451,0.00488408434546706,-0.0748077887558605,-0.0556621781216297,1.50859715189026e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,29434,-0.0762224455623902,0.00571061154239317,-0.0874152441854808,-0.0650296469392996,1.60700126364669e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,-0.0258784385585419,0.00193982248054151,-0.0296804906204033,-0.0220763864966805,1.75601549040344e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,28916,-0.0683984276474096,0.00513389790432901,-0.0784608675398944,-0.0583359877549247,2.24152661962143e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,-0.0351018740756856,0.00263661167967289,-0.0402696329678444,-0.0299341151835267,2.68640962633789e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,29725,0.0431114605550618,0.00324830457354721,0.0367447835909092,0.0494781375192143,4.37766838826434e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,29328,-0.04002875268421,0.00302043830053744,-0.0459488117532634,-0.0341086936151566,5.67856095042234e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28774,-0.0624585289954731,0.00472014387275064,-0.0717100109860643,-0.0532070470048818,7.46638316621173e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,-0.0533237036903165,0.00403205793333096,-0.0612265372396452,-0.0454208701409878,8.22322256944029e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,29581,-0.0982637194644971,0.00743054594754465,-0.112827589521685,-0.0836998494073096,8.24389245323068e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,-0.0964210701719322,0.0072985253011889,-0.110726179762262,-0.0821159605816019,9.83522940158082e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,-0.0843780296953885,0.00638800509329625,-0.0968985196782492,-0.0718575397125279,1.06239852064376e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,-0.0366915504388565,0.00278063052080852,-0.0421415862596412,-0.0312415146180718,1.20481321783921e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24805,-0.0440106535533687,0.0033434611935979,-0.0505638374928205,-0.0374574696139168,1.93827672834785e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24793,-0.106004535841784,0.00806472244591533,-0.121811391835778,-0.0901976798477901,2.48737644395229e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,29163,-0.0740639449729853,0.00563991444588499,-0.0851181772869199,-0.0630097126590507,2.78758164704318e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,29478,-0.062921434879346,0.00479242416367369,-0.0723145862401465,-0.0535282835185456,2.88216862053206e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,-0.053932627543694,0.00411392660059802,-0.0619959236808661,-0.0458693314065219,3.92768810612745e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29426,-0.0899092149705766,0.0068640025472502,-0.103362659963187,-0.0764557699779662,4.31249164712443e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NGRN,Neugrin,24845,-0.02046832748337,0.00156792847833431,-0.0235414673009052,-0.0173951876658347,8.05450131039566e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,-0.0308238537362236,0.00236882166225991,-0.035466744194253,-0.0261809632781942,1.32804713769334e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,-0.0635191918357653,0.00488334654042036,-0.0730905510549892,-0.0539478326165414,1.42689652946034e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,24816,-0.0594203143240305,0.0045687234973169,-0.0683750123787716,-0.0504656162692893,1.51455950817761e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,29218,-0.0558835378233236,0.00429871877461595,-0.0643090266215709,-0.0474580490250763,1.5644090355343e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24951,-0.0581735897316708,0.00447575840503909,-0.0669460762055475,-0.0494011032577942,1.68669704392819e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,29760,-0.0481458059692759,0.00370562661144907,-0.0554088341277161,-0.0408827778108357,1.71518960970814e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HPSE,Heparanase,24688,-0.0862322549215126,0.00663781213332998,-0.0992423667028393,-0.0732221431401858,1.83881593773556e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,24845,-0.0811624932930075,0.00625098854039583,-0.0934144308321833,-0.0689105557538316,2.01311937003583e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,-0.0709282447497001,0.00548128514583394,-0.0816715636355346,-0.0601849258638656,3.55222398481584e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,0.0195162360310617,0.0015119843733406,0.0165527466593142,0.0224797254028093,5.1884720857834e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,24229,0.0296281979097698,0.00229598810751545,0.0251280612190395,0.0341283346005001,5.67707458713896e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,29820,0.0272820231540708,0.0021207789993168,0.0231252963154099,0.0314387499927317,9.02912442164752e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,29218,-0.0522607355757101,0.00406911634551319,-0.060236203612916,-0.0442852675385043,1.18672762375763e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,24867,-0.0574166992953617,0.00447274096187459,-0.0661832715806359,-0.0486501270100875,1.33931691592294e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORT1,Sortilin,29433,-0.0336227784860877,0.00262256813724803,-0.0387630120350938,-0.0284825449370815,1.58567418498408e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,29694,-0.0584821653802442,0.00457062260524686,-0.067440585686528,-0.0495237450739603,2.18913051167552e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,29474,0.0196075828914679,0.00153277517027524,0.0166033435577284,0.0226118222252073,2.27923422421555e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,29079,-0.0342222426953142,0.00267654025540612,-0.0394682615959102,-0.0289762237947182,2.47541676395902e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.0272937598706389,0.00213844916350517,-0.031485120231109,-0.0231023995101688,3.44003489721472e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,29820,-0.0500585491431246,0.0039244074956602,-0.0577503878346186,-0.0423667104516306,3.62514577589139e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,29674,-0.0515131967417729,0.00404126340568375,-0.059434073016913,-0.0435923204666327,4.06507147619215e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNST,Consortin,29478,-0.0972405781777584,0.00762920072415245,-0.112193811597097,-0.0822873447584196,4.12149421694616e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREH,Trehalase,24938,-0.0673621403645663,0.00529501828536276,-0.0777403762038773,-0.0569839045252553,5.831306783545e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,24867,-0.070108412262926,0.0055196745929953,-0.0809269744651968,-0.0592898500606552,7.54794310557884e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,-0.0398573482594245,0.00314172654274023,-0.0460151322831954,-0.0336995642356537,8.82126677782162e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,-0.0431491505345024,0.00340976380504861,-0.0498322875923977,-0.0364660134766071,1.36978949825546e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,24922,-0.0652435745013655,0.00515714596331759,-0.075351580589468,-0.055135568413263,1.42960797133989e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,28654,-0.0628342359367425,0.00497032118271594,-0.0725760654548657,-0.0530924064186192,1.55325013440049e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24381,-0.0599975567619739,0.00476512016005201,-0.0693371922756758,-0.050657921248272,3.06976988663251e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,29331,-0.0254251013121809,0.00202086325013407,-0.0293859932824437,-0.0214642093419182,3.31936130325007e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24381,-0.0694365302992328,0.00552897394117982,-0.0802733192239452,-0.0585997413745204,4.6086098034941e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29536,-0.0626657921782108,0.00499221709233636,-0.07245053767919,-0.0528810466772315,4.7499734960573e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.035757551567648,0.00285121238035283,-0.0413459278331395,-0.0301691753021564,5.50201670686245e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,29443,-0.0668622688038073,0.00534023627962071,-0.0773291319118639,-0.0563954056957508,7.12215469525926e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,-0.0311340726979075,0.0024908944183753,-0.0360162257579231,-0.026251919637892,9.72791237308849e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,-0.0193593334606305,0.00154902051289579,-0.0223954136659062,-0.0163232532553547,9.87951091653311e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,29694,-0.108049132575905,0.00865163343460809,-0.125006334107737,-0.091091931044073,1.05590686028595e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,24229,-0.0436786904019585,0.00350634516230264,-0.0505511269200717,-0.0368062538838453,1.64516322562776e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24445,-0.0495736704277999,0.00398177218588607,-0.0573779439121366,-0.0417693969434632,1.78861123886274e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,29386,-0.0566793228479832,0.00455608765089965,-0.0656092546437465,-0.0477493910522199,1.93866909716581e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KAZN,Kazrin,24805,-0.0916920727202319,0.00737434411544661,-0.106145787186507,-0.0772383582539565,2.18088204450091e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,-0.0376453626819698,0.00302951010190413,-0.0435832024817018,-0.0317075228822377,2.30809872283954e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,28916,0.0205328273230994,0.00165237051543755,0.0172941811128418,0.023771473533357,2.31725336653216e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,29478,-0.0372643513170977,0.00300227012159603,-0.0431488007554259,-0.0313799018787695,2.75472999885462e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,-0.0681068355013373,0.00548836090039617,-0.0788640228661138,-0.0573496481365608,2.86368761618244e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,29390,-0.024684477925485,0.00199081937492727,-0.0285864839003425,-0.0207824719506276,3.23550652137594e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,24195,-0.0428060302797481,0.00345419825387878,-0.0495762588573505,-0.0360358017021457,3.67135551551226e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,29725,0.029737509954473,0.00240060448235699,0.0250323251690534,0.0344426947398927,3.73002576727502e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,24793,-0.0254404200560277,0.0020533195906078,-0.029464926453619,-0.0214159136584364,3.76769666815541e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,24845,-0.0720838654481283,0.00582027406602326,-0.0834916026175339,-0.0606761282787227,4.00337750517515e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,24111,-0.0417588956737244,0.0033789024714958,-0.0483815445178561,-0.0351362468295926,5.57958799101001e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,29353,-0.0428107790558006,0.00347478137587297,-0.0496213505525116,-0.0360002075590896,8.57419549569884e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,24381,-0.0611225138155429,0.00496096328160958,-0.0708460018474977,-0.0513990257835882,8.89688077293354e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,-0.0627036062126681,0.00509247793857189,-0.072684862972269,-0.0527223494530672,9.39289255188444e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,29725,-0.0957027993039838,0.00777515322227148,-0.110942099619636,-0.0804634989883317,9.87134881444188e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28797,-0.0316626320800474,0.00257673282227465,-0.0367130284117057,-0.0266122357483891,1.2849022308665e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,24867,-0.0477596392949959,0.00388726215827906,-0.0553786731252229,-0.040140605464769,1.35416418652534e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25976,0.027020733781754,0.00220334892053624,0.0227021698975029,0.031339297666005,1.7722631282718e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,29349,-0.0476120860534445,0.00388528732617091,-0.0552272492127395,-0.0399969228941495,1.93070437813993e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,-0.0462574346967621,0.00377392915634924,-0.0536543358432066,-0.0388605335503176,1.94303749956491e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,28774,-0.0616851455205031,0.00503764281164306,-0.0715589254313235,-0.0518113656096827,2.18076879273544e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29536,0.0706852688925322,0.0057754600557026,0.0593653671833551,0.0820051706017093,2.33376743801483e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,-0.0560070293318617,0.00457651972552782,-0.0649770079938962,-0.0470370506698271,2.44997715977045e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,24177,-0.0377708855607846,0.00309454383519988,-0.0438361914777764,-0.0317055796437929,3.65662844624119e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,-0.0376946854345411,0.0030916410724428,-0.043754301936529,-0.0316350689325532,4.29303827084911e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,-0.0385339936428809,0.00316231129669935,-0.0447321237844116,-0.0323358635013502,4.67920072207199e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,29478,-0.104402831701218,0.00857211802293026,-0.121204183026161,-0.0876014803762744,4.83564954921153e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,24229,-0.0302094316344787,0.00247985833952397,-0.0350699539799457,-0.0253489092890117,4.88142173608938e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,28797,-0.0328738839964624,0.00269944840918513,-0.0381648028784653,-0.0275829651144596,4.93785304462764e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,24845,-0.0647468402121141,0.00533161965232926,-0.0751968147306795,-0.0542968656935488,7.70667272471595e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,-0.0658619592737134,0.00542548289602408,-0.0764959057499206,-0.0552280127975062,8.19075652505442e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,24793,-0.0711283476748076,0.0058660967297503,-0.0826258972651182,-0.0596307980844971,9.66490498716909e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,29640,-0.0618044796049307,0.00510106474625083,-0.0718025665075823,-0.0518063927022791,1.04427480744875e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,24867,-0.0620240927355717,0.00512186236720172,-0.0720629429752871,-0.0519852424958564,1.16775540799425e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,24229,-0.0663602945286218,0.00549203627758444,-0.0771246856326873,-0.0555959034245563,1.62202354948042e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,-0.0487294158696597,0.00403683416116291,-0.056641610825539,-0.0408172209137804,1.80647279958319e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,29694,-0.0226944643570897,0.00188114340474645,-0.0263815054303927,-0.0190074232837866,1.95523645160029e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,24229,-0.0769746605502992,0.00638627786756419,-0.089491765170725,-0.0644575559298734,2.32662936903753e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,29434,-0.06916514585941,0.00574140844439544,-0.080418306410425,-0.0579119853083949,2.41823371981119e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,-0.0945309505834333,0.00785352341133616,-0.109923856469652,-0.0791380446972144,2.73168685136232e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,0.0244551259748511,0.00203623522480109,0.020464104934241,0.0284461470154613,3.75695829501066e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,24922,-0.0848710722490012,0.00706709575624169,-0.098722579931235,-0.0710195645667675,3.91918045304296e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,29820,-0.0358573952158203,0.00298654731419379,-0.0417110279516401,-0.0300037624800004,3.92642821127131e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,24845,-0.0564216454152849,0.00470302871694601,-0.0656395817004991,-0.0472037091300707,4.55475480555166e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,29333,-0.0289234256557502,0.00241323259205249,-0.0336533615361731,-0.0241934897753273,5.06600562733753e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,24229,-0.0464766931906348,0.00387721367109448,-0.05407603198598,-0.0388773543952896,5.14683961000721e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,24922,-0.0694985668113055,0.00581113142573929,-0.0808883844057545,-0.0581087492168565,7.12063438565179e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,24229,-0.0280681686543963,0.00234706691328639,-0.0326684198044376,-0.023467917504355,7.22581249982269e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.0323446259068249,0.00270591649112543,-0.0376482222294307,-0.0270410295842191,7.42302209744278e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,24732,-0.0394243128132574,0.00329785421622191,-0.0458881070770524,-0.0329605185494625,7.57400536899443e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,29498,-0.078336097521627,0.0065565542667757,-0.0911869438845074,-0.0654852511587467,7.94312787678761e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,24761,-0.024040675559463,0.00201181625200167,-0.0279838354133863,-0.0200975157055398,8.01956052948611e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,29581,-0.0720555028710016,0.00603219965491378,-0.0838786141946326,-0.0602323915473706,8.19107318270894e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,24195,-0.0383656821242256,0.00321264073685195,-0.0446624579684554,-0.0320689062799957,8.82899268701335e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,29349,-0.0755013554770606,0.00632854429576793,-0.0879053022967658,-0.0630974086573555,9.79769469998407e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,-0.0634719759019031,0.00532992679441675,-0.07391863241896,-0.0530253193848463,1.2698150294379e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,29478,-0.0448566326471329,0.00376788953113334,-0.0522416961281542,-0.0374715691661115,1.32458841002698e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,28719,-0.0385370904594211,0.00324089820671399,-0.0448892509445805,-0.0321849299742616,1.57434773296554e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,24240,-0.0863351847847009,0.00727650729276488,-0.10059713907852,-0.0720732304908817,2.21399299817745e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,29786,-0.0562474864209474,0.00474379631221793,-0.0655453271928945,-0.0469496456490003,2.33931978803959e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,29411,-0.0504969007751489,0.00426464870033839,-0.0588556122278121,-0.0421381893224856,2.8433308435258e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,24805,-0.0592198615930061,0.0050052611590696,-0.0690301734647825,-0.0494095497212297,3.27511426364995e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOST,Sclerostin,29433,-0.0322458769157539,0.00272752088635813,-0.0375918178530158,-0.0268999359784919,3.53613428566117e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24805,-0.0335225977500731,0.00283674666498324,-0.0390826212134402,-0.0279625742867059,3.87728488447853e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,24793,-0.033075520865002,0.00280154095953072,-0.0385665411456823,-0.0275845005843218,4.42068320407896e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,-0.0668700058203411,0.00566606848319211,-0.0779755000473976,-0.0557645115932845,4.65141015352146e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24867,-0.0633508682388913,0.00538318673961025,-0.0739019142485274,-0.0527998222292553,6.91139006440229e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,28277,-0.019104216702357,0.00162638776543589,-0.0222919367226113,-0.0159164966821026,8.73620513724241e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,29434,-0.0548927011621597,0.00469064920208313,-0.0640863735982426,-0.0456990287260767,1.45261175810455e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,24845,-0.0511372266946233,0.0043697854476582,-0.0597020061720334,-0.0425724472172133,1.49854572204958e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",24922,-0.0419107162630513,0.00358726305426888,-0.0489417518494184,-0.0348796806766843,1.87657379808146e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,24229,-0.0467242087260055,0.00400019802647461,-0.0545645968578957,-0.0388838205941153,1.9478933706282e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,-0.0630588674298457,0.00540891846280816,-0.0736603476169497,-0.0524573872427417,2.51255099780244e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,24845,-0.0314956101599383,0.00270227781445971,-0.0367920746762793,-0.0261991456435973,2.60455142808613e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,-0.0513283451245281,0.00440495844040583,-0.0599620636677235,-0.0426946265813327,2.70666809220498e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,28797,-0.0805033358381554,0.00691268620046095,-0.0940522007910589,-0.0669544708852519,2.83532069379052e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,29443,-0.0376338775757851,0.00323468084609206,-0.0439738520341255,-0.0312939031174446,3.22149040183937e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,0.0217804347209288,0.00187416984227915,0.0181070618300617,0.025453807611796,3.75573805334324e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,24951,-0.022671126722491,0.00195197648301515,-0.0264970006292007,-0.0188452528157813,4.18535216870979e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,-0.0534512820920591,0.00460366095261736,-0.0624744575591892,-0.0444281066249291,4.25014525026531e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,24565,-0.0901698646228848,0.00776580087318833,-0.105390834334334,-0.0749488949114357,4.36166630342743e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,24381,0.0176084067310446,0.00151759354126111,0.0146339233901728,0.0205828900719163,4.81038389123545e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,29786,-0.0284409474433286,0.00245286009306027,-0.0332485532257267,-0.0236333416609305,5.09296837091047e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,28797,-0.0438730907133088,0.00378448063285466,-0.0512906727537039,-0.0364555086729137,5.24745344065031e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,24890,-0.0383405603951835,0.00330708509774588,-0.0448224471867654,-0.0318586736036016,5.3442748412469e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,24867,-0.0453570240629914,0.00391441342799532,-0.0530292743818623,-0.0376847737441206,5.74939680946427e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,24793,-0.0515226147181791,0.00444765694758399,-0.0602400223354437,-0.0428052071009145,5.9541579825891e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28774,-0.0312585991910757,0.00270064410548076,-0.036551861637818,-0.0259653367443334,6.49841467036055e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29443,-0.02448577326791,0.00211933107050574,-0.0286396621661012,-0.0203318843697187,8.25678404942748e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,29163,-0.0518924773906604,0.00449608532883841,-0.0607048046351837,-0.0430801501461371,9.48364148264483e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,29349,0.0195100022279815,0.00169210204825045,0.0161934822134106,0.0228265222425524,1.08430620092564e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,0.0355538891628075,0.00308501524528289,0.029507259282053,0.0416005190435619,1.15182830264452e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28931,-0.0485487237226609,0.00421331471613074,-0.0568068205662772,-0.0402906268790447,1.18301647614017e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,24805,-0.0390086522321672,0.00339446053791178,-0.0456617948864743,-0.0323555095778601,1.73188571600683e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWC2,Brorin,29114,-0.0322304443681561,0.0028089652098623,-0.0377360161794863,-0.026724872556826,2.06895102758959e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,24381,0.023182939865617,0.00202459054760356,0.019214742392314,0.02715113733892,2.78879828092292e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29434,-0.0904492742163232,0.00790175933390564,-0.105936722510778,-0.0749618259218682,2.83054398880218e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,29030,-0.0235758962885889,0.00205960533706278,-0.0276127227492319,-0.0195390698279458,2.83385102136659e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28916,-0.061040093556555,0.00533265456436777,-0.0714920965027159,-0.0505880906103942,2.84623568921401e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,29581,-0.0621172459377532,0.0054307646779621,-0.0727615447065589,-0.0514729471689475,3.12537410353934e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,24867,-0.0491751802088586,0.00429850082070867,-0.0576002418174476,-0.0407501186002696,3.13857529611978e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,29443,0.0230175651471149,0.00201329089946284,0.0190715149841677,0.026963615310062,3.32061251735548e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,-0.0630534218853487,0.0055165501636235,-0.0738658602060508,-0.0522409835646466,3.43840789240534e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VASN,Vasorin,29065,0.0222007601699087,0.00194361154923792,0.0183912815334024,0.026010238806415,3.7472883825411e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,-0.0397351811218445,0.00348123531655023,-0.0465584023422829,-0.032911959901406,4.109207471944e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,-0.0508925198735184,0.0044637207225521,-0.0596414124897205,-0.0421436272573163,4.77532173922414e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,29218,-0.0285655835895708,0.00250715661453596,-0.0334796105540613,-0.0236515566250803,5.20661717189767e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,28931,-0.0913442000643925,0.00801748407289499,-0.107058468847267,-0.0756299312815183,5.24356679516422e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,28797,-0.0232395462738638,0.00204079304138199,-0.0272395006349725,-0.0192395919127551,5.59497847913314e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,29395,-0.053331096687889,0.00468599725601006,-0.0625156513096687,-0.0441465420661093,6.01206589508277e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,29349,-0.023779056557741,0.00209009193259109,-0.0278756367456195,-0.0196824763698624,6.28794751746916e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29454,-0.0417255463584971,0.00366820471550896,-0.0489152276008947,-0.0345358651160995,6.43829650035387e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,29820,0.020054595041267,0.00176430706493439,0.0165965531939956,0.0235126368885384,7.04783271510677e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,-0.0209688718795893,0.00184612789196207,-0.024587282547835,-0.0173504612113437,7.78901105542757e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,-0.0522521787809162,0.00460205926810619,-0.0612722149464044,-0.0432321426154281,8.1677557941241e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,24240,-0.0492625313169546,0.00434225286444468,-0.0577733469312661,-0.040751715702643,9.34362843672521e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,24195,-0.0644118553441382,0.00568315187422921,-0.0755508330176275,-0.053272877670649,1.06032238541158e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,29661,-0.0342020614928879,0.00302600838692108,-0.0401330379312532,-0.0282710850545226,1.46275844213197e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24681,-0.0483868399657943,0.00428532517482067,-0.0567860773084428,-0.0399876026231458,1.71189550279991e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,28774,-0.0537255980885256,0.00475989056456499,-0.0630549835950729,-0.0443962125819782,1.75208859441674e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,24805,-0.0548883474581075,0.00486844847172917,-0.0644305064626967,-0.0453461884535183,2.07287972535393e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,29632,-0.0471432677828138,0.00418663943158793,-0.0553490810687262,-0.0389374544969015,2.36127550024732e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,24240,-0.0613108735052472,0.00544891292034106,-0.0719907428291157,-0.0506310041813787,2.67829025130824e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,24845,-0.0443421956356176,0.00394226604686161,-0.0520690370874664,-0.0366153541837689,2.7921279219972e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,29518,0.0282394827372077,0.00251365409503198,0.023312720710945,0.0331662447634704,3.16730301444207e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,-0.0569830243726927,0.00508076990607992,-0.0669413333886093,-0.047024715356776,4.03691541197249e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,-0.0813627703542393,0.0072610456920226,-0.0955944199106036,-0.067131120797875,4.50719306871157e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,-0.0522399602272163,0.00466248006986187,-0.0613784211641455,-0.043101499290287,4.55887278750232e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,-0.0196262239443488,0.00175427435795349,-0.0230646016859376,-0.0161878462027599,5.36959298040554e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,29446,-0.0342181601504678,0.00305865244984698,-0.0402131189521679,-0.0282232013487678,5.3824923024661e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PI3,Elafin,29014,-0.0433107123160482,0.00388345775555072,-0.0509222895169276,-0.0356991351151688,7.95911080738296e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,29313,-0.0303949176381121,0.00272754023921031,-0.0357408965069643,-0.0250489387692599,8.78098404781332e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24922,-0.0468683501473269,0.00421223152201116,-0.0551243239304688,-0.038612376364185,1.08664666579294e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,-0.0731772958734947,0.00658397452885615,-0.0860818859500527,-0.0602727057969366,1.219677757058e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,29544,-0.0233190034611684,0.00209951128437698,-0.0274340455785473,-0.0192039613437895,1.32356789410567e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,24381,-0.0425942076915403,0.00383423584428127,-0.0501093099463316,-0.035079105436749,1.32992428720385e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,28916,-0.0423219431502131,0.00381483222185611,-0.049799014305051,-0.0348448719953751,1.53113438491505e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,28797,-0.0753841375086564,0.00680491965963126,-0.0887217800415337,-0.0620464949757791,1.8338292312251e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,24845,-0.0520013583701829,0.00469491809942477,-0.0612033978450554,-0.0427993188953103,1.91048461445928e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,29566,-0.0433351027110733,0.00391763508034985,-0.051013667468559,-0.0356565379535876,2.19144538922301e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,-0.0493222556264957,0.00445852213188741,-0.058060959004995,-0.0405835522479963,2.22258019424785e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,-0.0222139081175373,0.00200871929122561,-0.0261509979283395,-0.0182768183067351,2.31694234011502e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29478,-0.0273694603849696,0.00248501105592559,-0.0322400820545837,-0.0224988387153554,3.72036119643345e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,29786,-0.0384931515653026,0.00349605388514227,-0.0453454171801815,-0.0316408859504238,3.85618311565887e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,29581,-0.100740171456503,0.00915524318831208,-0.118684448105595,-0.0827958948074117,4.16568439538776e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,29786,-0.0209583090806979,0.00190700139398039,-0.0246960318128994,-0.0172205863484963,4.82358882560388e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,29454,0.0265350663237381,0.0024163444407463,0.0217990312198753,0.0312711014276008,5.31677860000786e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,-0.065411361477184,0.00596193115674279,-0.0770967465443999,-0.0537259764099681,6.07312455678335e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,28916,-0.038670104486854,0.00352811460579951,-0.0455852091142211,-0.031754999859487,6.71117077520726e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,29434,-0.0372613606770351,0.00340454856258631,-0.0439342758597043,-0.0305884454943659,7.98247153053362e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,29820,-0.0553838089400634,0.00506051836779792,-0.0653024249409473,-0.0454651929391795,7.99485459149634e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,29390,-0.0177480625329516,0.00162243529953773,-0.0209280357200456,-0.0145680893458576,8.4749713726337e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,-0.0257465854517919,0.00235398608234244,-0.0303603981731831,-0.0211327727304007,8.88604460896456e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,-0.0355881702410783,0.00325604835362568,-0.0419700250141847,-0.029206315467972,9.6325645936086e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,24793,-0.0372399650167156,0.00340948135615782,-0.0439225484747849,-0.0305573815586462,1.04112305092218e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24326,-0.0420458572073504,0.00385175961559705,-0.0495953060539206,-0.0344964083607802,1.12058644732348e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,28797,-0.0453431831594192,0.00415534473275218,-0.0534876588356135,-0.037198707483225,1.14424377005555e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,24240,-0.0412952352506034,0.00378431624257564,-0.0487124950860516,-0.0338779754151551,1.16890884086964e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,-0.0171929651455424,0.00157581093345168,-0.0202815545751077,-0.0141043757159771,1.1852703530097e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,24240,-0.036478198751109,0.00335396200123633,-0.0430519642735322,-0.0299044332286857,1.7335494603954e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29327,-0.0338827839626638,0.00311625054198609,-0.0399906350249565,-0.0277749329003711,1.75064957742974e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,-0.043480970888306,0.00399985305723161,-0.05132068288048,-0.0356412588961321,1.79413525897493e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRN,Progranulin,29313,-0.0188572697539372,0.00173867486924261,-0.0222650724976527,-0.0154494670102217,2.35437356218003e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,-0.041738798851043,0.00385281819318857,-0.0492903225096926,-0.0341872751923934,2.70049357312347e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BGN,Biglycan,28750,0.0915393775993504,0.00845905951165797,0.0749596209565007,0.1081191342422,3.07441500175695e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,29478,-0.0261282360737983,0.00241682464656975,-0.0308652123810751,-0.0213912597665216,3.43501986800831e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,-0.11227574143681,0.0103898086070611,-0.13263976630665,-0.0919117165669703,3.69317915993527e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,24805,-0.0516784428398462,0.004785048988206,-0.06105713885673,-0.0422997468229625,3.95651253075078e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,24381,-0.051314457823435,0.00476501498997094,-0.060653887203778,-0.041975028443092,5.54612430560691e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,24209,-0.0434074168262182,0.00403221670442468,-0.0513105615668906,-0.0355042720855458,5.78763902517768e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,24951,-0.0360808367811077,0.00335208901070717,-0.0426509312420938,-0.0295107423201217,5.85535879484004e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,-0.049627803934496,0.00461224387172433,-0.0586678019230757,-0.0405878059459163,5.98278791580862e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,29566,0.0219606897679386,0.00204179613159974,0.0179587693500032,0.0259626101858741,6.25756152759529e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29478,-0.0605595105935877,0.00563085773779929,-0.0715959917596743,-0.0495230294275011,6.30306209434438e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,24816,-0.0643647486964671,0.00598821915948407,-0.0761016582490559,-0.0526278391438784,6.89914755089378e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,-0.0825942911354744,0.00768528548698127,-0.0976574506899577,-0.0675311315809911,7.01167255416463e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,29349,-0.0449453112186325,0.00418377573383327,-0.0531455116569457,-0.0367451107803193,7.19203778367045e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,24805,-0.0450301841951403,0.00419100743169346,-0.0532445587612595,-0.0368158096290211,7.2104393075748e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,29434,-0.0303232344860992,0.00282565583677674,-0.0358615199261817,-0.0247849490460168,8.12740188306281e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,29725,-0.0214584767881393,0.00199978928804591,-0.0253780637927093,-0.0175388897835693,8.20880610623359e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24922,-0.0361159466627989,0.00336751616052517,-0.0427162783374283,-0.0295156149881696,8.90766202703188e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,29322,-0.0636187676808304,0.00593899180731737,-0.0752591916231725,-0.0519783437384884,1.00150015305351e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,-0.0467512764038617,0.00436708988518632,-0.0553107725788269,-0.0381917802288965,1.0979670382398e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,24966,0.023048256101026,0.00215448031851043,0.0188254746767456,0.0272710375253064,1.19027734213068e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,29434,-0.0630388615297808,0.00589565734020497,-0.0745943499165825,-0.051483373142979,1.2362522806691e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,24229,-0.0336034880795592,0.00314382628562194,-0.0397653875993782,-0.0274415885597402,1.31777495957257e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,29174,-0.0439770331747994,0.00411521188786275,-0.0520428484750104,-0.0359112178745884,1.31937883724347e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,-0.0266575346710865,0.00249491318624557,-0.0315475645161279,-0.0217675048260452,1.37083825214474e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,-0.059107786810659,0.00553425833278318,-0.069954933142914,-0.0482606404784039,1.41097480780731e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,-0.0459738863865768,0.00430500735031353,-0.0544117007931914,-0.0375360719799623,1.42534876439856e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,24922,-0.0486633930056094,0.00455977200538776,-0.0576005461361694,-0.0397262398750494,1.56508309804741e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28797,-0.0428413461743405,0.00401816611077371,-0.0507169517514569,-0.034965740597224,1.71913550664635e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,24845,-0.0348406841365207,0.00327258863205563,-0.0412549578553498,-0.0284264104176917,2.07060476022699e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,24229,-0.0665932456960205,0.00625496631406307,-0.0788529796715841,-0.0543335117204569,2.072096790472e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,24867,-0.0502567383234319,0.00472390529866122,-0.0595155927088079,-0.0409978839380559,2.2408286353983e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,-0.0429231859212108,0.00403685173561699,-0.0508354153230201,-0.0350109565194015,2.34063310606151e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALB2,Calretinin,28774,-0.0228905220743847,0.00215462177297104,-0.0271135807494079,-0.0186674633993614,2.58115497593933e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,24229,-0.0306517483726533,0.00288574214403553,-0.0363078029749629,-0.0249956937703436,2.69647471963144e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,29329,-0.0586349290937385,0.00552171223233359,-0.0694574850691124,-0.0478123731183647,2.71514793353757e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,29443,-0.0200239112223006,0.00188692421968071,-0.0237222826928748,-0.0163255397517264,2.92578082966974e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,24195,-0.098348947645985,0.00926935078476321,-0.116516875184121,-0.0801810201078491,3.05414292486429e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,29218,-0.0173957910153061,0.00164292240064775,-0.0206159189205757,-0.0141756631100365,3.76554742081858e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29349,-0.0233411784118485,0.00220852231307907,-0.0276698821454834,-0.0190124746782135,4.63739980691243e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,29434,-0.0505970935432204,0.00478919717329169,-0.0599839200028722,-0.0412102670835687,4.82929996958541e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,-0.0516701419165488,0.00489225114150256,-0.0612589541538938,-0.0420813296792038,4.9982133567262e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,24240,-0.0513942942408221,0.00486532548234365,-0.0609303321862157,-0.0418582562954286,5.01843458156453e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,29218,-0.0717699717615243,0.00679826979014308,-0.0850945805502048,-0.0584453629728439,5.24717783919579e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24381,-0.0401212183309248,0.0038001022684364,-0.0475694187770602,-0.0326730178847895,5.31311433522583e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,29218,-0.0504718490072625,0.00478147769651769,-0.0598435452924371,-0.0411001527220878,5.32528500802811e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,28774,-0.0611336605827065,0.00579509849815877,-0.0724920536390977,-0.0497752675263153,5.7147714047724e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,24240,0.031810952661297,0.00302135861403732,0.0258890897777838,0.0377328155448102,7.24649018529805e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28931,-0.0441497360584096,0.00419746702781555,-0.0523767714329281,-0.0359227006838911,7.93123460992362e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,24195,-0.0312638217675802,0.00297470296904724,-0.0370942395869128,-0.0254334039482476,8.84018417726196e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,24240,-0.0441822021350943,0.00420413243036913,-0.0524223016986178,-0.0359421025715708,8.90036103434811e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,-0.0844894430975092,0.00805248340600812,-0.100272310573285,-0.0687065756217333,1.0400154044479e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,24037,-0.0409724611757408,0.0039059834393892,-0.0486281887169436,-0.033316733634538,1.09515789275953e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,29443,-0.0249869167315379,0.00239071612381796,-0.0296727203342211,-0.0203011131288547,1.59622570506278e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,28931,-0.032456267589474,0.00311065464332077,-0.0385531506903827,-0.0263593844885653,1.92650822390981e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,24170,-0.0627209532204441,0.0060133332724368,-0.0745070864344202,-0.050934820006468,2.04167043342238e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,29545,-0.020117135233858,0.00193008569583463,-0.0239001031976939,-0.0163341672700221,2.15686801974879e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,24922,-0.0406909438078184,0.00390386840265171,-0.0483425258770157,-0.033039361738621,2.19056827856672e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,24195,-0.053375757619282,0.005125763787494,-0.0634222546427702,-0.0433292605957937,2.44120085911435e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,-0.0372285184279113,0.0035761905557519,-0.044237851917185,-0.0302191849386376,2.46760128322181e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,29581,-0.0189456072256605,0.00182090205883652,-0.0225145752609801,-0.015376639190341,2.61492941587842e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,-0.0373770097094152,0.00359332753548766,-0.0444199316789711,-0.0303340877398594,2.74330949724506e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,23405,0.0817168751976823,0.00786063727471398,0.0663100261392429,0.0971237242561217,2.94403175627843e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,29169,-0.038374195972893,0.0036969254128081,-0.0456201697819969,-0.0311282221637891,3.38212780216732e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24938,0.0242682412260872,0.00233798455530437,0.0196857914976906,0.0288506909544838,3.44218702694229e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,-0.0349250928542061,0.00336781669819885,-0.0415260135826758,-0.0283241721257363,3.81117719736582e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,-0.0263803798542791,0.00254570017101687,-0.0313699521894722,-0.021390807519086,4.13477997986307e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,29478,-0.0283910589554149,0.00274298428953774,-0.0337673081629089,-0.0230148097479209,4.59958266676314e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,-0.0699887616380902,0.00676623754065762,-0.0832505872177791,-0.0567269360584012,4.93199314576771e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,-0.0267485932397215,0.00258760257534835,-0.0318202942874042,-0.0216768921920387,5.39402853126366e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,29674,-0.0377410385870515,0.00365566827450625,-0.0449061484050837,-0.0305759287690192,6.05113546196002e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,24915,-0.0181560735239686,0.00176190358094146,-0.0216094045426139,-0.0147027425053233,7.51965550193358e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29581,-0.0756302323291327,0.00734219181454305,-0.0900209282856371,-0.0612395363726284,7.69999704440788e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,29443,-0.0417505690464741,0.00405565587725306,-0.0496996545658901,-0.0338014835270581,8.22828853953736e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,-0.0211504987530335,0.00205475106463677,-0.0251778108397216,-0.0171231866663454,8.29908922555022e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,29491,-0.0768697631652773,0.00747383643058038,-0.0915184825692148,-0.0622210437613397,9.05103995605345e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,24111,-0.0484056604268497,0.00470887749030155,-0.0576350603078408,-0.0391762605458587,9.79040092269403e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGMN,Legumain,29581,-0.0259553092874265,0.00252818559064577,-0.0309105530450922,-0.0210000655297608,1.09891357649723e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,24229,-0.0708204983059651,0.00689818539743458,-0.0843409416849368,-0.0573000549269933,1.12040584531874e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29725,-0.0283095526116288,0.00275917274203703,-0.0337175311860214,-0.0229015740372362,1.17122540663047e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28774,-0.048635801897503,0.00474188698677909,-0.05792990039159,-0.039341703403416,1.21840506018538e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,29023,-0.0542096012056401,0.00529734948723315,-0.0645924062006171,-0.0438267962106632,1.54755646179183e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29566,-0.0440959707161565,0.00431033401361913,-0.05254422538285,-0.035647716049463,1.59414859729938e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",29349,-0.0746471995952596,0.00730632446178713,-0.0889675955403624,-0.0603268036501569,1.83279047947021e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,24845,-0.0491644711262024,0.00481264902852385,-0.0585972632221092,-0.0397316790302957,1.88581939285997e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,29414,-0.0654048165309232,0.00640937826745752,-0.0779671979351399,-0.0528424351267064,2.07792929815432e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPARC,SPARC,29566,-0.0505541017959932,0.00495448155109612,-0.0602648856361415,-0.0408433179558448,2.0948609876542e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,24229,-0.0327702469167442,0.00321185974829161,-0.0390654920233957,-0.0264750018100926,2.15636042145479e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24867,-0.0488211151880495,0.00478579179161687,-0.0582012670996186,-0.0394409632764805,2.18626206145496e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,24016,-0.0368794989034862,0.00361528157950616,-0.0439654507993182,-0.0297935470076541,2.200664627097e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,-0.0315217932046554,0.00309013754002398,-0.0375784627831024,-0.0254651236262084,2.20352283497423e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28797,-0.0371669109012839,0.00364757677280347,-0.0443161613759787,-0.0300176604265891,2.4300940210972e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,29384,-0.0816778095309927,0.00801898416971984,-0.0973950185036436,-0.0659606005583418,2.5250175822996e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,24381,-0.0499932896457858,0.00490857414879547,-0.0596140949774249,-0.0403724843141467,2.59122830684858e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,24793,-0.0234024086144383,0.00229985618618161,-0.0279101267393542,-0.0188946904895223,2.84448947484096e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,-0.068800332532003,0.00676401299821937,-0.0820577980085129,-0.055542867055493,2.91462390886455e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,24793,-0.029370820358551,0.00288756544240507,-0.0350304486256649,-0.0237111920914371,2.96673642943933e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,28534,-0.0548597715295744,0.00539713117214467,-0.0654381486269779,-0.0442813944321709,3.13714031457294e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24922,-0.0205160071263345,0.00201815248901936,-0.0244715860048124,-0.0165604282478565,3.14441547707508e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,24610,0.0779038093901261,0.00766766580654622,0.0628751844092955,0.0929324343709567,3.33737435640787e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,23498,-0.0887877516621159,0.00875231064729072,-0.105942280530806,-0.0716332227934261,3.93162555004684e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,-0.0478962610969494,0.00472263620409835,-0.0571526280569821,-0.0386398941369166,4.02734450179604e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,-0.0721220204393307,0.00711433462602246,-0.0860661163063347,-0.0581779245723267,4.12339388544849e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,29674,-0.0220612948441791,0.00218084555543456,-0.0263357521328308,-0.0177868375555273,5.1360703848347e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,24822,-0.0696258507388483,0.0068839545337835,-0.083118401625064,-0.0561332998526327,5.31868015672711e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,-0.0226871091389118,0.00224440240271858,-0.0270861378482402,-0.0182880804295834,5.66285799549889e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,29214,0.0239575172824221,0.00237753266052138,0.0192975532678002,0.028617481297044,7.66735803239623e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,24922,-0.0645470160526779,0.0064128920769276,-0.077116284523456,-0.0519777475818998,8.74251067266177e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,-0.0626631822225972,0.00622714648842891,-0.0748683893399178,-0.0504579751052765,8.80771073159034e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,24867,-0.0343071734158621,0.00341225569710045,-0.040995194582179,-0.0276191522495453,9.78290432457314e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,29478,-0.0284894322525352,0.0028388878135867,-0.0340536523671652,-0.0229252121379053,1.16250982948399e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C3,Complement C3,23779,-0.0331128313523265,0.00330467814618704,-0.0395900005188531,-0.0266356621857999,1.38698677677176e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29349,-0.0230221627269452,0.00229836253001213,-0.027526953285769,-0.0185173721681215,1.40376994417595e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,24845,-0.0761883654374829,0.00760936086972976,-0.0911027127421533,-0.0612740181328126,1.48945617083597e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,0.0186046960208822,0.00185964606099739,0.0149597897413273,0.0222496023004371,1.61460529228558e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,24966,-0.0378219793520857,0.00378075072206631,-0.0452322507673357,-0.0304117079368358,1.62373397837843e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,24922,-0.0211014949766643,0.0021099584508152,-0.0252370135402621,-0.0169659764130665,1.67248005397274e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,24240,-0.0639172334826282,0.00639759702741684,-0.0764565236563652,-0.0513779433088912,1.85627161496726e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,-0.0611295415493745,0.00612044574230649,-0.0731256152042952,-0.0491334678944538,1.90976077036758e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28774,-0.0361392012537309,0.00361984448653229,-0.0432340964473342,-0.0290443060601276,1.96273077088093e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29673,-0.0214355282025437,0.00214728098563334,-0.0256441989343851,-0.0172268574707024,1.97720752411226e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,29443,0.02015918568382,0.00202086535160836,0.0161982895946676,0.0241200817729723,2.12510517040135e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,-0.0298166996509252,0.00298994868712743,-0.035676999077695,-0.0239564002241554,2.23392140534851e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,-0.0195937887686237,0.00196778136855817,-0.0234506402509977,-0.0157369372862496,2.59885870304064e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,-0.0538740251135742,0.00541231272286762,-0.0644821580503947,-0.0432658921767536,2.63779813800352e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.046152228305586,0.00463824835575457,0.037061261528307,0.0552431950828649,2.73580983103568e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,-0.0505167800838573,0.00507689699513226,-0.0604674981943165,-0.040566061973398,2.74002573655082e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,28931,-0.0646740940611848,0.00650777681212452,-0.0774293366129488,-0.0519188515094207,3.10069887216309e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24852,-0.0282606616899141,0.0028434972920649,-0.0338339163823613,-0.0226874069974668,3.12180299913081e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.0318726039165129,0.00320906396025154,-0.038162369278606,-0.0255828385544199,3.28238621823864e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,-0.0729916265531178,0.00735073736753016,-0.0873990717934769,-0.0585841813127587,3.35847591296622e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,-0.0719708934478041,0.00725486546210654,-0.0861904297535329,-0.0577513571420753,3.69011047878308e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,24111,-0.0414188663364697,0.00418209660120273,-0.0496157756748271,-0.0332219569981123,4.43362266277586e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,29566,-0.0391341085497047,0.00395524369885661,-0.0468863861994636,-0.0313818308999457,4.78913866570257e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,24381,-0.0517916434270974,0.00524335296592799,-0.0620686152403163,-0.0415146716138786,5.75166908570211e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,29163,0.0337834004279826,0.00342315244254898,0.0270740216405866,0.0404927792153786,6.15714176377592e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,28797,-0.030419365586888,0.00308320737221216,-0.0364624520364238,-0.0243762791373521,6.34671588317785e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24805,-0.0448248934598228,0.00455157927249336,-0.0537459888339098,-0.0359037980857358,7.68511861721056e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,28774,-0.0361632338328124,0.00367307528733651,-0.0433624613959919,-0.0289640062696328,7.79046114562368e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,-0.0324156773570234,0.00329407307472066,-0.0388720605834759,-0.0259592941305709,8.15592201621979e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,24867,-0.052721459541308,0.0053590093514761,-0.0632251178702012,-0.0422178012124149,8.50802570569961e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,-0.0598164305109182,0.00608102227536312,-0.0717352341706299,-0.0478976268512065,8.63959916288686e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29408,-0.0245635731681969,0.00249867168095019,-0.0294609696628593,-0.0196661766735345,9.00785918476377e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,-0.0238618351006956,0.00242771688839317,-0.0286201602019462,-0.0191035099994449,9.16513604877557e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,29079,0.0264053744317588,0.00268714927951235,0.0211385618439146,0.031672187019603,9.3907654168256e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",24240,-0.0606201904932476,0.00617498338029537,-0.0727231579186265,-0.0485172230678687,1.04818802038266e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,-0.0334144947505027,0.00340535369532964,-0.0400889879933488,-0.0267400015076566,1.09819581987133e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,-0.0249602246285564,0.00254478812371742,-0.0299480093510426,-0.0199724399060703,1.14233182858203e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29478,-0.0506655926132367,0.00516708036821679,-0.0607930701349416,-0.0405381150915318,1.15531934705838e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,-0.0278700870824006,0.00284490196669971,-0.033446094937132,-0.0222940792276692,1.28041436882944e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,24951,-0.0196903460176706,0.00201086600089601,-0.0236316433794267,-0.0157490486559144,1.33886029044035e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,24326,-0.0789363565987797,0.00806179886614596,-0.0947374823764258,-0.0631352308211336,1.34958934732172e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,29795,-0.0233876053916541,0.00238925277497797,-0.0280705408306109,-0.0187046699526973,1.36227955351567e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,24240,-0.0627836591508582,0.00641682269335159,-0.0753606316298273,-0.0502066866718891,1.4489598637944e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,29443,0.0166063521121755,0.00169775452181914,0.01327875324941,0.0199339509749411,1.4653488834378e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24845,-0.0368697143401422,0.00377209709032974,-0.0442630246371885,-0.0294764040430959,1.59351419805894e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,-0.0196403620572539,0.0020098579320523,-0.0235796836040765,-0.0157010405104314,1.60709892515976e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,24111,-0.0272517134390988,0.00278973936541901,-0.0327196025953201,-0.0217838242828776,1.69144145198558e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29400,-0.0581192175624118,0.00595227137180598,-0.0697856694511515,-0.0464527656736721,1.7350271880954e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,-0.0647520289670473,0.0066339341009511,-0.0777545398049114,-0.0517495181291831,1.79628943487937e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,-0.0463942102993368,0.00475674620371417,-0.0557174328586165,-0.037070987740057,1.9581510177688e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28538,-0.0838055319824943,0.00860301586291921,-0.100667443073816,-0.0669436208911726,2.17550102609785e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,29786,-0.0161761249040906,0.00166146995108004,-0.0194326060082075,-0.0129196437999737,2.28570141582672e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29604,-0.0224963340271016,0.002311839657856,-0.0270275397564994,-0.0179651282977038,2.40422451048317e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,29320,-0.0287939231702002,0.00295944992231345,-0.0345944450179346,-0.0229934013224659,2.44017071143904e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,-0.0812938654442483,0.00835649905093221,-0.0976726035840755,-0.0649151273044212,2.50577305583292e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,-0.061249020879286,0.00630629966076731,-0.0736093682143899,-0.048888673544182,2.92654481600187e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,29349,-0.0248309287646031,0.00255783656458158,-0.029844288431183,-0.0198175690980232,3.01736158981788e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,24240,-0.0352719742319864,0.00363476250039595,-0.0423961087327625,-0.0281478397312104,3.18019850653833e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,24229,-0.0397623099152567,0.00410067197060624,-0.0477996269776449,-0.0317249928528684,3.42297351311461e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,-0.035410351917239,0.00365431237785613,-0.042572804177837,-0.028247899656641,3.59453201598925e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,24805,-0.0232583716335454,0.00240029506521974,-0.0279629499613761,-0.0185537933057147,3.6477196384724e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28797,-0.0409994783061295,0.00423278090060355,-0.0492957288713124,-0.0327032277409465,3.73168244291669e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,29349,-0.0644449970757045,0.00665459967627022,-0.0774880124411941,-0.0514019817102148,3.79599433036067e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,29434,-0.0479037274478966,0.00495676692156491,-0.0576189906141638,-0.0381884642816293,4.61042589550802e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,24867,-0.042588247032131,0.00440757648634083,-0.0512270969453591,-0.033949397118903,4.75730259696695e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,24867,-0.0453817421294792,0.00469771113396349,-0.0545892559520477,-0.0361742283069108,4.85615775126848e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,24805,-0.0530698716696827,0.00549751654809657,-0.063845004103952,-0.0422947392354135,5.19767076043956e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,24111,-0.0461415307514884,0.00478282063025258,-0.0555158591867835,-0.0367672023161934,5.52802444060176e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,29694,-0.0430834559765731,0.00446864176950895,-0.0518419938448107,-0.0343249181083356,5.76338203772294e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,28931,-0.0478653518989659,0.00496815358826737,-0.0576029329319699,-0.0381277708659618,6.17183905236536e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,-0.0638134266026879,0.00662335251728728,-0.076795197536571,-0.0508316556688048,6.23806577868437e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,24381,-0.0381319758665028,0.00396142625787062,-0.0458963713319292,-0.0303675804010764,6.80500925909108e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,29218,-0.0547448154912331,0.00569217083010023,-0.0659014703182295,-0.0435881606642366,7.26342344908405e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,24229,-0.0297522882403688,0.00309332870217797,-0.0358152124966376,-0.0236893639841,7.3296420434704e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,28774,-0.0419376228768721,0.00436532068440422,-0.0504936514183043,-0.0333815943354398,8.0552090892999e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,23862,-0.055017152311771,0.00572841947161779,-0.0662448544761419,-0.0437894501474002,8.40162405570117e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,-0.0288358036854605,0.00300413768690994,-0.0347239135518039,-0.022947693819117,8.72520865905867e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,24528,-0.0191080419740109,0.0019912309137974,-0.0230108545650538,-0.015205229382968,9.067964511918e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28916,-0.0360492946823621,0.00376408192816358,-0.0434268952615628,-0.0286716941031615,1.07410391101588e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,29645,-0.0333125845044085,0.00347881111647043,-0.0401310542926906,-0.0264941147161265,1.0859758911785e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,24845,-0.0629332678914143,0.00657163348959779,-0.0758136695310259,-0.0500528662518026,1.09435069550953e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,24381,-0.0468623324937388,0.00489399180510745,-0.0564545564317494,-0.0372701085557282,1.10698603793092e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,24240,-0.0369869386420136,0.00387380194769227,-0.0445795904594905,-0.0293942868245368,1.44347094434131e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,-0.0703686530813891,0.00737508556356302,-0.0848238207859726,-0.0559134853768056,1.51487885813949e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,24111,-0.0290934209924129,0.00305032596797808,-0.0350720598896499,-0.0231147820951759,1.5922660760726e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,29434,-0.0248984504437507,0.00261106952288268,-0.0300161467086007,-0.0197807541789006,1.59892373474171e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29694,-0.0156424178029587,0.00164345768095764,-0.0188635948576356,-0.0124212407482817,1.89454089186539e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,-0.0281631409288456,0.0029612253687372,-0.0339671426515705,-0.0223591392061207,2.06035095020946e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,24240,-0.0204969340981931,0.00215829365832911,-0.0247271896685181,-0.016266678527868,2.35724716374586e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,24951,-0.0479273400041637,0.00505047900150121,-0.0578262788471061,-0.0380284011612213,2.51817705308564e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,29291,-0.037561154155314,0.00396024213708837,-0.0453232287440072,-0.0297990795666208,2.61183631005527e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,29349,-0.0364814881779895,0.00385566031447447,-0.0440385823943595,-0.0289243939616196,3.24529873786587e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,0.01410278206345,0.00149068279646817,0.0111810437823724,0.0170245203445276,3.33050477777539e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,29732,-0.0459542313683541,0.00486418465269142,-0.0554880332876293,-0.0364204294490789,3.71688644498735e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,29566,-0.047511725302192,0.0050308815247505,-0.057372253090703,-0.0376511975136811,3.84256573679976e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,28797,-0.0302047884525173,0.00319897968712307,-0.0364747886392785,-0.0239347882657561,3.92391836205745e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,24867,-0.0762685920688313,0.00808409584845919,-0.0921134199318113,-0.0604237642058513,4.26537031888675e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,28916,-0.0377757805173939,0.0040063614508004,-0.0456282489609627,-0.0299233120738251,4.44142275717206e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29725,-0.0357795448141013,0.003797480623736,-0.0432226068366239,-0.0283364827915788,4.73935763079078e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,28774,-0.0310211424946401,0.0032925380032687,-0.0374745169810468,-0.0245677680082335,4.7619565013724e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,24966,-0.0123609713283739,0.0013128684899,-0.0149341935685779,-0.00978774908816986,5.11476137246831e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,28916,-0.0230278071859436,0.00244709798066714,-0.0278241192280512,-0.018231495143836,5.30421946102201e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,29536,-0.0379680259436966,0.00404496598083854,-0.0458961592661401,-0.030039892621253,6.63385784934777e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,-0.0442602950830178,0.00472179143167752,-0.0535150062891058,-0.0350055838769299,7.59667067605759e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,-0.0602283315066731,0.00642633596941941,-0.0728239500067351,-0.047632713006611,7.69699340283473e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,24111,-0.052659646385647,0.00562120535738534,-0.0636772088861222,-0.0416420838851717,8.01719094224792e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,24240,-0.0194016357737823,0.00207179503242208,-0.0234623540373296,-0.015340917510235,8.27378845279152e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,29443,-0.034436118587177,0.00367860015505012,-0.0416461748910752,-0.0272260622832787,8.4262791073016e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28826,-0.0318142520812127,0.0034090506067287,-0.038495991270401,-0.0251325128920245,1.10806595148378e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,29786,-0.0387859789679528,0.00415726393402318,-0.0469342162786382,-0.0306377416572674,1.13307505387591e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,-0.0564852770412912,0.00605389698712643,-0.068350915136059,-0.0446196389465234,1.14182466885425e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24922,-0.0708585416901071,0.00759889310562862,-0.0857523721771392,-0.055964711203075,1.2008947170653e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,-0.0360365178119923,0.00386551225152545,-0.0436129218249821,-0.0284601137990024,1.21266187002088e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,-0.0264551285986819,0.00283819577694759,-0.0320179923214992,-0.0208922648758647,1.2438731339185e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,24195,-0.028612997087327,0.00307220155150694,-0.0346345121282806,-0.0225914820463734,1.33887334741934e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,29218,0.027617215360073,0.00297669481937138,0.0217828935141051,0.0334515372060409,1.84569326268071e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,29581,-0.0604382776203273,0.00651931413339227,-0.0732161333217761,-0.0476604219188784,1.97199933212121e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,24951,0.0318064694697254,0.00343259353043145,0.0250785861500798,0.0385343527893711,2.08369170649041e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,29296,-0.0201143039120442,0.0021762918951881,-0.0243798360266129,-0.0158487717974755,2.56705336237203e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,28916,-0.0237037439804337,0.00256729232009029,-0.0287356369278107,-0.0186718510330567,2.80672761423213e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,29732,0.0233204526239616,0.00252600874855632,0.0183694754767912,0.028271429771132,2.82378793499778e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,29566,-0.0446679485197118,0.00483990133614834,-0.0541541551385626,-0.0351817419008611,2.90563171892566e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29478,0.0511313612603791,0.00554092757370331,0.0402711432159206,0.0619915793048375,2.93773795734988e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,29497,0.0155749008606723,0.00168796365296883,0.0122664921008534,0.0188833096204912,2.96251674163286e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,24922,-0.0179830773095769,0.00194896767354642,-0.0218030539497278,-0.0141631006694259,2.99847060666748e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEXN,Nexilin,24951,-0.0450927676424489,0.00488885719856257,-0.0546749277516315,-0.0355106075332662,3.09438809616468e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,29218,-0.0515095702775321,0.00558823224759825,-0.0624625054828247,-0.0405566350722396,3.23900199231071e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,24229,-0.0275200486946302,0.00298885270220469,-0.0333781999909514,-0.021661897398309,3.59874099715062e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,24845,-0.0380276924406249,0.00413078948500418,-0.0461240398312331,-0.0299313450500167,3.64738841060923e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,-0.0383717771536953,0.00416969305601941,-0.0465443755434934,-0.0301991787638973,3.76305040917157e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,-0.0345483337894164,0.00375603365225978,-0.0419101597478456,-0.0271865078309872,3.92243938381444e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,24845,-0.0462093378982193,0.00502524780058482,-0.0560588235873655,-0.036359852209073,4.0197093708849e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,24297,-0.0428216926429758,0.00465990481301486,-0.0519551060764849,-0.0336882792094667,4.25824892179667e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,-0.0499169821303038,0.00543502969794816,-0.0605696403382822,-0.0392643239223254,4.405678003572e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,0.0206157838906367,0.0022462875268617,0.0162130603379878,0.0250185074432856,4.67943842058941e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,29409,0.0114258526590649,0.00124561906956352,0.00898443928272036,0.0138672660354093,4.89993485779561e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,29344,-0.0566947436415005,0.00618822792433988,-0.0688236703732067,-0.0445658169097943,5.43143374133914e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,24111,-0.0431876498191157,0.0047146145703443,-0.0524282943769905,-0.0339470052612409,5.57222162604062e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,-0.0219414371455334,0.00239572800654231,-0.0266370640383563,-0.0172458102527105,5.58632826048255e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28931,-0.0227052812312864,0.00248201159898188,-0.0275700239652908,-0.0178405384972819,6.17356684034275e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,29368,-0.0442575337199554,0.00483977442761688,-0.0537434915980845,-0.0347715758418263,6.36389472164608e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,24381,-0.0373066368417487,0.00408055711643901,-0.0453045287899691,-0.0293087448935282,6.56395548991432e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,24845,-0.0240103882636826,0.00263006837035737,-0.0291653222695831,-0.0188554542577822,7.41260230983122e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,29443,0.0203390577380437,0.00223173979348091,0.0159648477428211,0.0247132677332663,8.46556909345769e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,24195,-0.0317420814101005,0.00348318140184267,-0.0385691169577122,-0.0249150458624889,8.6224422585686e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,28722,-0.0580819936617633,0.00637655215656065,-0.0705800358886222,-0.0455839514349045,8.86564235582047e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,-0.0383021085302253,0.00422116979859901,-0.0465756013354793,-0.0300286157249712,1.22051790790271e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,24101,-0.0351988443953541,0.00388122112935937,-0.0428060378088984,-0.0275916509818097,1.29033337241695e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,24805,-0.0223944997275162,0.00246963818772789,-0.0272349905754628,-0.0175540088795695,1.30056078888513e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,29518,-0.0242974972299654,0.00268004386780454,-0.0295503832108623,-0.0190446112490685,1.30809257742368e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,24951,-0.0148608198245347,0.00164040415748081,-0.0180760119731971,-0.0116456276758723,1.40744346395213e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,24195,-0.0401678786514866,0.0044338501713327,-0.0488582249872987,-0.0314775323156745,1.40887121578355e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,-0.0155990017897279,0.00172230576218901,-0.0189747210836184,-0.0122232824958375,1.42110566092079e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,-0.0399819966657927,0.00441609314848305,-0.0486375392368195,-0.0313264540947659,1.46423803104438e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,0.0292347615687005,0.00322921154844237,0.0229055069337535,0.0355640162036476,1.47080912196563e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,29089,-0.0743936783877686,0.00822046880942876,-0.090505797254249,-0.0582815595212883,1.51916372093193e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,24951,-0.040982625782755,0.00452864393787194,-0.049858767900984,-0.032106483664526,1.53635820388601e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,24867,-0.0229406821406736,0.00253536758096476,-0.0279100025993646,-0.0179713616819827,1.55618531088139e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,24938,-0.0536500470140466,0.00593344868755304,-0.0652796064416506,-0.0420204875864426,1.6479226368612e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,-0.0189656090928743,0.00209880105031401,-0.0230792591514897,-0.0148519590342588,1.71644790692544e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,-0.0216330010639836,0.00239427479128693,-0.026325779654906,-0.0169402224730612,1.75462464515242e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,28931,-0.030944371671958,0.00342753890213584,-0.0376623479201442,-0.0242263954237718,1.85141302723535e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,24805,-0.0229337237289335,0.00254069443568003,-0.0279134848228664,-0.0179539626350007,1.89705319252792e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,28797,-0.033442172935668,0.00370656553306125,-0.040707041380468,-0.0261773044908679,1.95140633138544e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAX,Protein max,28774,-0.0669175296807954,0.00741929190234324,-0.0814593418093882,-0.0523757175522026,2.00588260155341e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,29497,-0.0153184443804676,0.00170123931336678,-0.0186528734346665,-0.0119840153262687,2.29808212109105e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,24951,-0.0171866387773843,0.00190871995652782,-0.0209277298921788,-0.0134455476625898,2.32226258870916e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,-0.0312898763009756,0.00347608035682252,-0.0381029938003477,-0.0244767588016035,2.38284716284603e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,-0.0316313346446879,0.00351417319167191,-0.0385191141003649,-0.024743555189011,2.3940712685448e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,29386,-0.0430922809374679,0.00479173565344253,-0.0524840828182153,-0.0337004790567206,2.54569278155705e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,-0.0356931350880938,0.00397367800516147,-0.0434815439782102,-0.0279047261979773,2.83787124262433e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,24845,-0.0295479670013105,0.00329423355863854,-0.036004664776242,-0.0230912692263789,3.18090897711514e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,28591,-0.0532872025341442,0.00594924216019092,-0.0649477171681184,-0.04162668790017,3.53497761327745e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24793,-0.0325109999464539,0.00363640917752979,-0.0396383619344123,-0.0253836379584955,4.14139106834748e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0207271091444778,0.00232036482051215,0.016179194096274,0.0252750241926816,4.43838995751445e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,24240,0.0410156839074831,0.00459261706824005,0.0320141544537326,0.0500172133612336,4.52363100255968e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,24925,-0.0123302441845971,0.00138230315381475,-0.015039558366074,-0.00962093000312021,4.97271984240343e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,29478,-0.0804486091592235,0.00902042161895271,-0.0981286355323708,-0.0627685827860762,4.99342489750518e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,29478,0.0224151356321438,0.00251680424360033,0.0174821993146871,0.0273480719496004,5.57819856595814e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28797,-0.0576478868919664,0.00647628520483341,-0.0703414058934399,-0.0449543678904929,5.83206786137052e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,29618,0.026012937048872,0.0029230757915645,0.0202837084974056,0.0317421656003384,5.94016180333528e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,-0.0431317985880645,0.00484821368916006,-0.0526342974188182,-0.0336292997573108,6.15229866757147e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28774,-0.0241291382239136,0.00271301912674627,-0.0294466557123363,-0.018811620735491,6.24153491649339e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24938,0.0135668666252698,0.00152646781002846,0.010574989717614,0.0165587435329256,6.64812427285364e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,24951,0.0164731180054358,0.00185965464137626,0.0128281949083384,0.0201180411025333,8.6649481601943e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,24381,0.0203141387355009,0.00229546348083755,0.0158150303130593,0.0248132471579425,9.36001713712768e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,-0.0237255970576927,0.00268983303421056,-0.0289976698047454,-0.01845352431064,1.21329191016418e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,29694,-0.0186924802686665,0.00212037099484841,-0.0228484074185693,-0.0145365531187636,1.25337954544529e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,-0.0199697464103693,0.00226560841619929,-0.0244103389061199,-0.0155291539146187,1.26931686382735e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TF,Serotransferrin,24966,-0.0134993552490694,0.00153204033809679,-0.0165021543117391,-0.0104965561863997,1.31523212129168e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,29566,-0.019863000888728,0.00225566027047757,-0.024284095018864,-0.0154419067585919,1.36810083737298e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24381,-0.0231594422922238,0.0026308120292527,-0.0283158338695591,-0.0180030507148885,1.4168351865774e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,28931,-0.0493179088752712,0.00560632227748804,-0.0603063005391478,-0.0383295172113947,1.48386049269652e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,-0.068208573044575,0.00775523092157476,-0.0834088256508615,-0.0530083204382884,1.50426336074574e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,24951,-0.0453432388104342,0.00516404692354704,-0.0554647707805864,-0.035221706840282,1.7289016895161e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,24867,-0.0360560651781878,0.00410713246238753,-0.0441060448044674,-0.0280060855519083,1.75508492046513e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,24867,0.028948509710788,0.00329782796200876,0.0224847669052508,0.0354122525163252,1.76815082255706e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,-0.0556757501012486,0.00634855389758126,-0.0681189157405079,-0.0432325844619894,1.90146261794604e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,24381,-0.0532105094365467,0.00608186508611401,-0.0651309650053301,-0.0412900538677632,2.28825546161753e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C2,Complement C2,29545,-0.0144249156162222,0.00164969732374749,-0.0176583223707673,-0.0111915088616771,2.36746157391685e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,-0.0645160706275982,0.00739149578302414,-0.0790034023623255,-0.0500287388928709,2.74495771482482e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,24381,-0.0670343815732833,0.00768643859536725,-0.0820998012202031,-0.0519689619263635,2.92714788652411e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,29683,-0.0371727429669425,0.00426478936313293,-0.045531730118683,-0.0288137558152019,3.02400567318569e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,24111,-0.0381409250912382,0.00437896417871261,-0.0467236948815149,-0.0295581553009614,3.22940456946731e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,29725,-0.0370602400970685,0.00425623414399214,-0.0454024590192931,-0.0287180211748439,3.27053348714433e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,29478,-0.0174157898908875,0.00200152031363024,-0.0213387697056028,-0.0134928100761723,3.44926493817637e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPART,Spartin,24381,-0.0477772167313732,0.00549284392711579,-0.0585431908285201,-0.0370112426342262,3.58459526421225e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,29443,-0.0449340787096419,0.0051686163294526,-0.055064566715369,-0.0348035907039148,3.68907904060671e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29478,-0.0414216911800677,0.00476944974938946,-0.050769812688871,-0.0320735696712643,3.9866565121919e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24571,-0.0344813649308567,0.00397380652567237,-0.0422700257211745,-0.0266927041405389,4.3047603737403e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,-0.0265121417056992,0.00305741719157568,-0.0325046794011875,-0.0205196040102109,4.48309959699036e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,29820,-0.0194964869019984,0.00224861479303093,-0.023903771896339,-0.0150892019076578,4.51866330840263e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,29443,-0.0397654566885125,0.00459181864440382,-0.048765421231544,-0.030765492145481,4.9514800154239e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,24867,-0.0726594352379921,0.00839537451587559,-0.0891143692891082,-0.0562045011868759,5.23634260812362e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,-0.0509340453184516,0.00588679340550129,-0.0624721603932341,-0.039395930243669,5.35023120445452e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24867,-0.0298730035707467,0.00345745919278828,-0.0366496235886117,-0.0230963835528817,5.94525450632624e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,-0.0345344071301537,0.00399768920962901,-0.0423698779810265,-0.0266989362792808,5.9712813572554e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,28931,-0.0497827928213444,0.00577556510384849,-0.0611029004248874,-0.0384626852178013,7.05853420512314e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,-0.0183955350074626,0.00213443664749294,-0.0225790308365488,-0.0142120391783764,7.18291320127503e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,24951,0.0365914895156417,0.00425528704759405,0.0282511269023574,0.0449318521289261,8.50124174710715e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,29116,-0.0178738956661301,0.00207956948741339,-0.0219498518614604,-0.0137979394707999,8.73658952301796e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,29381,-0.0248625136949271,0.00289779934744301,-0.0305422004159154,-0.0191828269739388,9.96488318308409e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,29786,-0.0383022203053453,0.00446546755928705,-0.0470545367215479,-0.0295499038891427,1.01647786578906e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,24805,-0.0345014846334774,0.00402755438085548,-0.0423954912199542,-0.0266074780470007,1.1292079133251e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,28628,-0.0677295257893824,0.00791324880603128,-0.0832394934492037,-0.0522195581295611,1.19454306145583e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,28774,-0.027379670275494,0.00320166726169478,-0.0336549381084158,-0.0211044024425723,1.27220479515095e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,-0.0649109055535881,0.00759249481207626,-0.0797921953852576,-0.0500296157219186,1.30793176505444e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,24329,-0.0624415080505037,0.00730647488083557,-0.0767621988169415,-0.048120817284066,1.34738149986396e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,-0.0231037222014258,0.00270544960465305,-0.0284064034265457,-0.0178010409763058,1.42295075732793e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,29453,-0.0463196460431523,0.00543491320936317,-0.0569720759335041,-0.0356672161528005,1.63333241966994e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,29725,0.0346304719070813,0.00406438287274637,0.0266642814764984,0.0425966623376642,1.66295662795972e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,-0.0169091034638999,0.0019859467018997,-0.0208015589996233,-0.0130166479281765,1.77115382692719e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28774,-0.0296497719949233,0.00348345206950475,-0.0364773380511526,-0.022822205938694,1.79758976912408e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLGN,Calmegin,24195,-0.0271559190097583,0.00319045951391423,-0.0334092196570301,-0.0209026183624864,1.81363571686841e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,24229,-0.0300021703299245,0.00352511691567153,-0.0369113994846407,-0.0230929411752083,1.82333846616783e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTD,Biotinidase,24966,-0.012474150605556,0.00146701367146239,-0.0153494974016223,-0.00959880380948971,1.9479541111789e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,28753,0.0277832730780234,0.00326870565188535,0.0213766100003281,0.0341899361557187,1.99009821772484e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,24229,-0.0545907472959624,0.00643414884865562,-0.0672016790393274,-0.0419798155525974,2.2880347023615e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,-0.0136720147259968,0.00161425024016668,-0.0168359451967235,-0.0105080842552701,2.59679024896074e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,29349,-0.053614552384124,0.00633267200629727,-0.0660265895164666,-0.0412025152517813,2.64861145323678e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,-0.023233834813189,0.00274707153088107,-0.0286180950137159,-0.0178495746126621,2.85246334015196e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,28774,-0.0305948193577846,0.00363029538166733,-0.0377101983058526,-0.0234794404097166,3.68944728357849e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.0397189044004912,0.0047155444442072,-0.0489613715111373,-0.0304764372898451,3.83560369209945e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,29694,-0.0173667259818504,0.00206507554825764,-0.0214142740564354,-0.0133191779072654,4.29121274315409e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,-0.012796337557985,0.00152196065156399,-0.0157793804350504,-0.00981329468091956,4.39953121897864e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,24914,0.011192374195639,0.00133228483032119,0.00858109592820946,0.0138036524630685,4.664535149156e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,-0.0210594013588988,0.00250814540795518,-0.025975366358491,-0.0161434363593067,4.8091362415545e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,-0.0582704714011463,0.00694765696631903,-0.0718878790551316,-0.044653063747161,5.24480531694767e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,24966,-0.0246971856957896,0.00294602411231267,-0.0304713929559224,-0.0189229784356567,5.41795804153948e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,24240,-0.0135807663770243,0.00162206240724248,-0.0167600086952196,-0.0104015240588291,5.94069577265221e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24805,-0.0452602273180641,0.005411616535242,-0.0558669957271384,-0.0346534589089897,6.40303157840978e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,29218,-0.059199703665206,0.00708347770114523,-0.0730833199594507,-0.0453160873709614,6.69051111834329e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,24845,-0.0160209244172774,0.0019168212926344,-0.0197778941508408,-0.012263954683714,6.70511586356482e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,-0.028988112849709,0.00346863252961475,-0.0357866326077539,-0.0221895930916641,6.76224028739132e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,24229,-0.0236487747345483,0.00283066088783584,-0.0291968700747065,-0.0181006793943901,6.91883907139619e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,24845,-0.041922639529557,0.00502394821943479,-0.0517695780396492,-0.0320757010194649,7.51527664914382e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,-0.0211852276141592,0.00254249176330882,-0.0261685114702445,-0.0162019437580739,8.33466540572757e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.01513807779151,0.00181827554636957,0.0115742577206256,0.0187018978623943,8.75540031815779e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DMD,Dystrophin,24240,-0.0305075865225005,0.00366797682354072,-0.0376968210966404,-0.0233183519483607,9.4687275451244e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24805,-0.0323266722129956,0.00389033022371152,-0.0399517194514702,-0.024701624974521,1.00975879454821e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28916,-0.0544217975929098,0.0065522749299006,-0.067264256455515,-0.0415793387303046,1.03443137016149e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,29646,-0.01329951756039,0.00160210359724056,-0.0164396406109815,-0.0101593945097985,1.07319049168856e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,28671,-0.0277911296425145,0.00335090105885639,-0.034358895717873,-0.021223363567156,1.14602415125599e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,-0.0390980682566885,0.00472163889106933,-0.0483524804831844,-0.0298436560301926,1.28837398269271e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,-0.0651838596698957,0.00788328024017,-0.0806350889406289,-0.0497326303991625,1.41135154231471e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,29216,-0.0340424763877271,0.00412151825943844,-0.0421206521762264,-0.0259643005992278,1.52151064289669e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,29379,-0.0601762824678629,0.00728691670169547,-0.074458639203186,-0.0458939257325398,1.54120911854001e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,-0.0485162110400579,0.00587534492810461,-0.0600318870991429,-0.0370005349809729,1.54787996461729e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,29166,-0.0409661523842114,0.00496355070851432,-0.0506947117728995,-0.0312375929955233,1.60380829173698e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,-0.0310046077042375,0.00375759545479326,-0.0383694947956323,-0.0236397206128427,1.64733022867096e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.0263138386089814,0.00319394229271528,0.0200537117152594,0.0325739655027033,1.81251021931881e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,29478,0.0407552038110938,0.00494888478387916,0.0310553896346907,0.050455017987497,1.8654714711367e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,-0.0229988908764227,0.00279539149180017,-0.028477858200351,-0.0175199235524943,2.00547361662077e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,24755,-0.051368831131328,0.00624832366435094,-0.0636155455134558,-0.0391221167492001,2.11231768439482e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,24445,-0.0197890534895085,0.00240950402344217,-0.0245116813754552,-0.0150664256035619,2.2646012406725e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,24229,-0.0527022438182739,0.00642171637094955,-0.065288807905335,-0.0401156797312128,2.38206532538131e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,29383,-0.0274095164737574,0.00334104572048382,-0.0339579660859057,-0.0208610668616091,2.42174369430035e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,24111,-0.044475386266511,0.00542279065282161,-0.0551040559460413,-0.0338467165869806,2.48998089529491e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,24195,-0.047039773277293,0.00573613101823753,-0.0582825900730385,-0.0357969564815474,2.5094309129023e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,29311,-0.0201845495817418,0.0024616825123453,-0.0250094473059386,-0.015359651857545,2.51166234517701e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,-0.0173481223196767,0.0021213338195119,-0.02150593660592,-0.0131903080334334,3.00525061801147e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,29354,-0.0514022695850831,0.00628582616299526,-0.0637224888645538,-0.0390820503056123,3.01401054877142e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,24445,-0.0315072250319608,0.0038539997374979,-0.0390610645174567,-0.0239533855464649,3.09579635413461e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,29349,-0.0265400006377963,0.00324685183868848,-0.0329038302416257,-0.0201761710339669,3.10046059791331e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,-0.0112258137550078,0.00137474156162574,-0.0139203072157942,-0.00853132029422134,3.320914475445e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,24240,-0.0532941099750312,0.00653226862989876,-0.0660973564896327,-0.0404908634604296,3.55265806943542e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,24240,-0.0138766333708339,0.00170535655963835,-0.0172191322277251,-0.0105341345139428,4.2418313592444e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,24421,-0.0221701040834207,0.00272514392570514,-0.0275113861778028,-0.0168288219890386,4.30006505011384e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,24229,-0.0177772163096726,0.00218792182332707,-0.0220655430833936,-0.0134888895359515,4.67926847032736e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,28916,-0.0438298154177278,0.005397553942859,-0.0544090211457314,-0.0332506096897242,4.83331907017657e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.0185790131737554,0.00228788070397197,-0.0230632593535405,-0.0140947669939703,4.85576616749999e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,-0.0298771000004977,0.0036830541437359,-0.0370958861222201,-0.0226583138787753,5.20623268495926e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,24845,-0.0261610523006555,0.00322921628530268,-0.0324903162198487,-0.0198317883814622,5.68259023232247e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,29434,-0.0385171050099711,0.00475697343660561,-0.047840772945718,-0.0291934370742241,5.84990519267882e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,24867,-0.0439103602623026,0.00542533270763866,-0.0545440123692744,-0.0332767081553309,6.05666508344935e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,29396,-0.0148004108195071,0.00183165465733258,-0.018390453947879,-0.0112103676911353,6.70369105378572e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28916,-0.0633020090576329,0.00783427788635555,-0.0786571937148898,-0.0479468244003761,6.71975234753455e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,24805,-0.0589017433765683,0.00729396684128874,-0.0731979183854942,-0.0446055683676424,7.02857236598479e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,24025,0.0359403755053328,0.00445259821543371,0.0272132830030827,0.0446674680075828,7.25054782140157e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,28884,-0.0234874352450239,0.00291090407432399,-0.0291928072306989,-0.0177820632593489,7.37390054342199e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,-0.0483648749688082,0.00599582518287175,-0.0601166923272368,-0.0366130576103796,7.51779391236999e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,28916,-0.0480629218918799,0.00595844730235476,-0.0597414786044952,-0.0363843651792646,7.52123411121684e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,24867,0.0256837231598139,0.0031867879839892,0.019437618711195,0.0319298276084327,8.00661065072202e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,24636,-0.0567064705568499,0.00704454998490848,-0.0705137885272705,-0.0428991525864292,8.6723063916478e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,29163,-0.0181017454200295,0.00224981779707681,-0.0225113883023,-0.0136921025377589,8.88606363947815e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,-0.036341890314513,0.00452328580860566,-0.0452075304993801,-0.0274762501296459,9.76093973681035e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,-0.0210681916944006,0.00262304355989419,-0.0262093570717932,-0.015927026317008,1.00150958670889e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,28879,-0.0241517429215031,0.00301614443692205,-0.0300633860178703,-0.0182400998251359,1.21445663516312e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,-0.0240068012159083,0.00299976740480981,-0.0298863453293356,-0.0181272571024811,1.26807549596921e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,-0.028781893472565,0.00360211351098914,-0.0358420359541037,-0.0217217509910263,1.39504248119743e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,28916,-0.0265231882177856,0.00332166321860322,-0.0330336481262479,-0.0200127283093232,1.45807363195574e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.0193472768950715,0.0024295582073017,-0.0241092109813828,-0.0145853428087601,1.74666520249587e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,29478,-0.0382966404669231,0.00482219815959,-0.0477481488597195,-0.0288451320741267,2.06418810877687e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,28931,-0.0369479018056131,0.00465802108936095,-0.0460776231407606,-0.0278181804704657,2.23197653959363e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,29566,-0.0348610687530306,0.0044172835980464,-0.0435189446052016,-0.0262031929008597,3.07684372007155e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.0345136598382876,0.00437397537409181,-0.0430866515715075,-0.0259406681050676,3.10773918812031e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",28774,-0.0301562664420591,0.00382554059268078,-0.0376543260037135,-0.0226582068804048,3.31187032226146e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,24938,-0.0339027360282663,0.00430239532213014,-0.0423354308596414,-0.0254700411968913,3.40777182010299e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29478,-0.0371910067972218,0.00472433042994091,-0.046450694439906,-0.0279313191545376,3.60278899505039e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,24904,-0.0267255628926382,0.00339788848210964,-0.0333854243175731,-0.0200657014677033,3.82955586315153e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,29623,-0.0327730110142375,0.00416910294789842,-0.0409444527921184,-0.0246015692363566,3.94187205672229e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,24111,-0.0213893473835289,0.00272505665306016,-0.0267304584235268,-0.016048236343531,4.36253032305968e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,-0.0643987344472303,0.00820653229885815,-0.0804835377529923,-0.0483139311414684,4.3965376886283e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,29443,0.0161076194809912,0.00205293342040665,0.0120838699769942,0.0201313689849882,4.43487320672638e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,24793,-0.023445146503317,0.00298837936655962,-0.0293023700617738,-0.0175879229448601,4.48777597277078e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,29349,-0.0330944982630133,0.00422189048342012,-0.0413694036105168,-0.0248195929155099,4.70264456672278e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,29478,-0.0364740936917121,0.00465589386465151,-0.045599645666429,-0.0273485417169951,4.88567408881441e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,29434,-0.0323259358947439,0.00413428544508405,-0.0404291353671087,-0.0242227364223792,5.5021565759825e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,-0.0200333557158547,0.00256547797685834,-0.025061692550497,-0.0150050188812123,6.00560155287129e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,29420,-0.0524657477791284,0.00671992834980744,-0.065636807344751,-0.0392946882135058,6.02715347376178e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,24229,-0.0160321851074621,0.0020541921158621,-0.0200584016545519,-0.0120059685603724,6.20858651367261e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,29192,-0.0262644745635152,0.00336850840674778,-0.0328667510407409,-0.0196621980862896,6.54676714157495e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,29566,0.0220509142033293,0.00282918016275355,0.0165057210843324,0.0275961073223263,6.6991429143041e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,-0.047120673943687,0.00605010922662867,-0.0589788880278792,-0.0352624598594948,7.05026530780724e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24846,-0.0110391173556636,0.0014185343609344,-0.0138194447030951,-0.00825879000823222,7.41228932739139e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,29566,-0.0139198548344264,0.00178903018071094,-0.0174263539886198,-0.0104133556802329,7.44852000924547e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,-0.0259587455825807,0.00334369964095162,-0.0325123968788458,-0.0194050942863155,8.58114907382749e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,24229,-0.0316207994912146,0.00407769193592924,-0.0396130756856359,-0.0236285232967933,9.21135735655634e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPL,Periplakin,24229,-0.017988336199915,0.0023220456658597,-0.022539545705,-0.01343712669483,9.79502886828352e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,24111,-0.0217785031188927,0.00281169250398479,-0.0272894204267029,-0.0162675858110825,9.87958346228073e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,-0.0256696111773414,0.00331541864310617,-0.0321678317178295,-0.0191713906368533,1.00683933082835e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,24111,-0.0379796145652038,0.00490929343870995,-0.0476018297050753,-0.0283573994253323,1.06377247956193e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0216264850599497,0.00279825978517258,0.0161418958810114,0.0271110742388879,1.12234525737958e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,-0.0415606037208019,0.00538698453885781,-0.0521190934169632,-0.0310021140246406,1.24783226862848e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24381,-0.0651403979072768,0.00844263441221691,-0.0816879613552219,-0.0485928344593317,1.24969863267902e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24793,-0.0186118486866839,0.00241642319515868,-0.0233480381491949,-0.0138756592241729,1.3870104535061e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,29478,-0.0155792637793861,0.00202443659113806,-0.0195471594980167,-0.0116113680607555,1.45219254874188e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,24240,-0.028427648769303,0.00369671341605655,-0.0356732070647738,-0.0211820904738321,1.52742477474618e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,24111,-0.0645351664328065,0.00839732430969984,-0.0809939220798181,-0.0480764107857948,1.58563728546751e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,24805,-0.0318331561623679,0.00414296874187373,-0.0399533748964404,-0.0237129374282954,1.60319967233198e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,-0.0641929675207777,0.00838336669147961,-0.0806243662360777,-0.0477615688054776,1.95874702492869e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,24720,0.0152834943215571,0.0019963138241067,0.011370719226308,0.0191962694168063,1.99042177793512e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,29443,0.0433008967657686,0.00565932889839247,0.0322086121249194,0.0543931814066179,2.0512123340238e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,29443,-0.0171323591144358,0.00224045995169698,-0.0215236606197618,-0.0127410576091097,2.12308406135796e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,28722,-0.0383620047287355,0.00501916422266974,-0.0481995666051682,-0.0285244428523028,2.18650783471689e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,29536,-0.0467638223913882,0.00612052871057136,-0.058760058664108,-0.0347675861186683,2.22947047766003e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",24845,0.0324990264620647,0.00425449444937722,0.0241602173412854,0.0408378355828441,2.27239442868406e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24922,-0.0174837865717233,0.00229178024279888,-0.0219756758476091,-0.0129918972958374,2.45203838511691e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,24016,-0.0303863646828571,0.00398357526027503,-0.0381941721929961,-0.022578557172718,2.47431143958378e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,24793,-0.0320936152518429,0.00420851986122162,-0.0403423141798373,-0.0238449163238486,2.51090494599044e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,24845,-0.0453819028933295,0.00595374355923778,-0.0570512402694355,-0.0337125655172235,2.57866109774982e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,-0.0151665140269127,0.00198979425543359,-0.0190665107675625,-0.0112665172862628,2.5835698265409e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,-0.0526485341761102,0.00691723206043739,-0.0662063090145675,-0.0390907593376529,2.81174487531005e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,29218,-0.0219512109380634,0.00288622521274045,-0.0276082123550347,-0.0162942095210922,2.92307111449151e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,29640,-0.0373543317049339,0.00491206690805847,-0.0469819828447285,-0.0277266805651393,2.94227480004884e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,-0.0227842268260817,0.00299755851568648,-0.0286594415168272,-0.0169090121353362,3.04661351158435e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,24109,-0.0222837138466345,0.00293171089730171,-0.0280298672053458,-0.0165375604879231,3.04728170350978e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,29434,-0.0178173531200142,0.00234446168273623,-0.0224124980181772,-0.0132222082218511,3.05489385812583e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,24793,-0.038109908274282,0.00501442593297246,-0.047938183102908,-0.028281633445656,3.06478298637023e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,24966,0.0121670401408664,0.00160545722925888,0.00902034397151905,0.0153137363102138,3.61570395850718e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,24229,0.0162718012857515,0.00214901436982816,0.0120597331208883,0.0204838694506147,3.81364180285072e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OPTC,Opticin,29349,0.0241434411615546,0.00319055237310349,0.0178899585102718,0.0303969238128375,3.92627824456494e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,29218,-0.0702858180982755,0.00929557052831849,-0.0885051363337797,-0.0520664998627712,4.11032817680026e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,24101,-0.0343849078850344,0.00454838267831976,-0.0432997379345411,-0.0254700778355276,4.18046801404668e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,29208,-0.0242415132035763,0.00321487993582507,-0.0305426778777934,-0.0179403485293591,4.82094538160728e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",24111,-0.033561069884876,0.00445729624622688,-0.0422973705274807,-0.0248247692422713,5.27336244467089e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,0.0260271955152234,0.00346722128986145,0.019231441787095,0.0328229492433519,6.27450768148309e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29581,-0.0149344731738537,0.00199352880238131,-0.018841789626521,-0.0110271567211863,7.00049032043225e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,-0.0182085976018902,0.00243100700908199,-0.0229733713396909,-0.0134438238640895,7.07132297652138e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,-0.0381841059243349,0.00510069667570122,-0.0481814714087093,-0.0281867404399606,7.29506119182264e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,29820,-0.0103300672830262,0.00138202901373854,-0.0130388441499537,-0.00762129041609864,7.95849834038413e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,24867,-0.0361018827724691,0.00482994255482114,-0.0455685701799186,-0.0266351953650197,7.99951494674595e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,-0.0142407346126817,0.00190714458203151,-0.0179787379934635,-0.0105027312318999,8.42932343959029e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,-0.0468026494477086,0.00627456903512729,-0.059100804756558,-0.0345044941388591,8.99587867515889e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,28916,-0.0234818161970304,0.00315375446499076,-0.0296631749484122,-0.0173004574456485,9.91427427545639e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,28797,-0.0254448213878417,0.00341859769814525,-0.0321452728762064,-0.018744369899477,1.0113152987151e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,-0.0305672970958914,0.00410787340716125,-0.0386187289739274,-0.0225158652178553,1.02560750367088e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELL,L-selectin,24966,0.0122313683746867,0.00164635676462356,0.0090045091160245,0.0154582276333488,1.12629456732047e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,-0.0416412184534818,0.00561747561425552,-0.0526514706574227,-0.030630966249541,1.27608723135705e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,28890,-0.0289813566381674,0.00391875066055363,-0.0366621079328525,-0.0213006053434823,1.44638859610112e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,29349,-0.0170265674440087,0.00230357982810973,-0.0215415839071038,-0.0125115509809137,1.49221542222525e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,29694,-0.0140393024790932,0.00189944072824977,-0.0177622063064627,-0.0103163986517237,1.49253181238644e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,-0.0154192855780795,0.00208778315881385,-0.0195113405693546,-0.0113272305868044,1.55926651231345e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,29039,-0.035830949538626,0.00485423100303815,-0.0453452423045808,-0.0263166567726712,1.60852422515018e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,24845,-0.0714327004872675,0.00968034827217377,-0.0904061831007281,-0.0524592178738069,1.64306998795974e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,24195,-0.0357990755441449,0.0048531774642392,-0.0453113033740537,-0.0262868477142361,1.6783581711812e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,24445,-0.0276726231994052,0.00375549273288992,-0.0350333889558694,-0.0203118574429409,1.77933661746097e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29349,-0.0293377661062012,0.0039821429848547,-0.0371427663565164,-0.021532765855886,1.78661791574351e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,24867,-0.0461947838839003,0.00627774364651818,-0.0584991614310759,-0.0338904063367247,1.91752312121651e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,28774,-0.0192264236748977,0.00261567357666668,-0.0243531438851644,-0.014099703464631,2.02773132711509e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,28774,-0.0369879499250786,0.00503661785380585,-0.046859720918538,-0.0271161789316191,2.13109301123201e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,24845,-0.0516146600186979,0.00706201637989688,-0.0654562121232958,-0.0377731079141,2.77738962987949e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,-0.0380751169844309,0.00521572239063751,-0.0482979328700804,-0.0278523010987813,2.96245228752253e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,24922,-0.0338004258490362,0.00463069974753812,-0.0428765973542109,-0.0247242543438615,2.98142999880572e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,-0.0436693730468841,0.0059989673460358,-0.0554273490451143,-0.0319113970486539,3.43493986696741e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,24229,-0.0330077189210271,0.00453604001184773,-0.0418983573442487,-0.0241170804978056,3.52316571593189e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,29786,-0.0313222670504953,0.00431241653637417,-0.0397746034617886,-0.0228699306392019,3.87091724725228e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,29725,-0.0234454858579124,0.00322829850005209,-0.0297729509180145,-0.0171180207978103,3.89360561102679e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,-0.0412298710585439,0.00568314851016098,-0.0523688421384594,-0.0300908999786284,4.14481070307183e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28774,-0.0326756341646582,0.00450993370110644,-0.0415151042188268,-0.0238361641104896,4.42466659728705e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,24793,-0.0199199260977472,0.00274958315081323,-0.0253091090733411,-0.0145307431221532,4.4603703935058e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,24240,-0.0166138740512516,0.00229505236439562,-0.0211121766854671,-0.0121155714170362,4.65491698608609e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAT,Catalase,24587,-0.0275228830244234,0.00380299678333367,-0.0349767567197574,-0.0200690093290894,4.71636244411105e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOC,Myocilin,29443,0.0233248393821943,0.00322389862144497,0.0170059980841622,0.0296436806802264,4.76972128821196e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,0.0180642824198548,0.00249836992206616,0.0131674773726052,0.0229610874671045,4.9575875591074e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,24793,-0.0347064910725857,0.00480085368105537,-0.0441161642874542,-0.0252968178577172,4.9980225132015e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,28774,-0.0250300732836738,0.00346979974439888,-0.0318308807826956,-0.0182292657846519,5.57994803205233e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24445,-0.0346756487776703,0.00480665255497865,-0.0440966877854284,-0.0252546097699121,5.58763621345369e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,-0.0169287998105747,0.00234765431070247,-0.0215302022595515,-0.0123273973615979,5.69205875603297e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.019236812972765,0.00267035483230224,0.0140029175014526,0.0244707084440773,5.9976744224984e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,29786,-0.021244486795315,0.00295191851595784,-0.0270302470865924,-0.0154587265040377,6.30804030594971e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,28452,-0.0305716359945551,0.00425407433599564,-0.0389096216931066,-0.0222336502960037,6.81412114262143e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,24805,-0.044636759183957,0.00621894023027689,-0.0568258820352997,-0.0324476363326143,7.2968799472892e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,29434,0.0134334988561027,0.00187247936121333,0.00976343930812457,0.0171035584040808,7.44619194719988e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,-0.0479640447093698,0.00669357188921401,-0.0610834456122293,-0.0348446438065104,7.95622356484103e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,28797,-0.0267756592729394,0.0037372229129979,-0.0341006161824153,-0.0194507023634635,7.98958785397124e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,29163,-0.0119101118016112,0.00166418491591347,-0.0151719142368016,-0.00864830936642083,8.45794568523926e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,0.0579393577944597,0.00809691596763222,0.0420694024979005,0.0738093130910188,8.51886878219611e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,29478,-0.0229338882645974,0.00320936732184748,-0.0292242482154185,-0.0166435283137764,9.14699006905162e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,29725,-0.0217136797538723,0.00304089301236361,-0.027673830058105,-0.0157535294496396,9.5085429405488e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24883,0.0075034062746247,0.00105148485773832,0.00544249595345759,0.00956431659579181,9.87131920761315e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,29349,0.0387125313779471,0.00542855816390932,0.0280725573766848,0.0493525053792094,1.01745597729014e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,28669,0.0452935022301112,0.0063622884602334,0.0328234168480538,0.0577635876121687,1.11224079979339e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,-0.0413778878771016,0.00581643314005383,-0.0527780968316071,-0.0299776789225961,1.15334052202072e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,24922,-0.0269958307167088,0.00379465573496243,-0.0344333559572352,-0.0195583054761825,1.15631698806688e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,28797,-0.0291950865528312,0.00410534214460514,-0.0372415571562573,-0.0211486159494052,1.17477370207249e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29566,-0.0419039155256407,0.00589639725660517,-0.0534608541485868,-0.0303469769026946,1.21544368824971e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,28774,-0.0339813229104868,0.00479846341662205,-0.043386311207066,-0.0245763346139076,1.45656416179804e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,29820,0.0151784191772151,0.00214532871850052,0.0109735748889541,0.0193832634654762,1.52634208567258e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,28797,-0.0336303167440829,0.00475576793347718,-0.0429516218936981,-0.0243090115944676,1.56786830482429e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,28706,-0.0376256288035706,0.00534219797161541,-0.0480963368279367,-0.0271549207792044,1.92244991268002e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,24445,-0.0352625585005224,0.00501660762628088,-0.0450951094480329,-0.0254300075530119,2.13236512309611e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",24966,-0.00828379290875952,0.00117850979196443,-0.0105936721010098,-0.00597391371650923,2.13309912049194e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,29349,-0.0371244196602597,0.00528885180613902,-0.0474905692002922,-0.0267582701202272,2.27710335847981e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSPN,Persephin,29434,-0.0465015369570514,0.00663178347150377,-0.0594998325611988,-0.033503241352904,2.40141088511937e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24793,-0.0242092751230128,0.0034547665239173,-0.0309806175098907,-0.0174379327361349,2.48825461353672e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.0120097065034539,0.0017144929259419,0.00864930036860775,0.0153701126383,2.52624686339477e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,-0.0329196609862183,0.00470090320881356,-0.0421334312754929,-0.0237058906969437,2.57214685220759e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,-0.0172258688822725,0.00246136767943776,-0.0220501495339705,-0.0124015882305745,2.64284863495986e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,29349,-0.0406749532740091,0.00581554451519821,-0.0520734205237976,-0.0292764860242206,2.72534843060156e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,-0.0485171963172498,0.00694045011112193,-0.0621204785350488,-0.0349139140994508,2.79883283189283e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,29395,-0.0198768817536763,0.00284406460607008,-0.0254512483815737,-0.0143025151257789,2.82959010643502e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALB1,Calbindin,29349,-0.0215103054572746,0.00308573411881858,-0.0275583443301591,-0.0154622665843902,3.21606359157123e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28931,-0.0155158320515939,0.0022328900108069,-0.0198922964727755,-0.0111393676304124,3.76298493657864e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,24240,-0.0398287916152316,0.00573288748641088,-0.0510652510885969,-0.0285923321418662,3.81436278797397e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29820,-0.0148755050117192,0.00214472695159665,-0.0190791698368487,-0.0106718401865898,4.12019837430121e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,-0.0172519247045425,0.00249406955419185,-0.0221403010307585,-0.0123635483783264,4.70316629467596e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,24101,-0.037460562348724,0.00542607001114523,-0.0480956595705687,-0.0268254651268794,5.18826482972976e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,-0.0295678381687034,0.00428838150931715,-0.037973065926965,-0.0211626104104418,5.52299747226687e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,28674,-0.0217721710656792,0.00316840179547332,-0.0279822385848069,-0.0155621035465515,6.47580733771407e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,24111,-0.0177056810616705,0.00257712699381162,-0.0227568499695413,-0.0126545121537997,6.56186571823149e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,29434,-0.03284601225282,0.00478574007215222,-0.0422260627942383,-0.0234659617114016,6.86172038318137e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,29786,0.0191651671809167,0.00279558328143297,0.0136858239493081,0.0246445104125253,7.24407421839824e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.0138467870401631,0.00202085579457363,0.00988590968279874,0.0178076643975274,7.42715510249963e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,29786,-0.0123094026078746,0.0017976175528852,-0.0158327330115296,-0.00878607220421959,7.65458724459003e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,-0.0425251556798572,0.00622110904929834,-0.0547185294164819,-0.0303317819432324,8.3542654219437e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,29279,-0.0290836042051864,0.00425563100809838,-0.0374246409810592,-0.0207425674293135,8.41113628511805e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.0205569172507913,0.00300905906750638,0.0146591614784788,0.0264546730231039,8.55533952344606e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24845,-0.0185948580458241,0.00272212695949074,-0.0239302268864259,-0.0132594892052222,8.62696287510192e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,-0.0181279283396783,0.00265568553422023,-0.02333307198675,-0.0129227846926067,8.89572041056834e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,24240,-0.0144649724123419,0.00212000052067055,-0.0186201734328562,-0.0103097713918277,9.11967890595111e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,-0.0721430118773997,0.0105866815512287,-0.0928929077178079,-0.0513931160369915,9.64105061307971e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,28931,-0.0242575218965451,0.0035618665986741,-0.0312387804299464,-0.0172762633631439,9.92730795252453e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,-0.0511352834847201,0.00751222274177127,-0.0658592400585918,-0.0364113269108485,1.02000604892345e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,29820,-0.0422112474632274,0.00620886798289635,-0.0543806287097042,-0.0300418662167505,1.07674851849871e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,24101,-0.0211742484713945,0.0031147459987315,-0.0272791506289083,-0.0150693463138808,1.08509525833487e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,24445,-0.0363147684534712,0.00536206867583748,-0.0468244230581127,-0.0258051138488298,1.29420571090701e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,29443,-0.0131580496639231,0.00194446982243612,-0.0169692105158979,-0.00934688881194827,1.34028262516763e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,-0.0145679706910824,0.00215480232016798,-0.0187913832386116,-0.0103445581435531,1.4038840406546e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,29373,-0.0318257492589524,0.00470831091996387,-0.0410540386620815,-0.0225974598558232,1.41074526085647e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,29443,-0.0577384205147782,0.00855445137025244,-0.074505145200473,-0.0409716958290835,1.51088835530938e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,28916,-0.0247803123021408,0.00367257778082719,-0.0319785647525621,-0.0175820598517195,1.53368733370307e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,29395,-0.0139195009391195,0.00206481673302198,-0.0179665417358426,-0.00987246014239646,1.59903692319996e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,-0.0133761144917924,0.00198605377241987,-0.0172687798857353,-0.0094834490978494,1.66898894719485e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,29349,-0.0642312873648902,0.0095380168228775,-0.0829258003377301,-0.0455367743920503,1.67828891477119e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,24966,-0.0170805431451683,0.00253701614361065,-0.0220530947866452,-0.0121079915036914,1.70351981073358e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24381,-0.0394725539448612,0.00586556836729855,-0.0509690679447664,-0.027976039944956,1.73979615385106e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,28931,-0.0137786341996898,0.00204828440422848,-0.0177932716319777,-0.00976399676740203,1.76527071600677e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,29218,0.0160372262067607,0.00238408617797963,0.0113644172979206,0.0207100351156007,1.76656545907884e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,29566,-0.0103704856122625,0.00154198417437616,-0.0133927745940397,-0.0073481966304852,1.78279618953315e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,24776,-0.0450525231031532,0.00669876344454583,-0.058182099454463,-0.0319229467518434,1.7880171445148e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,-0.0513795981463953,0.00764527457848664,-0.0663643363202291,-0.0363948599725615,1.85107966174075e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24445,-0.0358047579967839,0.005329556507965,-0.0462506887523953,-0.0253588272411725,1.88090398805437e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,24805,-0.0255646917477088,0.00381061844157366,-0.0330335038931932,-0.0180958796022244,2.00450985810673e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFB,Complement factor B,24538,-0.0156328394257318,0.0023313505714701,-0.0202022865458132,-0.0110633923056504,2.05097526582736e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,29434,-0.0114988753203502,0.00171561442289494,-0.0148614795892243,-0.00813627105147613,2.08606624512734e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24922,-0.0336717464509269,0.00502527745838286,-0.0435212902693573,-0.0238222026324965,2.12172729008279e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24523,-0.0265373425129665,0.00396128941097539,-0.0343014697584782,-0.0187732152674547,2.14149256250968e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,-0.0472023367015921,0.00705503880558515,-0.061030212760539,-0.0333744606426452,2.27002842432911e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,24711,-0.0229301275335299,0.00343105530460175,-0.0296549959305494,-0.0162052591365105,2.38899908417033e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,24805,-0.02854218644809,0.00427399298592731,-0.0369192127005075,-0.0201651601956724,2.47164410700869e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,24793,-0.026042291713767,0.00390961754664891,-0.0337051421051989,-0.0183794413223351,2.77506942568704e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,-0.0252159678160449,0.00378567310184544,-0.032635887095662,-0.0177960485364278,2.77835667392658e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28931,-0.0184676968688811,0.00277341133955163,-0.0239035830944023,-0.01303181064336,2.80940500415384e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,24922,-0.0338536832877776,0.00508810386331834,-0.0438263668598815,-0.0238809997156737,2.92145277227002e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,24951,-0.043086064614292,0.00648490285500907,-0.0557964742101098,-0.0303756550184742,3.11450052113627e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,-0.0162102054056528,0.00244106459712596,-0.0209946920160197,-0.0114257187952859,3.17736986818674e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,28774,-0.0287798397576997,0.00433540322215498,-0.0372772300731234,-0.0202824494422759,3.22895802574161e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,24951,0.0115706349367143,0.0017445706118392,0.00815127653750952,0.0149899933359192,3.37100052709658e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,29694,-0.0139925346769488,0.00211178275294407,-0.0181316288727192,-0.00985344048117841,3.5095670562779e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,29343,-0.0508355606213653,0.00767482659688837,-0.0658782207512665,-0.0357929004914641,3.5642963786669e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,-0.0132437046081828,0.00200021460529457,-0.0171641252345602,-0.00932328398180549,3.63886492977457e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,-0.0442564519462112,0.00669119013556591,-0.0573711846119204,-0.031141719280502,3.80117770850358e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,24726,-0.0162592162483419,0.00246023261105035,-0.0210812721660006,-0.0114371603306832,3.95300490592113e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,28774,-0.0156174723466481,0.00236919414432646,-0.020261092869528,-0.0109738518237683,4.41765079331557e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,-0.0139395227036489,0.00211555200182713,-0.01808600462723,-0.00979304078006769,4.49991083233133e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,24195,-0.0289530790948354,0.00439898501836917,-0.037575089730839,-0.0203310684588318,4.7441774465131e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,24805,-0.0143847059745076,0.00218707027227154,-0.0186713637081598,-0.0100980482408554,4.89072705436142e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,24101,-0.0463683138357055,0.00705578156495047,-0.0601976457030084,-0.0325389819684026,5.07681854830815e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,-0.0222414567570698,0.00338600916004256,-0.0288780347107532,-0.0156048788033864,5.17828438476741e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,24606,0.0144505163148895,0.00220099086494421,0.0101365742195989,0.0187644584101802,5.29064806136732e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,-0.042638891880012,0.00649874806255025,-0.0553764380826105,-0.0299013456774135,5.44926534281215e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,24732,-0.0231628598100596,0.00353207869373773,-0.0300857340497856,-0.0162399855703336,5.56646430571849e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24845,-0.0492528738808848,0.00752207877783521,-0.0639961482854419,-0.0345095994763278,5.9541316851638e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,-0.0342108980907424,0.00522836944294761,-0.0444585021989197,-0.0239632939825651,6.13587188376106e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,24381,0.0100166681925304,0.00153156870645026,0.00701479352788792,0.013018542857173,6.26804002670877e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,28916,-0.0618669464602324,0.00946183455073304,-0.0804121421796692,-0.0433217507407957,6.31412934663205e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,-0.0310830481943486,0.00477017421546528,-0.0404325896566606,-0.0217335067320367,7.33381978703176e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,24805,-0.0197872591306683,0.0030406660279196,-0.0257469645453907,-0.0138275537159459,7.78490863362716e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,-0.0374430574759019,0.00576489907691573,-0.0487422596666567,-0.026143855285147,8.43535083153881e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,29443,-0.0411524264852604,0.00634610874407299,-0.0535907996236435,-0.0287140533468774,9.03341209940727e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,24845,-0.0102598103506574,0.00158214677959652,-0.0133608180386666,-0.00715880266264822,9.05556637429983e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,24381,-0.0115507276301003,0.00178178187994353,-0.0150430201147896,-0.00805843514541096,9.18294895733001e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,28774,-0.0332387269104022,0.00513974180693518,-0.0433126208519952,-0.0231648329688093,1.01568551033823e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,29688,-0.0426269482844905,0.00659652869500606,-0.0555561445267024,-0.0296977520422786,1.04909911374561e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,-0.0377125500980983,0.00583665482545073,-0.0491523935559817,-0.0262727066402149,1.05713308124743e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,24445,-0.0339609488657432,0.00526637751251121,-0.0442830487902652,-0.0236388489412212,1.14971036583481e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24769,-0.0399818716150594,0.00620926202217617,-0.0521520251785247,-0.0278117180515941,1.22412015425956e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,24195,-0.0311324132032567,0.00483512350097524,-0.0406092552651682,-0.0216555711413452,1.22678910678534e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,29725,-0.00962202816203361,0.00149541077340972,-0.0125530332779167,-0.00669102304615056,1.2587164298962e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,24195,-0.0311856927383333,0.00484936226407807,-0.0406904427759263,-0.0216809427007403,1.29232708656864e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,29434,0.0212266683365371,0.00330515326074443,0.014748567945478,0.0277047687275961,1.36282475193863e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,29786,-0.033223868643968,0.00517838764839157,-0.0433735084348155,-0.0230742288531206,1.42121490208053e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,24805,-0.0313177966192167,0.00488205202684705,-0.0408866185918369,-0.0217489746465965,1.43472570716985e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,24240,-0.0534843402908437,0.00833775580809792,-0.0698263416747156,-0.0371423389069718,1.43689747236061e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28719,-0.0191847257016297,0.00299361129268024,-0.025052203835283,-0.0133172475679765,1.49181686452333e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,-0.011812713735061,0.00184410313933995,-0.0154271558881673,-0.00819827158195473,1.52381349107847e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.0315977113285779,0.00495612815356381,-0.041311722509563,-0.0218837001475929,1.85583111007163e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,-0.0275515610724327,0.00434032825082727,-0.0360586044440541,-0.0190445177008112,2.22283630431327e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,-0.0300648999292405,0.00474206248356293,-0.0393593423970238,-0.0207704574614571,2.33782178553549e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29349,-0.00971576008435075,0.00153731182453886,-0.0127288912604469,-0.00670262890825458,2.65375682307544e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24793,-0.0178721992155094,0.0028375411855908,-0.0234337799392674,-0.0123106184917514,3.05623893687577e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,24240,-0.0190737149884952,0.0030328149208049,-0.0250180322332728,-0.0131293977437176,3.24738244822695e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,24240,-0.02334085888777,0.00372194399342947,-0.0306358691148917,-0.0160458486606482,3.64449590786774e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,28931,-0.0221953505146021,0.00354121640983256,-0.029136134677874,-0.0152545663513303,3.71540332614432e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,24381,-0.0558358581257011,0.00891988793321902,-0.0733188384748104,-0.0383528777765918,3.92137894608464e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,24111,-0.0545635886153218,0.00872051340481443,-0.0716557948887581,-0.0374713823418855,3.99251845785851e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,24381,-0.0127215570108131,0.00203480379154614,-0.0167097724422435,-0.00873334157938263,4.11998109475258e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,-0.033695294021395,0.00539144587299265,-0.0442625279324606,-0.0231280601103294,4.16816731317741e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,-0.0193597728109642,0.00309773876252165,-0.0254313407855066,-0.0132882048364218,4.17144165116455e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,-0.0161817897574331,0.00259233964792785,-0.0212627754673717,-0.0111008040474945,4.38674621493256e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNC,Tenascin,29594,0.0210341436516988,0.00337398135723275,0.0144211401915226,0.027647147111875,4.60160468238771e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,29594,-0.0205307679367057,0.00329417258730096,-0.0269873462078156,-0.0140741896655958,4.65384299772234e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,24240,-0.0249351857316016,0.00401129025061988,-0.0327973146228166,-0.0170730568403867,5.17480311266086e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,-0.0429894356702252,0.00691890079837155,-0.0565504812350335,-0.029428390105417,5.25726873120327e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,24805,-0.042233056518026,0.00679808178580693,-0.0555572968182075,-0.0289088162178444,5.29786748365881e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,-0.0215008079538517,0.00346294610352044,-0.0282881823167518,-0.0147134335909516,5.40957984674295e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,-0.032353715486435,0.00521620961019699,-0.0425774863224211,-0.0221299446504489,5.63173330070515e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24793,-0.0191897467421132,0.00309458479855695,-0.0252551329472848,-0.0131243605369416,5.69651214929886e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,24938,-0.0365159731520439,0.00588888668705951,-0.0480581910586806,-0.0249737552454073,5.70486251432617e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,28774,-0.0195434319174157,0.00315282030500308,-0.0257229597152217,-0.0133639041196097,5.76990277440109e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,29478,-0.011527620079377,0.00185980508100789,-0.0151728380381524,-0.0078824021206015,5.78341412882956e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,-0.0276259188123702,0.00445868585965967,-0.0363649430973032,-0.0188868945274373,5.8857105366112e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,29694,0.0130900959894377,0.00212054583973793,0.00893382614355136,0.0172463658353241,6.7879916055195e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,-0.0217215346170916,0.00352022345229889,-0.0286211725835975,-0.0148218966505858,6.91535719119472e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,29434,-0.0267172556215862,0.00433388979582117,-0.0352116796213957,-0.0182228316217767,7.15207628078526e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,-0.0369389317950165,0.0059934001975375,-0.04868599618219,-0.025191867407843,7.2203718493918e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,0.0281534310794027,0.00457222589536825,0.0191918683244809,0.0371149938343245,7.48592501322577e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,24805,0.0220221132168881,0.00357688051447182,0.0150114274085233,0.0290327990252528,7.53720046307872e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,24229,-0.0115339292357555,0.00187571640222813,-0.0152103333841226,-0.00785752508738836,7.91526220012837e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,24938,-0.0237312195465348,0.00385968871173732,-0.0312962094215399,-0.0161662296715296,7.94167312198404e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,29301,-0.0289026225462246,0.00470136629646358,-0.0381173004872932,-0.019687944605156,7.96253903464095e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,28916,-0.0212388372784305,0.00345502451618841,-0.0280106853301598,-0.0144669892267012,7.98774409172182e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,28984,-0.0147823853139251,0.00240875193812959,-0.0195035391126591,-0.0100612315151911,8.52117772161678e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,29478,-0.0272326929161642,0.00444248688156582,-0.0359399672040332,-0.0185254186282952,8.89622231647522e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,28931,-0.0244168012177224,0.00398477121966425,-0.0322269528082643,-0.0166066496271805,9.04058515900573e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,28931,-0.0355479070283615,0.00580608962782337,-0.0469278426988953,-0.0241679713578277,9.32906420383016e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.0209158826185596,0.00341719927238879,-0.0276135931924416,-0.0142181720446776,9.45550807731324e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,24111,-0.0260418952243718,0.00427059520131056,-0.0344122618189405,-0.0176715286298031,1.09068134848344e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,-0.0204595427097327,0.0033563418828598,-0.0270379728001379,-0.0138811126193275,1.105040332964e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,29283,-0.0165067000095602,0.00271387729310505,-0.0218258995040461,-0.0111875005150743,1.19914178209107e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,29757,-0.0128850682454539,0.00211946472284494,-0.01703921910223,-0.00873091738867781,1.22101910453558e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24764,-0.0175619933318774,0.0029099955447868,-0.0232655845996595,-0.0118584020640953,1.61163711289585e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.044493707311923,0.00737733518417715,-0.0589532842729102,-0.0300341303509357,1.64748752993223e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,-0.0183494345152072,0.00304650448370208,-0.0243205833032633,-0.0123782857271512,1.7315958378829e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,24381,-0.016588019198872,0.00275490902987201,-0.0219876408974211,-0.0111883975003228,1.75542615825029e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,24805,0.0127502822728171,0.00212618087530067,0.00858296775722781,0.0169175967884064,2.04028445906639e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,-0.0179781651891875,0.00299906975796744,-0.0238563419148037,-0.0120999884635713,2.06426481709678e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,24845,0.0158887907583807,0.00265057227795198,0.0106936690935948,0.0210839124231666,2.06959680642251e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24805,-0.0483647745245808,0.00807210359122643,-0.0641860975633846,-0.032543451485777,2.10659167885054e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28774,-0.0309289473766067,0.0051758750214653,-0.0410736624186787,-0.0207842323345347,2.31943048115785e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,28719,-0.0279522333841949,0.00468115120968016,-0.037127289755168,-0.0187771770132217,2.38236264877194e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,24381,-0.0402587089480818,0.00674570342036227,-0.0534802876519918,-0.0270371302441717,2.43420954849234e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,-0.033395390553533,0.0056107368418293,-0.0443924347635185,-0.0223983463435476,2.67866040048065e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,-0.0189544849420386,0.00318630276623678,-0.0251996383638627,-0.0127093315202145,2.73944069043588e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,24867,-0.0127104826124617,0.00213850023206703,-0.0169019430673131,-0.00851902215761033,2.82472167208839e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24381,-0.0368419971396708,0.00620014246306257,-0.0489942763672735,-0.0246897179120682,2.85179945762116e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,29218,-0.0179887483413329,0.00302911884879215,-0.0239258212849655,-0.0120516753977003,2.90700672832059e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,24281,-0.0180483431500816,0.00304109515814182,-0.0240088896600395,-0.0120877966401236,2.98167318351487e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",24445,-0.0193005762383198,0.0032562501230408,-0.0256828264794797,-0.0129183259971598,3.12201912955592e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,24381,-0.0139085903391664,0.00234893648626903,-0.0185125058522537,-0.0093046748260791,3.23826693666977e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,24647,-0.0183549785059834,0.00311471933138145,-0.024459828395491,-0.0122501286164757,3.84226334532351e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,24445,-0.0146358701118444,0.00248582808583354,-0.0195080931600781,-0.00976364706361067,3.96667592560954e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,-0.0210266310336146,0.00357728874171945,-0.0280381169673847,-0.0140151450998444,4.20302378536126e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,28867,-0.024804566046775,0.004226413975916,-0.0330883374395704,-0.0165207946539797,4.43382217315511e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,24229,-0.0223502659331778,0.00381107473194272,-0.0298199724077855,-0.01488055945857,4.56180556992697e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,28650,-0.0126233497461863,0.00215376923823162,-0.0168447374531202,-0.00840196203925229,4.64983242125389e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,29163,-0.0312710242725524,0.00533928174570246,-0.0417360164941292,-0.0208060320509755,4.76973653013851e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,29466,-0.0165237641633989,0.00282166139688051,-0.0220542205012847,-0.0109933078255131,4.7905932115695e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,29786,-0.0321050120174473,0.00548456651432788,-0.0428547623855299,-0.0213552616493646,4.85788615005367e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,-0.0251815523755214,0.00430316903238883,-0.0336157636790035,-0.0167473410720393,4.91284064383151e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,24229,-0.00848120574488343,0.00144935659570652,-0.0113219446724682,-0.00564046681729866,4.92826349857196e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,29753,-0.021610306933697,0.00369773096817014,-0.0288578596313105,-0.0143627542360836,5.14289287600615e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,-0.0223517313721768,0.00382722466234863,-0.0298530917103801,-0.0148503710339735,5.26896710959105e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,24793,-0.0336117760623309,0.00577215581337717,-0.0449252014565502,-0.0222983506681117,5.84827583693657e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,24111,-0.0282271468291204,0.00484890316072645,-0.0377309970241442,-0.0187232966340965,5.9115338319617e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,28931,-0.0198988126528179,0.0034186705888665,-0.0265994070069962,-0.0131982182986395,5.92451105289099e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,-0.0238269929927171,0.00409585735814542,-0.0318548734146822,-0.0157991125707521,6.04239331187203e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,29349,-0.0350817545713093,0.0060388355785241,-0.0469178723052166,-0.0232456368374021,6.33602601192492e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBN1,Drebrin,24229,-0.0211718125193717,0.00364498330937023,-0.0283159798057373,-0.014027645233006,6.38310026255739e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,29566,-0.0151375772611528,0.00260638508261972,-0.0202460920230874,-0.0100290624992181,6.39155136631562e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,29293,-0.0229811053185068,0.00395871768254355,-0.0307401919762922,-0.0152220186607215,6.49562668668391e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28931,-0.0268814231073662,0.0046313687193491,-0.0359589057972904,-0.017803940417442,6.53460690423339e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,-0.0184064894715695,0.00317499204851957,-0.0246294738866679,-0.0121835050564712,6.8067133850674e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LXN,Latexin,29117,0.02752579925289,0.00474913395452508,0.0182174967020208,0.0368341018037591,6.86310170161147e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.0197843509558793,0.00341511616274856,-0.0264779786348665,-0.0130907232768922,6.97728844496e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24445,-0.0286481815967077,0.0049484427216224,-0.0383471293310876,-0.0189492338623278,7.15312560370964e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28774,-0.0167960012232631,0.00290970893541281,-0.0224990307366722,-0.011092971709854,7.89531940772665e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,28774,0.0302036922529624,0.00523396054980275,0.019945129575349,0.0404622549305758,7.97456842730897e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,24867,-0.0112447938826239,0.00194967711709979,-0.0150661610321395,-0.00742342673310828,8.14018631868222e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29333,-0.0106050944569475,0.00184150890385534,-0.014214451908504,-0.00699573700539104,8.55008327112589e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F3,Tissue factor,29541,0.0111160816127916,0.0019303359629835,0.00733262312534391,0.0148995401002392,8.56418297452325e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,29478,-0.027353032242009,0.00477270792064536,-0.0367075397664739,-0.0179985247175441,1.00733104789336e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,28954,-0.0167892585795321,0.00293033255172531,-0.0225327103809137,-0.0110458067781505,1.01742089472122e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,24111,0.0145714651207842,0.00254555280366159,0.0095821816256075,0.0195607486159609,1.05104350262366e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,29378,-0.016405361536504,0.00287828491749568,-0.0220467999747956,-0.0107639230982125,1.21166805587652e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,24845,0.0169884561754578,0.00298123604480107,0.0111452335276477,0.0228316788232679,1.2226209950867e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,24016,-0.031016945300062,0.00544690565786675,-0.0416928803894809,-0.0203410102106432,1.25240583784951e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,29536,-0.0126761857702,0.00222672158035226,-0.0170405600676904,-0.00831181147270954,1.26188178786156e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,29623,-0.0330017931028647,0.00581265560471727,-0.0443945980881106,-0.0216089881176189,1.37894013882857e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,24240,-0.0295997514144364,0.00521438179357927,-0.0398199397298518,-0.0193795630990211,1.39000713459368e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24764,-0.0282529354954253,0.00498437567349769,-0.0380223118154807,-0.0184835591753698,1.45825270938075e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,24016,-0.0145087458387022,0.00256024243814645,-0.0195268210174692,-0.00949067065993514,1.47033987704986e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLG,Plasminogen,24421,-0.00891576956961659,0.00157365620500718,-0.0120001357314307,-0.00583140340780252,1.48125603481018e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,28916,-0.0133488026739823,0.00236683429406631,-0.0179877978903522,-0.00870980745761229,1.71697200129178e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,-0.0158709205396849,0.00281847504631204,-0.0213951316304565,-0.0103467094489133,1.81073630990622e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,-0.0161834086722492,0.00287729205519263,-0.0218229011004267,-0.0105439162440716,1.88067723017313e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,24789,-0.0227538632488475,0.00404636954435352,-0.0306847475557804,-0.0148229789419146,1.8938453300485e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,-0.0373501055756431,0.00664789060916006,-0.0503799711695968,-0.0243202399816894,1.94547748717549e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,24951,0.0239029838895975,0.00426730978386566,0.0155390567132208,0.0322669110659742,2.14846128907919e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,-0.0148102539866303,0.00264646533504241,-0.0199973260433134,-0.00962318192994717,2.2136477031317e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",28916,-0.0172288252525346,0.00307933330429282,-0.0232643185289485,-0.0111933319761206,2.22635930895686e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,24229,-0.0342936167631705,0.00613473135646535,-0.0463176902218426,-0.0222695433044984,2.29413565171625e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28797,-0.0298480195603423,0.00534035569646,-0.0403151167254039,-0.0193809223952807,2.30255230086563e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.0234544208074363,0.0041982425047209,0.0152258654981833,0.0316829761166892,2.33462164865048e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,28797,-0.0172833492102422,0.0030974917467709,-0.0233544330339131,-0.0112122653865712,2.42975218026499e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,29820,0.0108283156246145,0.00194121007340744,0.00702354388073594,0.0146330873684931,2.4522986943481e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,29453,-0.0370248533135503,0.00664068362556295,-0.0500405932196537,-0.0240091134074469,2.4904185616238e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24801,-0.0150838021647413,0.00272549059968667,-0.0204257637401271,-0.00974184058935542,3.15555288387606e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,24195,-0.0199530053023988,0.00360838792446018,-0.0270254456343407,-0.0128805649704568,3.24246298806544e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,29434,-0.0304493924923328,0.00550872272690413,-0.0412464890370649,-0.0196522959476007,3.27603643133876e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28916,-0.0241305620910548,0.00436669935306435,-0.0326892928230609,-0.0155718313590487,3.30359492767799e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,28757,-0.0427027317263133,0.00774860389167499,-0.0578899953539963,-0.0275154680986303,3.59813964440716e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29349,-0.0151426344637683,0.0027579790647329,-0.0205482734306448,-0.00973699549689186,4.04157305960216e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24845,-0.0273404857607274,0.00497949115066844,-0.0371002884160375,-0.0175806831054172,4.04449706575614e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,24938,-0.0341439684676654,0.00622520607108414,-0.0463453723669904,-0.0219425645683405,4.17973586365659e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,24922,-0.010696885720064,0.00195369240798868,-0.0145261228397218,-0.00686764860040617,4.41199036117358e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,24951,-0.010141664643867,0.00185349126432189,-0.0137745075219379,-0.00650882176579612,4.50139995981961e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,0.00793649089168681,0.00145144434068339,0.00509165998394736,0.0107813217994263,4.59672434670847e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,-0.0095551278204264,0.00174913651713779,-0.0129834353940165,-0.00612682024683633,4.72543532520234e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,24177,-0.0226740323360264,0.0041538959018177,-0.0308156683035891,-0.0145323963684637,4.84901242161099e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24845,0.0263550974978877,0.00483087037777045,0.0168865915574576,0.0358236034383178,4.92851888805807e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,0.0272599474424993,0.00500602798676477,0.0174481325884404,0.0370717622965583,5.21726724622595e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,29456,0.0245717532729707,0.0045160518079964,0.0157202917292978,0.0334232148166437,5.34098969181258e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,24938,0.0192382199862793,0.00353942435425758,0.0123009482519344,0.0261754917206242,5.51833955103144e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,-0.0457891337240623,0.00842675944492184,-0.0623055822361091,-0.0292726852120155,5.56095816315314e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,24111,-0.0148225193510043,0.00273024428919244,-0.0201737981578215,-0.00947124054418713,5.72151163459358e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,24195,-0.0186091644519763,0.00343458637778715,-0.0253409537524391,-0.0118773751515135,6.07878043345683e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,-0.045612381380535,0.00843127452594777,-0.0621376794513926,-0.0290870833096773,6.3547794066434e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,-0.00923981559100092,0.00170847697387699,-0.0125884304597998,-0.00589120072220203,6.41519909914144e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,29566,0.00926800323156065,0.0017158011816343,0.00590503291555742,0.0126309735475639,6.65733585904835e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,28931,-0.0181319633122393,0.00336461476470687,-0.0247266082510648,-0.0115373183734139,7.13978939946865e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,24793,-0.0171193596209722,0.00317898664891253,-0.0233501734528408,-0.0108885457891037,7.30376296857083e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,29478,-0.0328982051961942,0.00611405641462608,-0.0448817557688613,-0.0209146546235271,7.47417162470242e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,24922,-0.0201158334975735,0.00373983658421091,-0.0274459132026269,-0.0127857537925201,7.56593260273822e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,24111,-0.0194053788102969,0.00361437972190283,-0.0264895630652264,-0.0123211945553673,7.99341398913336e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,29434,-0.0118020610255896,0.00220522852861406,-0.0161243089416732,-0.00747981310950607,8.77083621290163e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,-0.0205476109266394,0.0038510862148341,-0.0280957399077143,-0.0129994819455646,9.60983901337759e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,28774,-0.0135269331112141,0.0025372756739828,-0.0184999934322204,-0.00855387279020784,9.82562655755138e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,29497,-0.0111765853086263,0.00210184650004136,-0.0152962044487074,-0.00705696616854522,1.05963373388319e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,-0.0202168310353877,0.00380291149421063,-0.0276705375640405,-0.0127631245067348,1.06777386807867e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,24111,-0.0210185333018887,0.00395479892376146,-0.0287699391924611,-0.0132671274113162,1.07788166234432e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,29443,0.00736996678791567,0.00138901678657858,0.00464749388622165,0.0100924396896097,1.12936328552715e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,24938,-0.016309329755943,0.00308375650614976,-0.0223534925079965,-0.0102651670038894,1.2416853988672e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,-0.0272138607280818,0.00514571684249228,-0.0372994657393666,-0.0171282557167969,1.24286715847409e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,29581,-0.0326610211429459,0.00617944042104584,-0.0447727243681958,-0.0205493179176961,1.26295980862953e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,24240,-0.0289260723429926,0.00547981921110392,-0.0396665179967563,-0.0181856266892289,1.31256340658835e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,29757,0.0171893214051255,0.00325733062037615,0.0108049533891883,0.0235736894210628,1.32149286763025e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,24229,-0.0449500278535011,0.00852527690533907,-0.0616595705879657,-0.0282404851190366,1.35687997794246e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,29349,-0.0155826134777855,0.00295760888018474,-0.0213795268829476,-0.00978570007262338,1.38398213121738e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,28931,-0.0107213967025283,0.00203835884715987,-0.0147165800429616,-0.00672621336209491,1.45223174210288e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,-0.0132982327977807,0.00253871837831339,-0.0182741208192749,-0.00832234477628643,1.63293507324417e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,24381,-0.0164777036873854,0.00314645100502514,-0.0226447476572347,-0.0103106597175361,1.64636021327855e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,29694,0.00855437544396815,0.00163366606350291,0.00535238995950245,0.0117563609284338,1.64937362932328e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,29497,-0.0121545041442404,0.00232133000337856,-0.0167043109508624,-0.00760469733761848,1.65210352519382e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,-0.0413013516055908,0.00790068782400455,-0.0567866997406397,-0.0258160034705418,1.72956756265719e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,24805,-0.016518882609319,0.00316917824446943,-0.022730471968479,-0.0103072932501589,1.87951645867513e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,29725,0.0221354500055102,0.00424841727927113,0.0138085521381388,0.0304623478728816,1.89811896085094e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,-0.0133806366704446,0.00256987741079254,-0.018417596395598,-0.00834367694529125,1.93730853288329e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,-0.0338194609842209,0.00649928143483722,-0.0465580525965018,-0.0210808693719399,1.97048670784103e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,21656,-0.0388722812052072,0.00748205743000622,-0.0535371137680194,-0.024207448642395,2.06131800808495e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29454,-0.108376429916574,0.0208706555908337,-0.149282914874608,-0.0674699449585397,2.08569137894694e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,29218,0.0132720889511735,0.00255702192829563,0.00826032597171408,0.0182838519306329,2.11191556611127e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,24793,-0.0188917349758208,0.00365166628821373,-0.0260490009007197,-0.0117344690509219,2.3159208521683e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,29400,-0.0320391258047882,0.00620384638206967,-0.0441986647136447,-0.0198795868959316,2.4278704480224e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,29121,-0.0208419018020348,0.00404337799669882,-0.0287669226755645,-0.0129168809285051,2.558646640425e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29349,-0.00764109064202024,0.00148240740318947,-0.0105466091522716,-0.00473557213176888,2.55936340261705e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,29218,-0.0120660861797484,0.00234140616986348,-0.0166552422726808,-0.00747693008681598,2.57537245813075e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,-0.00811354362082185,0.00157525831730529,-0.0112010499227402,-0.0050260373189035,2.61311518749821e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,24111,-0.0362444357859692,0.0070600127243117,-0.0500820607256201,-0.0224068108463183,2.86211580338186e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,24229,-0.0136434026720446,0.0026615018175089,-0.018859946234362,-0.00842685910972715,2.97914278966609e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28931,-0.0210734961898125,0.00411378002490531,-0.0291365050386269,-0.0130104873409981,3.03188592105844e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,24240,-0.0347515486373311,0.00679830243130507,-0.048076221402689,-0.0214268758719731,3.21532509102175e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,24069,-0.0356272591520474,0.00698630321845966,-0.0493204134602284,-0.0219341048438665,3.42977641860293e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,29581,-0.0120190410339624,0.00236130518748416,-0.0166471992014313,-0.00739088286649342,3.60257608610322e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,28845,-0.0158280934446864,0.00311680897844541,-0.0219370390424394,-0.00971914784693335,3.83195495462176e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24867,-0.0453397198530108,0.00898021241437417,-0.0629409361851841,-0.0277385035208374,4.47622933779313e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.010961570041603,0.00217778953105601,-0.0152300375224728,-0.00669310256073325,4.84880960229469e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24381,0.0091332273441411,0.00181546434634502,0.00557491722530487,0.0126915374629773,4.91922258766768e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,24920,-0.0131383625030152,0.00261425858992865,-0.0182623093392754,-0.00801441566675506,5.05189309606574e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,29349,-0.0100719789818859,0.00200688554059525,-0.0140054746414526,-0.00613848332231921,5.23232349378169e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,24273,0.0122010229783736,0.00244057369723585,0.00741749853179136,0.0169845474249559,5.79563908384042e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,-0.0110671246096501,0.00221807369510489,-0.0154145490520557,-0.00671970016724449,6.09484041140201e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,29349,-0.025673519745508,0.00514891365277156,-0.0357653905049402,-0.0155816489860757,6.19288842184564e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,-0.0167469675329557,0.00336291772970307,-0.0233382862831737,-0.0101556487827376,6.39877019757758e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,29349,0.00531743632215164,0.00107145522466054,0.00321738408181698,0.0074174885624863,6.98667733217306e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,24966,-0.0115177574972168,0.00232398843295592,-0.0160727748258104,-0.0069627401686232,7.24189385035332e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28797,-0.0206497804368615,0.00416993606406146,-0.028822855122422,-0.012476705751301,7.38466320205413e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,-0.030838203325973,0.006238460448927,-0.0430655858058699,-0.0186108208460761,7.73538040589218e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,24195,-0.0209097666251236,0.00423457792546918,-0.0292095393590431,-0.012609993891204,7.95092732975217e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,-0.0240371377560147,0.00487130171188849,-0.0335848891113162,-0.0144893864007133,8.09116140096924e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRNN,Cornulin,28580,0.0232809587589022,0.00472228780840794,0.0140252746544226,0.0325366428633818,8.26830518457754e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,24240,-0.0215035745356619,0.00436510360673128,-0.0300591776048552,-0.0129479714664686,8.43766464313244e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLU,Clusterin,24966,0.0110776329352695,0.00225348678030453,0.00666079884587267,0.0154944670246664,8.89930854175023e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,24867,-0.0103687252816732,0.00210985294191702,-0.0145040370478306,-0.00623341351551586,8.96074611398013e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,24229,-0.0136232341466777,0.00277421708338706,-0.0190606996301163,-0.00818576866323908,9.13617932413613e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,24623,0.0145664498390524,0.00297069184451306,0.00874389382380683,0.020389005854298,9.47984645612374e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,24016,-0.0127171110862198,0.0025941144765072,-0.0178015754601739,-0.0076326467122657,9.53421916167169e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,24111,-0.0217751843164952,0.00444229787492122,-0.0304820881513408,-0.0130682804816496,9.55872981711505e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,0.0100792892086552,0.00205712937614575,0.00604731563140951,0.0141112627859008,9.66125416512644e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,24016,-0.0213329512150661,0.00436186393990471,-0.0298822045372793,-0.0127836978928528,1.01082622497e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.00893340633399907,0.00182831474404024,0.00534990943568021,0.0125169032323179,1.03365757886076e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,29457,-0.0334505283080062,0.00684977302292574,-0.0468760834329406,-0.0200249731830717,1.04791370100186e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,24101,-0.0294278054603428,0.00602967001379517,-0.0412459586873814,-0.0176096522333043,1.06493465169437e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,29434,-0.0192277531277918,0.00394007001541713,-0.0269502903580094,-0.0115052158975742,1.06611516256113e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,29820,0.0101442581392838,0.00208029723230495,0.0060668755639661,0.0142216407146015,1.08622685839844e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,29536,0.0155276954156732,0.00319246050745973,0.00927047282105216,0.0217849180102943,1.15707900848054e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,24793,-0.0177298819774771,0.00365585249473052,-0.0248953528671489,-0.0105644110878053,1.24381851410133e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,-0.0126928819955618,0.0026329025989191,-0.0178533710894432,-0.00753239290168038,1.43780115150063e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,28797,-0.0274452723179998,0.00570101222130853,-0.0386192562717645,-0.0162712883642351,1.48610812420356e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,29443,0.0166635410152256,0.00346263653345559,0.00987677340965267,0.0234503086207986,1.49878203554058e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,-0.0248343087781053,0.00516124671400601,-0.034950352337557,-0.0147182652186535,1.50408879735229e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,24445,-0.00998084835343324,0.00207932408751149,-0.0140563235649558,-0.00590537314191072,1.59567805330953e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,-0.0296812632200558,0.00618789627663328,-0.041809539922257,-0.0175529865178545,1.62280239613213e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,29531,0.00951062664791442,0.0019857967594245,0.00561846499944241,0.0134027882963864,1.68154257770397e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,24229,-0.0213969030248029,0.00447437891100693,-0.0301666856903765,-0.0126271203592293,1.74497630968007e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28797,-0.0158724837685541,0.00332028596729303,-0.0223802442644484,-0.00936472327265978,1.75760641361556e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24867,-0.0129994655654015,0.00272413095380186,-0.0183387622348531,-0.00766016889594982,1.83470700276969e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,24111,-0.0154857076817289,0.00324545318729029,-0.0218467959288179,-0.00912461943463997,1.83921977039702e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,-0.0345878905263779,0.00726103473391355,-0.0488195186048485,-0.0203562624479074,1.91371018596225e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRL,Prolactin,29694,-0.0254171164057815,0.00534865860816359,-0.0359004872777821,-0.0149337455337809,2.02302230542684e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,-0.0240314458672128,0.00506733463826657,-0.0339634217582153,-0.0140994699762103,2.12347832471759e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,-0.0108379292677568,0.00228567645552505,-0.0153178551205858,-0.00635800341492766,2.13135711839603e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,-0.0248173532614525,0.00524454649732227,-0.0350966643962041,-0.0145380421267008,2.2350472254192e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,24805,-0.0205229511323265,0.0043429473907778,-0.029035128018251,-0.012010774246402,2.30716220500684e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),24484,0.059897478187033,0.0126879877211528,0.0350290222535735,0.0847659341204925,2.3621654678594e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,24111,0.0105858777085854,0.00224308228483914,0.00618943643030066,0.0149823189868701,2.37934135747939e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFD,Complement factor D,24966,-0.00654880727241617,0.00138864228545669,-0.00927054615191128,-0.00382706839292107,2.41852081938143e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,-0.0297615778913894,0.00632229129188213,-0.0421532688234784,-0.0173698869593004,2.52270815055434e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,29443,0.0135066185927593,0.00287154622082772,0.00787838799993702,0.0191348491855817,2.56767165541648e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,24111,-0.0234425747811159,0.0049864003934591,-0.0332159195522957,-0.013669230009936,2.59937528517016e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0186288436050194,0.00396383995395698,-0.0263979699147751,-0.0108597172952637,2.61727157291649e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29349,-0.0177540254667484,0.00378213987465213,-0.0251670196210666,-0.0103410313124302,2.68893832388073e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,29478,-0.0252414553421598,0.0053905930753869,-0.0358070177699181,-0.0146758929144015,2.84658221676524e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,24195,0.0103896759747933,0.00222134529831327,0.00603583919009925,0.0147435127594873,2.92390316919704e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,24867,-0.0147886293436384,0.00316278324635377,-0.0209876845064918,-0.008589574180785,2.94307937823668e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,-0.00904861270119462,0.00193944537007731,-0.0128499256265461,-0.0052472997758431,3.09102792797992e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,24229,-0.0186090563398981,0.00398933740249359,-0.0264281576487856,-0.0107899550310107,3.10720573486357e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24845,-0.0154069337728728,0.00331006430778017,-0.021894659816122,-0.0089192077296237,3.26330672005692e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,24845,-0.0170250060165083,0.00365876166426182,-0.0241961788784615,-0.00985383315455517,3.28484613890993e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",29725,-0.0239980589988952,0.00517494702185572,-0.0341409551617324,-0.013855162836058,3.54399766983934e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24951,-0.0238712531823106,0.00515847331869876,-0.0339818608869602,-0.013760645477661,3.71822179880313e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24805,-0.0163592536706609,0.00355748276885876,-0.0233319198976241,-0.00938658744369774,4.27547532649771e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,24229,0.00862514142429771,0.00187773821108216,0.00494477453057667,0.0123055083180187,4.38345841011524e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,-0.0185924918367163,0.00404812889752173,-0.0265268244758589,-0.0106581591975737,4.3901549397835e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24445,-0.01897188658089,0.00414244476216242,-0.0270910783147284,-0.0108526948470517,4.67545196112737e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,28797,-0.0235416761928349,0.0051482085331502,-0.0336321649178093,-0.0134511874678605,4.83275356705078e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,29545,-0.0083227745029249,0.0018275312827781,-0.01190473581717,-0.00474081318867982,5.28184179084967e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,28931,-0.0192246308084202,0.00423369993192203,-0.0275226826749873,-0.010926578941853,5.62516304311133e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,24966,-0.023386301771077,0.00515883502670585,-0.0334976184234205,-0.0132749851187336,5.83520603067069e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,29434,-0.0205991505246625,0.00454510975418857,-0.0295075656428721,-0.0116907354064529,5.8614152435905e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,29566,0.00879707350010905,0.0019420855983225,0.00499058572739694,0.0126035612728212,5.92971509631286e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,-0.00959099278083221,0.00212274103368776,-0.0137515652068602,-0.0054304203548042,6.2609185573965e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,24922,-0.0312197865119757,0.00694351115412356,-0.0448290683740579,-0.0176105046498935,6.94730798251733e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,29349,0.00931188781884982,0.00207161621861443,0.00525152003036554,0.0133722556073341,6.98402038611591e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,24867,-0.0198881966591385,0.00442739459325187,-0.0285658900619121,-0.0112105032563648,7.08495345754527e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,28916,-0.0166707869132906,0.00371530166409113,-0.0239527781749092,-0.00938879565167196,7.24905693639935e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,29478,-0.0100779037081591,0.00224675655338272,-0.0144815465527892,-0.00567426086352896,7.30060350648546e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,24793,-0.01333585492051,0.00297599688336907,-0.0191688088119134,-0.00750290102910663,7.45779946713517e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,29581,-0.00665759187971004,0.00148695452504856,-0.00957202274880522,-0.00374316101061486,7.58633825430697e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,-0.0198040709974802,0.00442475560436659,-0.0284765919820387,-0.0111315500129217,7.64829951092243e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,24845,-0.012157269430012,0.00272381563839067,-0.0174959480812577,-0.00681859077876629,8.10530254073807e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,29454,-0.0113235120826312,0.00254187812592337,-0.016305593209441,-0.00634143095582137,8.42876934086998e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNLY,Granulysin,29443,-0.0163860844821433,0.00368503154802138,-0.0236087463162652,-0.00916342264802139,8.75343627540721e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,29725,0.0187555032276847,0.00422346423439424,0.010477513328272,0.0270334931270974,8.99536186970722e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,-0.0376877228528977,0.0084870019086669,-0.0543222465938848,-0.0210531991119105,9.00179373367646e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,24867,-0.021653166870663,0.00489566847701321,-0.0312486770856089,-0.0120576566557171,9.77873855768246e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,-0.0275466066085078,0.00623114587433482,-0.039759652522204,-0.0153335606948115,9.86973388063803e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,29491,-0.0201662310900483,0.00456261426975728,-0.0291089550587726,-0.011223507121324,9.91056094392337e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,-0.0311561457394945,0.00705083295138948,-0.0449757783242179,-0.0173365131547711,9.96097010264641e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,28931,-0.0168264068300829,0.00382345330327726,-0.0243203753045063,-0.00933243835565947,1.08218203372383e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,29434,0.0132815839676639,0.00301811107246363,0.00736608626563517,0.0191970816696926,1.08317414801048e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,-0.0180316709635791,0.00410684975569552,-0.0260810964847423,-0.00998224544241587,1.13414457946879e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,24951,-0.0081745978874266,0.00186277611639063,-0.0118256390755522,-0.00452355669930096,1.14658684203686e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,-0.0220532408155833,0.00502647098302729,-0.0319051239423168,-0.0122013576888499,1.15098868315091e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.0152187199140944,0.00347140312502647,-0.0220226700391463,-0.00841476978904255,1.16908574771011e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,28745,-0.0174217867418411,0.00397653879108504,-0.0252158027723678,-0.00962777071131442,1.18475873935287e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,29443,-0.00746933543220787,0.00170822460228739,-0.0108174556526912,-0.00412121521172458,1.23212192252028e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29374,-0.0101404384946958,0.00231922652978943,-0.0146861224930831,-0.00559475449630853,1.2334631511984e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,24867,-0.024003947882234,0.00550758174873377,-0.0347988081097522,-0.0132090876547158,1.31574572342175e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28797,-0.0122635519697443,0.00281925048066327,-0.0177892829118443,-0.00673782102764426,1.36646884481394e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.0144095116132542,0.00331303873697161,0.00791595568878983,0.0209030675377186,1.3709502816337e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24845,-0.0738550014611723,0.0169926479195552,-0.1071605913835,-0.0405494115388441,1.3900848194096e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,24111,0.0124222519021843,0.00286349664894364,0.0068097984702548,0.0180347053341139,1.44276986394462e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,24111,-0.0185107906066079,0.00426793448487707,-0.026875942196967,-0.0101456390162489,1.44909907389854e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,28722,-0.0110804993954888,0.00255567453078872,-0.0160896214758347,-0.0060713773151429,1.4582738830489e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,29632,-0.0188203832334785,0.0043446576481075,-0.0273359122237692,-0.0103048542431878,1.48351120744781e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,24867,-0.00785626234917777,0.00181580194653821,-0.0114152341643927,-0.00429729053396288,1.52014009953308e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,-0.0125013029898425,0.00289072860183567,-0.0181671310494404,-0.00683547493024456,1.53405260206813e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,29349,-0.00700037733086309,0.00162237838253595,-0.0101802389606336,-0.00382051570109263,1.60207581659028e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,-0.00843044328320129,0.00195392640636336,-0.0122601390396735,-0.00460074752672909,1.60413214526686e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,24502,-0.0130193230965365,0.00302831233535342,-0.0189548152738292,-0.00708383091924382,1.72077316405941e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,24111,0.00842215759470188,0.0019590177369587,0.00458248283026283,0.0122618323591409,1.72109151047173e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,-0.0163394546189639,0.00382216249308513,-0.0238308931054108,-0.00884801613251705,1.91934528574644e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,-0.0144642711058553,0.0033870038557625,-0.0211027986631498,-0.00782574354856078,1.95643286888062e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24805,-0.0294822346056946,0.00697246295523434,-0.0431482619979539,-0.0158162072134353,2.36221378879148e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,29434,-0.0193765319562709,0.00460469389635788,-0.0284017319931323,-0.0103513319194094,2.58409149384108e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCT,Secretin,24195,-0.0140205880776211,0.00333419337831956,-0.0205556070991275,-0.00748556905611481,2.61915091044035e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,24793,-0.0117489671286024,0.00280253779355948,-0.017241941203979,-0.00625599305322586,2.77147159140774e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,-0.0193313466089788,0.00461535194314221,-0.0283774364175375,-0.0102852568004201,2.81803599739173e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,28774,-0.0126475226383769,0.00302402790028653,-0.0185746173229385,-0.0067204279538153,2.89374280037478e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,29242,0.0146350049754655,0.00350632429224041,0.00776260936267433,0.0215074005882567,3.00310749068967e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',24111,-0.0127446366459595,0.00305510391177023,-0.0187326403130291,-0.00675663297888981,3.03542197450577e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,-0.0126870986152715,0.00304189336294986,-0.0186492096066532,-0.00672498762388976,3.04577390021186e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRTN,Neurturin,28931,-0.0145270691815914,0.00349305846974917,-0.0213734637822997,-0.007680674580883,3.20790717616502e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,24016,-0.0124825280049992,0.0030059079319434,-0.0183741075516083,-0.00659094845839015,3.29761015464539e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,24229,-0.00500080817493206,0.00120662370067859,-0.00736579062826209,-0.00263582572160202,3.41767196771581e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,24833,-0.00922768772829234,0.00222797239086605,-0.0135945136143898,-0.00486086184219488,3.45817115995003e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,29761,-0.0175002359793854,0.00424166659591032,-0.0258139025073696,-0.00918656945140117,3.70464669488269e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28662,-0.0168047100029824,0.00407492236869688,-0.0247915578456283,-0.00881786216033653,3.73505540544731e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,-0.0110275171535878,0.00269046358209217,-0.0163008257744885,-0.00575420853268716,4.16517840825481e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",24867,-0.00658471707769715,0.00161103483869384,-0.00974234536153707,-0.00342708879385723,4.37869926266574e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,-0.00757632584822668,0.00185402857296071,-0.0112102218512297,-0.00394242984522368,4.39504528638767e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,28847,-0.025707735732836,0.00630274548261699,-0.0380611168787653,-0.0133543545869068,4.53872949318633e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24793,-0.0151421712854363,0.00372301907079484,-0.0224392886641941,-0.00784505390667838,4.77335432351995e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24845,-0.00957186491908775,0.00235962248381932,-0.0141967249873736,-0.00494700485080189,4.99606010283859e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,-0.00823129944991544,0.00203254559896189,-0.0122150888238807,-0.00424751007595014,5.14285373147305e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.0221714045855697,0.00547498914294844,-0.0329023833057486,-0.0114404258653908,5.14440116815044e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,28443,-0.0102465001282007,0.00253774495683745,-0.0152204802436021,-0.00527252001279933,5.41331472188891e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,24833,-0.013535909250537,0.00335738987440598,-0.0201163934043728,-0.0069554250967013,5.55457521231729e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,28931,-0.0190201738394174,0.00472651260724035,-0.0282841385496085,-0.00975620912922634,5.73280464330936e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,24793,-0.0114401851697157,0.00284295105022527,-0.0170123692281572,-0.00586800111127414,5.73749065885419e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,24229,-0.00950335498732983,0.0023704228647263,-0.0141493838021934,-0.00485732617246629,6.11230598930523e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MB,Myoglobin,29820,-0.0148268805382859,0.00370924927390015,-0.0220970091151301,-0.00755675196144157,6.42306567934766e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,28797,-0.0100405948958509,0.00251455620802542,-0.0149691250635807,-0.0051120647281211,6.54075401922887e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,24111,0.0102174934050288,0.00256174220386213,0.00519647868545903,0.0152385081245986,6.6690365730224e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,24111,0.0116860769719087,0.00293413452674423,0.00593517329949005,0.0174369806443274,6.83074434930082e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,-0.0127139591447084,0.00319504934040029,-0.018976255851893,-0.00645166243752381,6.93243399292299e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.0137649280347836,0.00347515395610562,-0.0205762297887507,-0.00695362628081663,7.48258473323325e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,24951,0.0405068485192977,0.0102633520785123,0.0203906784454136,0.0606230185931819,7.94375050867905e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,-0.0132273842100837,0.00335334187322958,-0.0197999342816137,-0.00665483413855368,8.01434372747295e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29473,-0.0108648245217739,0.0027560289946992,-0.0162666413513843,-0.00546300769216348,8.0923230881297e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,29434,-0.0144686796545937,0.00367721427245005,-0.0216760196285959,-0.00726133968059164,8.34971840894471e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,24845,-0.00851540871079801,0.00216618880513417,-0.012761138768861,-0.00426967865273503,8.48030143314926e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,-0.0107775995072815,0.00274184736489876,-0.0161516203424831,-0.00540357867207996,8.4905994763459e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,29165,0.0133304399226798,0.0033969350097874,0.00667244730349648,0.0199884325418631,8.7198064592724e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,0.00852675839957037,0.00217469175412301,0.00426436256148927,0.0127891542376515,8.84623284568183e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,0.00848722181579484,0.00216558580016041,0.00424267364748043,0.0127317699841092,8.9073025835111e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,24556,-0.0171090872802149,0.0043812322800901,-0.0256963025491915,-0.00852187201123828,9.44440334199079e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,-0.0105547203244618,0.00270566485123777,-0.0158578234328879,-0.0052516172160358,9.60667298215643e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,24016,0.00722003886532591,0.00185139932902533,0.00359129618043626,0.0108487815502156,9.65445970390035e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",24111,-0.0156020021243417,0.00400618161146624,-0.0234541180828155,-0.00774988616586785,9.867422374425e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",24111,0.0132343402921627,0.00339846512486702,0.00657334864742337,0.0198953319369021,9.87845131628815e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C7,Complement component C7,24374,-0.00898141332396908,0.00230771357853758,-0.0135045319379027,-0.00445829471003543,9.97228721410252e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,29523,-0.0152105169409655,0.00390913392183136,-0.022872419427755,-0.00754861445417607,0.00010004292653359
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,-0.0332904337630768,0.00856017925761858,-0.0500683851080092,-0.0165124824181444,0.000100884282782367
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGN,Cingulin,24195,-0.0109899061162005,0.00283947665185539,-0.0165552803538371,-0.00542453187856394,0.000108942878995569
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,29327,-0.0161820217752819,0.00418597067415962,-0.0243865242966347,-0.00797751925392902,0.000110975605307941
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,0.00711041772346704,0.00183940375862295,0.00350518635656606,0.010715649090368,0.000111102440353134
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,29443,-0.0120253747724064,0.00311219437766827,-0.0181252757526362,-0.00592547379217656,0.00011180554130879
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28797,-0.0143627450216389,0.00372138207155298,-0.0216566538818828,-0.00706883616139505,0.000113858304846591
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24445,-0.0120461389400498,0.00312340302703507,-0.0181680088730386,-0.00592426900706111,0.000115206094911762
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FN1,Fibronectin,24966,-0.00731665177196119,0.00189902317112646,-0.0110387371873691,-0.00359456635655333,0.000117042826810436
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,-0.00768102622471498,0.00199896061550017,-0.0115989890310953,-0.00376306341833464,0.000122092983459394
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,-0.0132382020261138,0.0034688719273933,-0.0200371910038047,-0.00643921304842298,0.000135804472693108
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,29725,0.0119827890316815,0.00315262597976784,0.00580364211133654,0.0181619359520265,0.000144464151508003
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,29478,0.00912158274149619,0.00240789844363004,0.0044021017919813,0.0138410636910111,0.000152048776113326
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,-0.0147264513716717,0.00389735715201136,-0.022365271389614,-0.00708763135372944,0.000158097507737291
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,28852,-0.0195623919758859,0.00518208299146709,-0.0297192746391614,-0.00940550931261046,0.000160324681530107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,29820,-0.00702619586057758,0.00186173673218676,-0.0106751998556636,-0.00337719186549153,0.000160961357347463
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,24793,-0.0165118710871564,0.004384526184161,-0.025105542408112,-0.00791819976620086,0.000166305782531266
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,29590,-0.0109336105107232,0.00290579071290364,-0.0166289603080143,-0.00523826071343204,0.000168415039739629
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24938,-0.0163551383912916,0.00435015203361618,-0.0248814363771793,-0.00782884040540388,0.000170525720404102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,24195,-0.0174094983624889,0.0046418695890031,-0.0265075627569349,-0.00831143396804277,0.000176868543997793
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,24445,0.00983785086761749,0.00262308945880968,0.00469659552835051,0.0149791062068845,0.000176902019407746
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28797,-0.0108058391879472,0.00289053790602908,-0.0164712934837642,-0.00514038489213015,0.000185591191766937
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,24966,0.00446162242632663,0.00119628084508253,0.00211691196996487,0.0068063328826884,0.000192225304178281
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,29132,0.0179049902582381,0.00480192320100638,0.00849322078426558,0.0273167597322106,0.000192825267700487
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,0.00783107624721329,0.00210186948583591,0.0037114120549749,0.0119507404394517,0.000195164383076083
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.0107585965925727,0.00288862987919457,0.00509688202935133,0.016420311155794,0.000196100189193797
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,28797,-0.0195927887512677,0.00526109100814685,-0.0299045271272355,-0.00928105037529986,0.000196393053719551
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.00813837235679095,0.00218707363875868,0.00385170802482393,0.012425036688758,0.000198775205246612
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,24111,0.0110847111540219,0.00298023722051995,0.00524344620180281,0.016925976106241,0.000200144988325619
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",29395,-0.0286865921350598,0.00773311979152827,-0.0438435069264552,-0.0135296773436644,0.000207989265640401
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,0.0166122907189572,0.00448307322729819,0.00782546719345275,0.0253991142444617,0.000211395364596026
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,24845,-0.0254161103583965,0.00686792481583815,-0.0388772429974393,-0.0119549777193537,0.000215472181000794
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,-0.00712201636230515,0.00192824124364082,-0.0109013691998412,-0.00334266352476916,0.0002215699329521
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,24229,0.0112685416124568,0.00305308037246223,0.00528450408243083,0.0172525791424828,0.000223972878457069
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,28604,0.0181719794691974,0.00493480046841759,0.00849977055109894,0.0278441883872959,0.000231460890759312
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,-0.00580641883599854,0.00158053072134127,-0.00890425904982743,-0.00270857862216965,0.000239479600503738
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,-0.0165563286546095,0.00451180302543668,-0.0253994625844654,-0.00771319472475362,0.000243486964337164
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,29787,0.011152560391132,0.00304614464579594,0.00518211688537195,0.017123003896892,0.000251465871996738
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,24229,-0.0167512363798948,0.00458119438057524,-0.0257303773658223,-0.00777209539396734,0.00025620201497978
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,0.00892798940774846,0.00244398393726026,0.00413778089071834,0.0137181979247786,0.000259695778454079
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,28931,-0.00915039263401376,0.00250678814062231,-0.0140636973896335,-0.00423708787839404,0.000262450938963031
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,24381,-0.0290720384470921,0.00796661250891237,-0.0446865989645603,-0.0134574779296238,0.000263571923597209
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28774,-0.0373516021364371,0.0102583381208974,-0.057457944853396,-0.0172452594194781,0.000271955210280049
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,24343,-0.0149350252003234,0.00410181137105192,-0.0229745754875852,-0.00689547491306167,0.000272059266561842
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,29434,-0.00997280254312668,0.0027433056338197,-0.0153496815854133,-0.00459592350084007,0.000278105593945663
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,-0.0264791719842594,0.00729517085848328,-0.0407777068668866,-0.0121806371016322,0.000284338053003306
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00763848333658562,0.00210830016641692,-0.0117707516627628,-0.00350621501040845,0.000291726194284369
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VIM,Vimentin,28916,-0.029732406396465,0.00824260896519812,-0.0458879199682533,-0.0135768928246766,0.000310088901002385
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,29713,-0.00540528392135021,0.00149910260234587,-0.00834352502194812,-0.0024670428207523,0.000311846677544001
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,24738,0.00693839498956767,0.00192859057540296,0.00315835746177788,0.0107184325173575,0.000321731019637025
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,24867,-0.0175734685437816,0.00489046030450337,-0.0271587707406082,-0.007988166346955,0.000326998859857931
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29566,-0.00693751945377823,0.00193143118873928,-0.0107231245837072,-0.00315191432384924,0.000328800661764674
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24966,0.00661738443751101,0.00184856626899773,0.00299419455027546,0.0102405743247465,0.000344590306636509
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,0.0148364898733939,0.00416691397557071,0.00666933848127529,0.0230036412655125,0.000370796708037489
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,24016,0.00766120492070883,0.00215189250965933,0.00344349560177654,0.0118789142396411,0.000371264092745859
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,24229,0.00861395562858774,0.00242224225562853,0.00386636080755581,0.0133615504496197,0.000376988510968281
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,24240,-0.00751801401681031,0.00211482256820893,-0.0116630662504998,-0.00337296178312082,0.000378821465461383
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,24381,0.00711737049430319,0.00200412255369685,0.00318929028905736,0.011045450699549,0.000383961391384534
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,24101,0.00839165830206817,0.0023636912815312,0.00375882339026702,0.0130244932138693,0.00038562155095072
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,0.00794285163252342,0.00223999305359836,0.00355246524747063,0.0123332380175762,0.00039197651079627
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,-0.00989389306038664,0.00279927849458072,-0.0153804789097649,-0.00440730721100842,0.000409399477802175
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",24195,-0.00979366788684402,0.0027714396239734,-0.0152256895498319,-0.00436164622385615,0.000410420503756999
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,-0.0140243759739475,0.00397553681282763,-0.0218164281270897,-0.00623232382080539,0.000419993481394722
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,0.00779850184958687,0.002212526370514,0.00346195016337943,0.0121350535357943,0.000424596250491046
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,24111,-0.0110246364185205,0.00313028578897633,-0.0171599965649141,-0.00488927627212694,0.000429214890021835
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,0.00942179803232306,0.00267561079666817,0.00417760087085345,0.0146659951937927,0.000430126908169405
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,24195,0.00795411933449612,0.0022664959891889,0.00351178719568588,0.0123964514733064,0.000449876879817965
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,29694,-0.0161969501747373,0.00461996905361042,-0.0252520895198138,-0.0071418108296609,0.000455811369261772
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",28916,-0.0208663738560179,0.00595478278325492,-0.0325377481111975,-0.00919499960083824,0.000458782588632021
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,24111,-0.018333719081025,0.00524787236790813,-0.0286195489221249,-0.00804788923992503,0.000477493639343085
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,24381,-0.0190391159002568,0.00545038901020776,-0.029721878360264,-0.00835635344024955,0.000478175199142808
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,24852,-0.0160714147435124,0.00460431531931954,-0.0250958727693787,-0.00704695671764607,0.000482933325636467
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29662,-0.0156241497472412,0.00450019221586422,-0.0244445264903351,-0.00680377300414732,0.000517553757390644
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,24195,-0.0171195348120736,0.00493685254392182,-0.0267957657981604,-0.00744330382598684,0.000525841097181622
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,28722,-0.0149909673272113,0.00435153772311219,-0.0235199812645112,-0.00646195338991144,0.000571914284951951
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,24195,-0.0131991259484417,0.00383418201275485,-0.0207141226934412,-0.0056841292034422,0.000577364402921448
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,24445,0.00841443914099428,0.00244655651737666,0.00361918836693601,0.0132096899150525,0.000584196182286286
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,28797,-0.0184865570975433,0.00539212871391078,-0.0290551293768084,-0.00791798481827812,0.000607924018276644
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29674,-0.0161305343245726,0.00471644049143498,-0.0253747576877851,-0.00688631096135999,0.00062690384298701
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,24381,0.022687236667206,0.00664105235857529,0.00967077404439842,0.0357036992900136,0.000636026196967589
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,-0.00556644439727158,0.00163625755278688,-0.00877350920073387,-0.0023593795938093,0.000669980370202064
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.0120757396758973,0.00357910958532645,0.00506068488865742,0.0190907944631371,0.000742104689096804
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,-0.011755059730793,0.00350631212938638,-0.0186274315043903,-0.00488268795719569,0.000801928158716119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRELP,Prolargin,29454,-0.0054949718039801,0.00164478532568235,-0.0087187510423175,-0.0022711925656427,0.000836278522669547
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,28774,-0.0158587714474624,0.00476942754187927,-0.0252068494295458,-0.00651069346537905,0.000885008086915529
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,24101,0.00666223569255412,0.00200400630220273,0.00273438334023676,0.0105900880448715,0.000887226094221475
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,24938,0.00784805201043204,0.00236538677935151,0.00321189392290308,0.012484210097961,0.000908356719320722
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,24867,-0.01403913361294,0.00423872065204131,-0.0223470260909409,-0.005731241134939,0.000927252697658539
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,0.0075386280639719,0.0022761740425478,0.00307732694057821,0.0119999291873656,0.000927766337436622
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,24445,0.00799957047515269,0.00241656815090449,0.00326309689937989,0.0127360440509255,0.000933302867400789
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,23970,0.0096014722505152,0.00290295576717834,0.00391167894684565,0.0152912655541847,0.000942775284551058
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,-0.0171193829513916,0.00520941183015282,-0.0273298301384911,-0.00690893576429206,0.00101652933626817
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,28353,0.00730897473617701,0.00222989910125739,0.00293837249771253,0.0116795769746415,0.00104776757738813
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.0197558264297287,0.00604333167401899,-0.0316007565108059,-0.00791089634865148,0.00108067672361967
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,-0.0106327575280927,0.00325544814468705,-0.0170134358916794,-0.00425207916450612,0.00109175658390402
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,28931,-0.013721742926066,0.0042059048184273,-0.0219653163701836,-0.00547816948194853,0.00110564176079341
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,24149,-0.0157724540221578,0.00483911896989184,-0.0252571272031458,-0.0062877808411698,0.00111816522047804
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,24016,0.00811135849202297,0.00249483514823832,0.00322148160147587,0.0130012353825701,0.00115053034365136
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,-0.0162817063816836,0.00501482065109643,-0.0261107548578326,-0.00645265790553462,0.00116901505342135
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,-0.0137087814863795,0.00423619535835315,-0.0220117243887517,-0.00540583858400729,0.0012133472706587
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,24195,-0.0138360795464334,0.00429939490947162,-0.0222628935689978,-0.00540926552386899,0.00129192265230016
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,24111,0.0126628264433673,0.00394067187433121,0.00493910956967816,0.0203865433170565,0.00131360915192685
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,24381,-0.00825282492444624,0.0025717405608675,-0.0132934364237465,-0.00321221342514594,0.00133350137891996
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,29639,0.00576729433870272,0.00179835820852381,0.00224251224999605,0.00929207642740938,0.00134279924367984
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,29169,0.00726815190244447,0.00227080390061388,0.00281737625724127,0.0117189275476477,0.00137243182550353
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,24793,-0.00844186137753625,0.00264456765538674,-0.0136252139820943,-0.00325850877297824,0.00141393364414704
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,29114,-0.0235275520836154,0.00738153971440068,-0.0379953699238407,-0.00905973424339005,0.00143734566048009
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,24919,0.0247332015949199,0.00777514518829656,0.00949391702585866,0.0399724861639812,0.00146917256106813
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.00834321189473857,0.00262322857051102,0.00320168389653698,0.0134847398929402,0.00147199856010571
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28916,-0.012829909998503,0.00406534884695996,-0.0207979937385445,-0.0048618262584615,0.00160157667380992
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29361,-0.00755636476932517,0.00239786050120958,-0.0122561713516959,-0.0028565581869544,0.00162711830653846
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,-0.0149492154140024,0.00474864690140192,-0.0242565633407501,-0.0056418674872546,0.00164530342625987
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,29566,-0.0176165747604739,0.00560064892181482,-0.0285938466472309,-0.00663930287371683,0.00165994542560989
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,24016,0.00568839153085235,0.00180927556432478,0.00214221142477579,0.00923457163692892,0.00166849322105504
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,-0.0194041613810105,0.00618359812830771,-0.0315240137124936,-0.00728430904952735,0.00170306025150696
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,24016,0.00693504878422535,0.00221344348636792,0.00259669955094422,0.0112733980175065,0.00173149547888788
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,24101,0.020126251785089,0.00643458456555061,0.00751446603660979,0.0327380375335682,0.00176315059648014
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,24195,-0.0108218213143888,0.00346697990315539,-0.0176171019245733,-0.0040265407042042,0.00180207087603811
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,0.0116194415496212,0.00373160723634006,0.00430549136639465,0.0189333917328477,0.00184917210628305
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,24111,0.00885108177303169,0.00285046066283986,0.00326417887386556,0.0144379846721978,0.00190408969920209
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,24951,0.00496735162387756,0.00160089016597984,0.00182960689855707,0.00810509634919806,0.00191868952424468
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,24229,-0.00901321068515067,0.00290512775885306,-0.0147072610925027,-0.00331916027779868,0.00192102697885389
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,28774,-0.00849971706875887,0.00273983737338464,-0.0138697983205928,-0.00312963581692496,0.00192228216959341
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,24016,-0.016064283292281,0.00518938907401768,-0.0262354858773557,-0.00589308070720635,0.00196639864775331
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,29218,0.00265695459669758,0.000859219470744523,0.000972884434038319,0.00434102475935685,0.00198806770633606
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,28931,-0.0085047353399552,0.0027538121568331,-0.0139022071673481,-0.00310726351256233,0.00201462008959031
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,0.006954088080987,0.00225257923526606,0.00253903277986552,0.0113691433821085,0.00202261669557728
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,29349,-0.0412325453664799,0.0133639029646572,-0.067425795177208,-0.0150392955557518,0.00203490254007739
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,24229,-0.00475034998429645,0.00154294190601666,-0.0077745161200891,-0.0017261838485038,0.00208095532712835
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,24966,-0.00564012265538695,0.00183751542762619,-0.00924165289353428,-0.00203859241723963,0.00214698740502522
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,24867,-0.00815281887321307,0.00265962884271681,-0.013365691404938,-0.00293994634148812,0.00217614178704056
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,24229,-0.00642576372186172,0.00210272941010243,-0.0105471133656625,-0.00230441407806095,0.0022461852366279
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,29137,0.0135123517739317,0.00442365383509836,0.00484199025713891,0.0221827132907245,0.00225588445270504
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,28797,-0.0113590064672143,0.0037187346818164,-0.0186477264435745,-0.00407028649085418,0.00225615470351049
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,29434,-0.0191955737133413,0.00629166943744852,-0.0315272458107404,-0.00686390161594217,0.00228321066484295
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,24101,-0.00951870693814759,0.00313530263430882,-0.0156639001013929,-0.0033735137749023,0.00240013665944966
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,24307,-0.018090856050013,0.00596477364679652,-0.0297818123977342,-0.00639989970229182,0.0024243181755317
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.00857652505731314,0.00283004124538919,-0.014123405898276,-0.00302964421635032,0.0024438381480439
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,24229,-0.0227735761166408,0.00754330823818999,-0.0375584602634932,-0.00798869196978843,0.00253838023291468
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,-0.00588674690483446,0.00195396635944015,-0.00971652096933714,-0.00205697284033178,0.00259180594935074
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,0.00714140942883512,0.00237105058259175,0.00249415028695529,0.011788668570715,0.00259824026436739
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.0129535389583727,0.00430926575674339,0.00450737807515562,0.0213996998415897,0.00264955243352565
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,-0.00708072679859117,0.00235752293786496,-0.0117014717568065,-0.00245998184037585,0.00267200802810255
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,28931,-0.00723746926991448,0.0024121390663068,-0.0119652618398758,-0.00250967669995316,0.0026982299934871
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,29199,0.0269965824446409,0.00900658295310315,0.00934367985655874,0.0446494850327231,0.00272497356366917
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,24101,0.00913856889627982,0.00305173990450203,0.00315715868345584,0.0151199791091038,0.002751347544209
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,28797,0.0172998449943384,0.00577884978835732,0.00597329940915806,0.0286263905795188,0.00275897384687466
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00660692481522781,0.00221436027298257,0.00226677868018199,0.0109470709502736,0.00285049793811122
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,24349,0.00779037039024524,0.00261326787651138,0.00266836535228294,0.0129123754282075,0.00287514310795215
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,-0.0113453863121914,0.00381294001918499,-0.018818748749794,-0.00387202387458881,0.00292758644936577
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,-0.0163075078774761,0.00548856436953842,-0.0270650940417714,-0.00554992171318076,0.00296949866229331
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,-0.00732199211360392,0.00247206723536169,-0.0121672438949128,-0.002476740332295,0.00305998052803218
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,24845,0.015862758796054,0.00535898586949655,0.00535914649184072,0.0263663711002672,0.00307899664523949
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.00966196760127984,0.00328565166093045,-0.0161018448567035,-0.00322209034585615,0.0032777155046019
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,-0.00672986217948309,0.00228866516849156,-0.0112156459097265,-0.00224407844923963,0.00327974939864143
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,24101,0.0131587607133536,0.00447528951911786,0.00438719325588262,0.0219303281708246,0.00328190366946864
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,24229,-0.0160224321700108,0.00546207084079294,-0.026728091017965,-0.00531677332205666,0.00335587139747775
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,29478,-0.0093242021685852,0.00318146447841609,-0.0155598725462807,-0.00308853179088967,0.00338361550934048
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,-0.00617677127886579,0.00211060138133666,-0.0103135499862856,-0.00203999257144594,0.00343058858152503
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.0202906760531317,0.00694807556528362,0.00667244794517586,0.0339089041610876,0.00349924693353294
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,24101,-0.0230042896453618,0.00789640320612657,-0.0384812399293698,-0.00752733936135369,0.00358003294918781
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,24016,0.00541500081902642,0.00186386116814094,0.00176183292947018,0.00906816870858266,0.00367283468374209
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29594,-0.00567311619802227,0.00195418370598986,-0.0095033162617624,-0.00184291613428214,0.0036980662836039
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,24101,0.00726145403693022,0.00250285082232137,0.00235586642518034,0.0121670416486801,0.00371986128781337
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C5,Complement C5,24966,-0.00311766455669039,0.00107619491984738,-0.00522700659959126,-0.00100832251378951,0.00377157760769952
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,24381,-0.0106750176209862,0.00368898004876824,-0.017905418516572,-0.00344461672540049,0.00380998172874247
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,0.00762750595766512,0.00263900282154989,0.00245506042742734,0.0127999514879029,0.003852196591545
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,29216,-0.0105546110235925,0.00365708072746264,-0.0177224892494193,-0.0033867327977657,0.00390364348399234
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24445,0.00580048461137744,0.00201013058243692,0.00186062866980108,0.00974034055295381,0.00390978213629849
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,29313,-0.0141613064862302,0.00491433430121227,-0.0237934017166063,-0.00452921125585415,0.0039590783893309
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,24016,0.0095844074611102,0.00333134185129162,0.00305497743257863,0.0161138374896418,0.00401777039789794
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.0141375848843305,0.00493250024896902,0.00446988439635118,0.0238052853723097,0.00415714458753855
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,24805,-0.0163264447519751,0.00569964948793119,-0.0274977577483202,-0.00515513175562997,0.00418065482722012
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,29820,0.00480737162017124,0.0016807337599627,0.00151313345064434,0.00810160978969813,0.00423559218783332
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29820,0.00638875126665844,0.00223865805606957,0.00200098147676209,0.0107765210565548,0.00432252983570548
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,28490,-0.00530902690351453,0.0018605738797975,-0.00895575170791763,-0.00166230209911144,0.00432805332581444
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.00522452999636159,0.00183804627428413,0.00162195929876471,0.00882710069395848,0.00448064580939164
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,-0.00955558665448259,0.003369496167193,-0.0161597991421809,-0.00295137416678431,0.00457323961917326
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,29594,0.00605828838340173,0.00213679964803306,0.00187016107325694,0.0102464156935465,0.00458257759773695
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,24445,0.00576391113695852,0.00203494052119628,0.00177542771541382,0.00975239455850322,0.00462274668867488
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,24229,0.00847399927688455,0.00300499807063514,0.00258420305843968,0.0143637954953294,0.00480674119598662
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,24615,-0.0128624164791074,0.00456543075384472,-0.021810660756643,-0.00391417220157173,0.00484603114549219
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,29518,-0.00899464755239202,0.0032007606608628,-0.0152681384476831,-0.00272115665710093,0.00495495751349129
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.00687934400215648,0.00245792232561994,0.0020618162439414,0.0116968717603716,0.00513186644245271
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24845,-0.00558443077579833,0.00199677890280996,-0.00949811742530585,-0.00167074412629081,0.00516640016204371
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,24793,-0.0104779655290039,0.00375015716835878,-0.0178282735789871,-0.00312765747902069,0.00520993168810348
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28931,-0.0089304831580475,0.00320128333098086,-0.01520499848677,-0.00265596782932502,0.00527983912305837
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,29693,-0.00634488645632245,0.00227449008177465,-0.0108028870166008,-0.00188688589604413,0.00528090607430623
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HLA_A,,24867,-0.00645972389041927,0.00232476635185244,-0.01101626594005,-0.00190318184078849,0.00546254104918785
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,29725,-0.0122526931590876,0.00444502409422812,-0.0209649403837747,-0.0035404459344005,0.00584598786989952
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,24240,-0.014293416499168,0.00519854731279393,-0.0244825692322441,-0.00410426376609193,0.00597301285315857
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,29341,-0.0139719517936718,0.00509150186356038,-0.0239512954462501,-0.0039926081410934,0.00607008111393423
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,-0.00868307388466573,0.00317036044614646,-0.0148969803591128,-0.00246916741021866,0.00617035948827444
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,0.00984143877153247,0.00361069632902608,0.00276447396664135,0.0169184035764236,0.00642243550690684
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,24229,-0.00877196905446277,0.00325137927795741,-0.0151446724392593,-0.00239926566966625,0.00698220369596117
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.00762458026369489,0.00282813140506908,-0.0131677178176303,-0.0020814427097595,0.00702310191603489
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,28774,0.00623848581814063,0.00231606052975746,0.00169900717981601,0.0107779644564652,0.00707309526765826
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,24756,-0.0112038798045247,0.00417776366687005,-0.01939229659159,-0.00301546301745939,0.00732782720309223
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,24111,0.00730669566799024,0.00273245831120871,0.00195107737802116,0.0126623139579593,0.00749946360436533
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,24867,-0.00941459329724107,0.00353614977572842,-0.0163454468576688,-0.00248373973681336,0.00776389446936706
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,0.0116391583018763,0.00437339801208181,0.00306729819819599,0.0202110184055567,0.00778788096879628
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,-0.0120302263846792,0.00452928475174247,-0.0209076244980945,-0.00315282827126401,0.00790947105086684
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28797,-0.00890035682827679,0.00335700018202776,-0.0154800771850512,-0.00232063647150238,0.00802305775148629
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F2,Prothrombin,24966,0.00278416976330279,0.00105127431994058,0.000723672096219258,0.00484466743038632,0.00809303820188047
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,-0.0111911003186576,0.00422860103291786,-0.0194791583431766,-0.00290304229413862,0.00813762319162855
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,-0.00852919412918343,0.0032272046650833,-0.0148545152727467,-0.00220387298562017,0.00822510611334882
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,24111,0.00639934050888134,0.00242503518432068,0.0016462715476128,0.0111524094701499,0.00832375981474885
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERVV_1,,24111,0.00861796523212521,0.00328075288543985,0.0021876895766631,0.0150482408875873,0.00862400631933048
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,24195,0.00689152303536868,0.00262668114108244,0.00174322799884709,0.0120398180718903,0.00870447283698224
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,-0.00688304868895457,0.00262452471149198,-0.0120271171234789,-0.00173898025443028,0.00873188584805576
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.00700596684729772,0.00267224791053927,0.00176836094264075,0.0122435727519547,0.00875263207605458
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24793,0.0096673048683748,0.0036995743915662,0.00241613906090504,0.0169184706758446,0.00897829967320767
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,24445,-0.00846237519216595,0.00323861301698102,-0.0148100567054488,-0.00211469367888315,0.00898160586170205
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,24195,-0.0139836338122145,0.00536123574026879,-0.0244916558631413,-0.00347561176128768,0.0091052954727789
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,-0.021408841594597,0.00821202103376014,-0.0375044028207669,-0.00531328036842713,0.00913905673689562
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.031518031264206,0.0121396131571247,0.00772438947624163,0.0553116730521704,0.00942822824120978
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFP,Properdin,24966,-0.00423795230609734,0.00163515339028319,-0.00744285295105239,-0.00103305166114228,0.00955373717138133
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,29478,-0.0147874969546519,0.0057072063106909,-0.0259736213236061,-0.00360137258569778,0.00957385393376683
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,24111,0.00925041353260335,0.00358375115637553,0.00222626126610732,0.0162745657990994,0.00985132667704186
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,-0.0123665068621834,0.00479234713857674,-0.0217595072537938,-0.00297350647057298,0.00987134252288728
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,24016,-0.0102398458370514,0.00398351291071717,-0.018047531142057,-0.00243216053204572,0.010159492049507
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,24111,-0.020274995789457,0.00789042346405458,-0.035740225779004,-0.00480976579991004,0.010188437571846
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,0.00754802158536671,0.00293842394290517,0.00178871065727258,0.0133073325134608,0.0102131237268098
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,-0.0197667585928362,0.00769587875528745,-0.0348506809531996,-0.00468283623247281,0.010220467332901
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,24111,-0.0164850027679996,0.00641889275852644,-0.0290660325747114,-0.00390397296128779,0.0102287740717286
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,-0.0108071907114076,0.00421101623599765,-0.019060782533963,-0.00255359888885224,0.0102806659761059
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28916,-0.00885640478174631,0.00345161649959544,-0.0156215731209534,-0.00209123644253924,0.0102966858205243
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,24922,-0.00483896272463228,0.00188643938905771,-0.00853638392718539,-0.00114154152207916,0.0103195100597437
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,24111,-0.00915929430441606,0.00357854910165733,-0.0161732505436644,-0.0021453380651677,0.010488351151881
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARTN,Artemin,28931,-0.00808362136730559,0.0031632632558557,-0.0142836173487828,-0.00188362538582842,0.0106095487884508
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24445,-0.00970300659574358,0.00380258358428497,-0.0171560704209421,-0.00224994277054505,0.0107262841139333
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,29413,-0.0230323232357137,0.00904607306287061,-0.0407626264389401,-0.00530202003248732,0.010898051637271
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,24111,0.00843931817626606,0.0033189275443139,0.00193422018941083,0.0149444161631213,0.0110034960324067
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,29566,0.00676430383188747,0.00266256260558774,0.0015456811249355,0.0119829265388395,0.0110737255479521
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28797,-0.00825918095302929,0.00326591815107406,-0.0146603805291344,-0.00185798137692414,0.0114473528022432
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,29169,-0.00714083591210811,0.00282936624807155,-0.0126863937583283,-0.00159527806588787,0.0116137127697823
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,0.00447359078552257,0.00177332135181471,0.000997880935965741,0.0079493006350794,0.0116515028242339
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,24195,-0.0093683731253514,0.00371750991415691,-0.0166546925570989,-0.00208205369360385,0.0117396430144514
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,-0.0256602091200076,0.0102179042968768,-0.0456873015418862,-0.005633116698129,0.012035302657101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,-0.00857364131957344,0.00343211024667252,-0.0153005774030516,-0.00184670523609529,0.0124938700679849
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,24966,-0.00451630672594935,0.00181082087227397,-0.00806551563560633,-0.000967097816292361,0.0126353270363679
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,28751,-0.0153120989819706,0.00614592848090969,-0.0273581188045536,-0.0032660791593876,0.0127288994690983
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,24833,-0.00456398492244026,0.00183459026227174,-0.00815978183649286,-0.00096818800838766,0.0128622534256509
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,24016,-0.0127647565367305,0.0051413189116343,-0.0228417416035337,-0.00268777146992728,0.0130429887717135
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,24101,0.00870815254068785,0.0035095061542208,0.00182952047841508,0.0155867846029606,0.013097028767059
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,28872,-0.00984862084585551,0.00397631169837175,-0.0176421917746641,-0.00205504991704689,0.0132614426085601
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,29497,0.00582329419560593,0.00235255819756241,0.0012122801283836,0.0104343082628283,0.0133178977551204
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.00665580511370386,0.00268987199053339,-0.0119279542151493,-0.00138365601225842,0.0133528384245145
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,24016,0.00817060520128677,0.00330590680905979,0.00169102785552958,0.014650182547044,0.013460998086457
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,29820,-0.0126396987766395,0.00512837917077225,-0.0226913219513531,-0.00258807560192586,0.0137200205831563
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,24195,0.00755121461300724,0.00306673049235833,0.00154042284798491,0.0135620063780296,0.0138117843384658
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,24329,0.00535531894190724,0.00217652557582384,0.0010893288132925,0.00962130907052197,0.013881652916747
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,24867,-0.00530166073127639,0.00215689881635174,-0.00952918241132579,-0.00107413905122699,0.0139780294245788
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,24101,0.0166858142867149,0.00680727063583223,0.00334356384048372,0.0300280647329461,0.014246109261702
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.00751190168235788,0.00306976951936462,0.00149515342440323,0.0135286499403125,0.0144096483209846
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,24195,0.00502697813612999,0.00206021714918919,0.000988952523719173,0.00906500374854081,0.0146934411060613
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,-0.00700978206795732,0.00287539046520089,-0.0126455473797511,-0.00137401675616358,0.014781918767449
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,-0.0148010951308769,0.00607937521173505,-0.0267166705458776,-0.00288551971587619,0.0149137860087722
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,24195,-0.0100013139731803,0.00411032231470747,-0.018057545710007,-0.00194508223635369,0.0149724468304335
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,-0.0120738854736103,0.00496213748964525,-0.021799674953315,-0.00234809599390561,0.0149731107597491
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,24229,-0.00631581640478952,0.00260132140098559,-0.0114144063507213,-0.00121722645885777,0.0151926694036539
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29662,-0.00697838403295941,0.00287671249252381,-0.0126167405183061,-0.00134002754761275,0.0152798095989452
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,28916,-0.0082982506947106,0.00344135359936423,-0.0150433037494645,-0.00155319763995671,0.015900509194941
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,24914,0.00253003264725604,0.00104941762462962,0.000473174102981986,0.00458689119153009,0.0159207514109069
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,24793,-0.0103956561280357,0.00433803301689064,-0.0188982008411413,-0.00189311141493,0.0165644407669182
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HLA_DRA,,29322,-0.00611179118847869,0.0025535613467845,-0.0111167714281763,-0.00110681094878107,0.0166975451512083
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,-0.00974996783928724,0.00407761606917161,-0.0177420953348636,-0.00175784034371089,0.0168058558915915
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENG,Endoglin,29820,0.00290321920203208,0.00121707306899013,0.000517755986811434,0.00528868241725272,0.0170662692572706
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.00481449064812909,0.00201837136174917,-0.00877049851715747,-0.000858482779100708,0.0170699398930142
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,24793,0.018918640587769,0.00793389693181099,0.0033682026014195,0.0344690785741186,0.0171082817146948
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29628,0.00339525767510638,0.00143254360071738,0.000587472217700318,0.00620304313251244,0.0177901108377119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,-0.010423005349284,0.00439836570665679,-0.0190438021343313,-0.00180220856423665,0.0178081888652946
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,-0.0145591834472772,0.00615293510054228,-0.0266189362443401,-0.00249943065021436,0.0179787732827871
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,28830,-0.00814597721299703,0.00345094727912638,-0.0149098338800847,-0.00138212054590933,0.0182567105656853
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,-0.0162922769215286,0.00690264769586845,-0.0298214664054307,-0.00276308743762641,0.0182681678528129
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,24195,0.00632414294650787,0.00268091323471247,0.00106955300647144,0.0115787328865443,0.0183345827730051
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,28774,-0.00665083952324021,0.00282710756029607,-0.0121919703414205,-0.00110970870505992,0.0186531663543645
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,24240,0.00662403909065791,0.00282413945244783,0.00108872576386017,0.0121593524174556,0.0190092390589708
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,24195,-0.0151635606516549,0.0065301972801248,-0.0279627473206995,-0.00236437398261032,0.0202375487093939
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,28774,-0.00624707766831487,0.00270158212387234,-0.0115421786311047,-0.000951976705525093,0.0207639151078
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,24445,-0.00718254701610896,0.00311189165154059,-0.0132818546531285,-0.00108323937908941,0.0210020662648047
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,24793,-0.00601254854309933,0.00261733452629582,-0.0111425242146391,-0.000882572871559514,0.021615492008278
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,24101,0.00754199028657509,0.00328697662579197,0.00109951610002284,0.0139844644731273,0.0217699640368582
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.0121782452091384,0.00531287626041721,-0.0225914826795561,-0.00176500773872064,0.0219019247703385
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,24101,0.00618700119892202,0.00270088225950934,0.00089327197028371,0.0114807304275603,0.0219874343390352
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,24195,-0.0102417307577872,0.00447561287566706,-0.0190139319940946,-0.00146952952147972,0.0221262267172145
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,24016,-0.00968204642510458,0.0042367837006714,-0.0179861424784205,-0.00137795037178862,0.0223077318578758
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",24195,-0.0137157308380541,0.00600386911341209,-0.0254833143003418,-0.0019481473757664,0.0223518432684382
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,24101,0.00553313665966662,0.00243122882679304,0.000767928159152262,0.010298345160181,0.022863124557516
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,24966,-0.00337010450044405,0.00148458719296674,-0.00627989539865886,-0.000460313602229246,0.0232123313712094
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,-0.00658959251980721,0.00291418131594564,-0.0123013878990607,-0.00087779714055376,0.0237546821713592
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,24657,-0.00479396028691899,0.00212279041469109,-0.00895462949971352,-0.000633291074124462,0.0239338293245939
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,29218,-0.00558922892305346,0.00247629645229238,-0.0104427699695465,-0.0007356878765604,0.0240096832565416
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,24445,0.00626096241812723,0.0027771481655156,0.000817752013716663,0.0117041728225378,0.0241762226281771
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,-0.0165993246014605,0.00736547848404989,-0.0310356624301983,-0.00216298677272275,0.0242261384020421
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24805,-0.00416285993340388,0.00185049326907568,-0.00778982674079221,-0.000535893126015555,0.0244834185337266
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,24016,0.00755805233667824,0.00336072180453268,0.000971037599794188,0.0141450670735623,0.0245255205247998
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,28797,-0.00628103420759522,0.00279344352761763,-0.0117561835217258,-0.000805884893464667,0.0245523956857945
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,28931,-0.0100172394008172,0.00445709374705961,-0.0187531431450541,-0.00128133565658038,0.024616725574925
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,24867,-0.0120990317181087,0.00538416969838179,-0.022652004326937,-0.00154605910928034,0.0246392413362491
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,24101,0.00944052853332793,0.00420611057855735,0.00119655179935551,0.0176845052673003,0.0248106134695865
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,29478,0.0185324555758817,0.00826126568628683,0.00234037483075948,0.0347245363210038,0.0248852006787728
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.0219004518579443,0.00978400686876214,-0.0410771053207181,-0.00272379839517049,0.0252042351245307
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,28931,-0.00971408317871291,0.00435261298503269,-0.018245204629377,-0.00118296172804884,0.0256370075915862
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALLD,Palladin,24229,0.00633065664191902,0.0028408665362994,0.000762558230772195,0.0118987550530658,0.0258613641823607
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,-0.00696601549804409,0.0031269389605714,-0.013094815860764,-0.000837215135324142,0.0259068276395621
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,0.006363213104984,0.00286287955433356,0.000751969178490223,0.0119744570314778,0.0262478063921213
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,24793,-0.00547955708676865,0.00248040760415091,-0.0103411559909044,-0.000617958182632866,0.0271743146449438
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,29579,-0.0237560419155961,0.0107687587415403,-0.044862809049015,-0.00264927478217721,0.0273906208478895
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,28774,-0.0069628682370854,0.00316404403924259,-0.0131643945540009,-0.000761341920169932,0.0277706397813979
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00655060256840063,0.00298098742701947,0.000707867211442464,0.0123933379253588,0.0279967567953866
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,24195,-0.00802442088089895,0.00367608530980679,-0.0152295480881203,-0.000819293673677638,0.0290548780633286
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,24195,-0.012054545522863,0.00552406584702431,-0.0228817145830306,-0.00122737646269531,0.0291053135946132
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00369623265715224,0.00169400155164534,-0.00701647569837711,-0.000375989615927374,0.0291222961985314
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,24845,0.00410999410608213,0.00188404687479791,0.000417262231478239,0.00780272598068603,0.0291579240136366
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,-0.012094937029577,0.0055522932998704,-0.022977431897323,-0.00121244216183106,0.0293867572292033
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,-0.0129571756635798,0.00595391006058755,-0.0246268393823314,-0.00128751194482823,0.0295449466987106
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,-0.00649542020714662,0.00298591683427142,-0.0123478172023186,-0.000643023211974643,0.0296131680768169
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,-0.0123464974356995,0.0056759198081717,-0.023471300259716,-0.00122169461168299,0.0296217358073311
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,24111,-0.00731243391241451,0.00336875171289219,-0.0139151872696832,-0.000709680555145827,0.0299661799160173
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,29519,-0.00469325395988652,0.00216277306160319,-0.00893228916062878,-0.000454218759144266,0.0300135224668957
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,24938,0.0136803870719681,0.00630920479486825,0.00131434567402635,0.0260464284699099,0.0301436303866891
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,-0.00463145987825425,0.0021360858555075,-0.00881818815504895,-0.000444731601459553,0.0301516974021556
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,29120,-0.00660042433478891,0.00305741023995702,-0.0125929484051047,-0.000607900264473143,0.030871621611664
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,29820,-0.0039794403799996,0.00184436977108264,-0.00759440513132159,-0.000364475628677624,0.0309657205850114
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,24111,-0.00564225148709462,0.00261710155893357,-0.0107717705426044,-0.00051273243158482,0.0311000805611397
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29594,0.00525068402505213,0.00243614947162757,0.000475831060662099,0.0100255369894422,0.0311447685001051
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29789,-0.00868598998829702,0.00406894353413367,-0.016661119315199,-0.000710860661395028,0.0327933381837008
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,-0.0103490248458035,0.00484805923721994,-0.0198512209507545,-0.000846828740852396,0.0327974214682407
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,24445,0.00626817775792143,0.00296203518106813,0.000462588803027904,0.012073766712815,0.0343402146394282
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,28774,-0.0085580345051815,0.00406788463961949,-0.0165310883988357,-0.000584980611527305,0.0354041530372582
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TTN,Titin,24111,-0.010033014958613,0.00477326579775654,-0.0193886159222158,-0.000677413995010222,0.0355707809369495
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NENF,Neudesin,24793,-0.016331636531462,0.00781003818167873,-0.0316393113675523,-0.00102396169537167,0.0365285059733749
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,24240,-0.012771321366908,0.0061107688320265,-0.0247484282776799,-0.000794214456136026,0.0366309273928758
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,24381,-0.00785392730035036,0.00376608095312376,-0.0152354459684729,-0.00047240863222779,0.037039964923509
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,-0.00547289814437666,0.00263135220150889,-0.0106303484593341,-0.000315447829419242,0.0375452810142378
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCIN,Adseverin,24101,-0.0108687857483169,0.00523487380643181,-0.0211291384089232,-0.000608433087710528,0.0378835514377484
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,24111,-0.00676489389732516,0.00325940580989701,-0.0131533292847233,-0.000376458509927025,0.0379508817830259
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.00552277163139295,0.0026668674210509,0.000295711486133183,0.0107498317766527,0.0383803094408137
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,-0.00993203055144107,0.00481230066224951,-0.0193641398494501,-0.000499921253432027,0.0390376609830607
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,29565,-0.0056331500627864,0.00273042446894035,-0.0109847820219095,-0.000281518103663308,0.0391114485223134
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,24016,0.00609257034745136,0.00295538807749804,0.000300009715555195,0.0118851309793475,0.0392648869532764
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,24195,-0.00458805743631127,0.00222618321484995,-0.00895137653741717,-0.000224738335205377,0.0393182586179614
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,-0.00551767257524345,0.00267794994147744,-0.0107664544605392,-0.000268890689947678,0.0393700340131577
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,0.00831632434270141,0.00404260868661383,0.000392811316938295,0.0162398373684645,0.0396808696273799
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,24111,0.00644519850149955,0.00313609930691367,0.00029844385994876,0.0125919531430503,0.0398739181993531
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.00861067562547253,0.00419997005546715,0.000378734316756914,0.0168426169341881,0.0403581105693814
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,29434,-0.00501489034611634,0.00245175109756723,-0.0098203224973481,-0.000209458194884571,0.0408211542122351
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,0.00613603353802681,0.00300361550741168,0.000248947143499912,0.0120231199325537,0.0410745984107075
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,24195,-0.00485568465055246,0.00238547603057898,-0.00953121767048725,-0.000180151630617656,0.0418094377906447
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,29218,-0.00679321798438909,0.00334787926832942,-0.0133550613503147,-0.000231374618463429,0.0424560577733787
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,24195,-0.00598746832794019,0.00296255341105497,-0.0117940730136079,-0.000180863642272443,0.0432855952155522
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,24938,-0.00679748842336546,0.00336442690304627,-0.0133917651533361,-0.000203211693394776,0.0433525784002012
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,24111,0.00485101282034237,0.0024019395369955,0.00014321132783119,0.00955881431285354,0.0434335336074484
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,29157,0.00399924878832957,0.00199045977391027,9.79476314654447e-05,0.0079005499451937,0.0445242249453679
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,24229,-0.0124705456947978,0.0062187848852687,-0.0246593640699245,-0.000281727319671146,0.0449418106211023
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,28774,0.0050000662637832,0.00249461256786411,0.000110625630769547,0.00988950689679685,0.0450423871629868
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,24845,0.00562004658458744,0.00280649672570925,0.000119313002197305,0.0111207801669776,0.045240423525593
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,24016,-0.00885631663053031,0.00442685954877027,-0.01753296134612,-0.00017967191494059,0.0454481836618957
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,-0.00743343273819433,0.00372183999295441,-0.014728239124385,-0.000138626352003681,0.0458094586525738
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,28931,0.00402388861932804,0.00202042511061563,6.38554025214092e-05,0.00798392183613467,0.0464238117659837
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,24195,0.00487814423848529,0.00246095334734994,5.46756776793975e-05,0.00970161279929118,0.0474662293158877
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.012236396603883,0.00617388152491135,-0.0243372043927093,-0.000135588815056761,0.0474945600277867
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,24445,-0.00747066825526773,0.00377906945594244,-0.0148776443889149,-6.36921216205406e-05,0.0480693710203119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,29218,0.00783029935004822,0.00396785755604174,5.32985402064041e-05,0.01560730015989,0.0484557119127376
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,24111,0.00756409223991276,0.00384243274390486,3.2924061859234e-05,0.0150952604179663,0.0490141013118711
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.00789475068091429,0.00401830961788763,1.88638298545384e-05,0.0157706375319741,0.0494590345980381
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,29434,-0.0083186266274013,0.00426406015454907,-0.0166761845303175,3.89312755148773e-05,0.0510820034631594
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,28797,-0.00640274275648056,0.00328214241655777,-0.0128357418929338,3.02563799726751e-05,0.0510927319452685
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,24016,0.00614075304970017,0.00315640097544573,-4.57928621734674e-05,0.0123272989615738,0.0517274427487171
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,24016,0.00511720633949161,0.00263246812210851,-4.24311798410681e-05,0.0102768438588243,0.0519214012943738
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,24229,0.00606730114301134,0.00312460701713997,-5.6928610583009e-05,0.0121915308966057,0.0521752547646443
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,24111,0.00636530193512851,0.00327989373625691,-6.32897879350282e-05,0.012793893658192,0.0523058735060966
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,24229,0.00403908272303,0.00208857228142124,-5.45189485556272e-05,0.00813268439461562,0.0531374870374942
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,-0.00481790563016076,0.00249735122755124,-0.00971271403616119,7.6902775839661e-05,0.0537166661760147
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPHS2,Podocin,24229,0.0141178735958781,0.00735106270623978,-0.000290209308351901,0.028525956500108,0.0548037971515179
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,24195,-0.0068554066821294,0.00357569411113145,-0.013863767139947,0.000152953775688235,0.0552212456564052
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,24111,0.00703915245002504,0.00368078838370965,-0.000175192782045879,0.0142534976820959,0.0558363073073119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,-0.00896763280925648,0.00470238213573545,-0.018184301795298,0.000249036176785006,0.0565272323235216
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,29820,-0.00550438516744717,0.00289523389241882,-0.011179043596588,0.000170273261693713,0.0572869714497097
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,-0.00552763223571079,0.00290780627308787,-0.011226932530963,0.000171668059541437,0.0573164907990341
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,24445,-0.00970720912464147,0.00511273729715697,-0.0197281742270691,0.000313755977786195,0.0576245852527094
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,24229,0.00733169500771663,0.00387293522027553,-0.000259258024023407,0.0149226480394567,0.0583619314475579
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,24229,0.00624141094147375,0.00329714980641381,-0.000221002679097314,0.0127038245620448,0.0583735592695255
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,24195,-0.0138729056866447,0.00733958298558117,-0.0282584883383838,0.000512676965094392,0.0587499784409323
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAG,S-arrestin,24101,0.00709961255257479,0.00376231844465447,-0.000274531598947974,0.0144737567040975,0.0591681340573764
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,-0.00656954932606996,0.00348151908676454,-0.0133933267361285,0.000254228083988544,0.059175258817162
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,24101,-0.0145402293568092,0.00771025061359008,-0.0296523205594457,0.00057186184582738,0.0593297585240036
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,24229,-0.012402397157967,0.0065821791594855,-0.0253034683105586,0.00049867399462456,0.0595446538782832
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,24229,0.00647780649690199,0.00343957432388325,-0.000263759177909174,0.0132193721717132,0.0596694855545293
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,24938,-0.00624837594927951,0.0033185198258943,-0.0127526748080323,0.000255922909473316,0.0597282135743932
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,24445,0.00473283726565071,0.00252138346156606,-0.000209074319018772,0.00967474885032019,0.0605191021214975
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,28916,-0.00802584153625979,0.00427782664500153,-0.0164103817604628,0.000358698687943205,0.0606448489654437
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,0.00577525158160774,0.0030817143123197,-0.000264908470538867,0.0118154116337543,0.0609371952865382
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,24229,-0.00872276680278529,0.00466806939034969,-0.0178721828078707,0.000426649202300091,0.0616901824321982
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24445,-0.00515610655015886,0.00276130995910275,-0.0105682740700003,0.000256060969682535,0.0618760960593676
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,-0.0111454153400984,0.00597420822996474,-0.0228548634708293,0.000564032790632496,0.0621110322394541
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,29274,0.00377852716531108,0.0020319864898838,-0.000204166354861173,0.00776122068548333,0.0629629635230973
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,29218,-0.007984221298678,0.00430396878603169,-0.0164200001193001,0.000451557521944125,0.0635943798906179
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,24111,0.00663505375383283,0.00359635772066611,-0.000413807378672745,0.0136839148863384,0.0650589534585011
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,29349,0.00364564330308131,0.0019907902802762,-0.000256305646260052,0.00754759225242267,0.0670727285273839
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,24101,0.00619893142736913,0.0033862996307377,-0.000438215848876759,0.012836078703615,0.0671738819407144
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,28797,-0.00428823839863029,0.00234868499708703,-0.00889166099292088,0.000315184195660294,0.0678901501936727
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,29725,0.00591272502413602,0.00323876624933187,-0.000435256824554454,0.0122607068728265,0.0679190161155688
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29443,0.00436401293867425,0.00239527762297915,-0.00033073120236489,0.00905875707971339,0.0684767171630853
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,24195,-0.0107185672522102,0.0058843863914011,-0.0222519645793564,0.000814830074935925,0.0685391725045767
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,24793,0.00713498710193451,0.00393888631632076,-0.000585230078054182,0.0148552042819232,0.070087585864068
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,24445,-0.00534840240262552,0.00295530662328991,-0.0111408033842737,0.000443998579022702,0.0703449455974262
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,29725,0.00749320751846312,0.00414230231183986,-0.000625705012743001,0.0156121200496692,0.0704692596841325
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,29434,0.00627597930919059,0.00349051423419893,-0.000565428589839303,0.0131173872082205,0.072185680175936
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,28774,-0.00700885164872426,0.00393329038420801,-0.014718100801772,0.00070039750432344,0.0747710497672494
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,24229,-0.00443307838423325,0.00249975017903472,-0.00933258873514131,0.000466431966674809,0.0761735965668788
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,24195,-0.00758558753251906,0.00428578032023071,-0.0159857169601712,0.000814541895133126,0.0767492103555738
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,24195,0.00422027702299935,0.00238655547730158,-0.000457371712511739,0.00889792575851044,0.0770142008286609
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,24111,0.00431746948745661,0.00244452852552905,-0.000473806422580327,0.00910874539749354,0.0773788571515148
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,28774,-0.006001159236843,0.0033994071451467,-0.0126639972413305,0.000661678767644537,0.0775147887891221
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,0.00501320097344877,0.00285316745391539,-0.0005790072362254,0.0106054091831229,0.0789194109370978
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,24016,-0.00741098782588546,0.00422217388107381,-0.0156864486327901,0.000864472981019209,0.0792286176350691
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,28931,0.00495189368723474,0.00282946236503502,-0.000593852548233902,0.0104976399227034,0.0801085188623016
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,0.00439075729212336,0.00250972925230835,-0.000528312042401002,0.00930982662664772,0.0802183239157621
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,24867,0.00440712716548659,0.00252277906275724,-0.000537519797517599,0.00935177412849078,0.0806612323997813
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,28931,0.00374747722944702,0.00214738991604511,-0.000461407006001402,0.00795636146489544,0.0809726485943315
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,29434,-0.00509994844911039,0.00292370873901931,-0.0108304175775882,0.000630520679367468,0.0811098852653838
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.00420953512031669,0.00242872722573063,-0.000550770242115339,0.00896984048274872,0.0830658765181242
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,29694,0.00384820681057823,0.0022220960704105,-0.000507101487426348,0.00820351510858281,0.0833211045430528
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",24016,-0.0113912676855684,0.00658314183985106,-0.0242942256916765,0.00151169032053964,0.0835771375772229
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,24111,0.00885181669614637,0.0051293949122526,-0.00120179733186872,0.0189054307241615,0.0844135195693185
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,24016,0.00583781186286473,0.00339436199148045,-0.00081513764043695,0.0124907613661664,0.0854716171022668
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,0.00617218786278517,0.00359038528498197,-0.000864967295779485,0.0132093430213498,0.0856110623587034
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24729,-0.0053995829069756,0.00314572030299557,-0.0115651947008469,0.000766028886895717,0.0860857721556299
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,24195,0.00455612033949318,0.0026796135369263,-0.000695922192882361,0.00980816287186872,0.0890892330676109
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,0.00535780425254814,0.00315639606877165,-0.000828732042244287,0.0115443405473406,0.0896256785899971
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,24229,0.00701850682528066,0.00414380805019107,-0.00110335695309385,0.0151403706036552,0.0903287821773513
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.0117782029489322,0.00700335030620672,-0.0255047695490974,0.00194836365123294,0.0926214614511272
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,24405,0.00632156670647171,0.00376591115783229,-0.00105961916287958,0.013702752575823,0.0932372312619072
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,24229,-0.00351205454650412,0.00209267116596156,-0.00761369003178878,0.00058958093878054,0.0933084890201112
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,24867,0.00614345768540684,0.0036794664171544,-0.00106829649221579,0.0133552118630295,0.0949992572352495
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,28774,0.00608226281098314,0.00365385033220527,-0.00107928384013919,0.0132438094621055,0.0960000063505414
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,-0.00531162512506024,0.00319123367464208,-0.0115664431273587,0.000943192877238227,0.0960366658002269
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,0.00356376996940055,0.00214346617381806,-0.000637423731282847,0.00776496367008394,0.0964015137526464
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,28931,-0.0037562903600681,0.00226187052516736,-0.00818955658939612,0.000676975869259926,0.0967843791057113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,24445,-0.00269939562645782,0.00163875231321923,-0.00591135016036751,0.000512558907451864,0.0995244359643562
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,24826,0.00278936411115019,0.00169501517715178,-0.00053286563606729,0.00611159385836767,0.0998530763915928
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,24229,-0.00880413351114392,0.00536091227750524,-0.0193115215750542,0.00170325455276635,0.100544414660371
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,24240,-0.00441147491475434,0.00270518355464982,-0.00971363468186798,0.000890684852359303,0.102956327961453
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,24016,0.00475358373997412,0.00292405810908982,-0.000977570153841937,0.0104847376337902,0.104030806110029
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,24229,-0.00469938805526274,0.00290490423759174,-0.0103930003609426,0.000994224250417074,0.105731052381923
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,0.0034145921017577,0.0021146999232862,-0.00073021974788325,0.00755940395139865,0.106389756206964
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,29478,-0.0045200568230954,0.00280100811564742,-0.0100100327297643,0.000969919083573544,0.106597797411596
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,24903,-0.00412287893515662,0.00255649814661323,-0.00913361530251856,0.000887857432205317,0.106821156880144
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCLN,Nicalin,28931,-0.00593390230936495,0.00369775900667408,-0.0131815099624462,0.00131370534371626,0.108564306001681
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,24016,0.00912684014756698,0.00570974711096812,-0.00206426418993053,0.0203179444850645,0.109952332116814
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,-0.0057237684784511,0.00358619767989175,-0.0127527159310389,0.00130517897413672,0.11048735066132
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,24938,-0.00299225757619444,0.00187751909644419,-0.00667219500522504,0.000687679852836164,0.111009313465377
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,24111,0.00825231137075363,0.00518024849602868,-0.00190097568146259,0.0184055984229698,0.11116570634486
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,28774,-0.006712044156273,0.00421710774623822,-0.0149775753388999,0.00155348702635391,0.111480510751903
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,24229,-0.0035656285373598,0.00226258146768518,-0.00800028821402276,0.000869031139303154,0.115059224707356
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.00314916505371793,0.00200601723343811,-0.000782628723820773,0.00708095883125663,0.116458557974495
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,24229,0.00635151607320897,0.00405001464760232,-0.00158651263609157,0.0142895447825095,0.116831223436645
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEB,Nebulin,24111,-0.00422053225090253,0.00269494459104866,-0.0095026236493579,0.00106155914755283,0.117340117353516
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESPL1,Separin,24016,0.00617740578013488,0.00394648326931538,-0.00155770142772327,0.013912512987993,0.117527220199962
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00389571295630039,0.00250856512502741,-0.00102107468875334,0.00881250060135413,0.120442575176362
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,24805,-0.0124998141058391,0.00805083119877198,-0.0282794432554322,0.00327981504375397,0.120528711857334
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,24016,0.0033943865991039,0.00219023934652714,-0.000898482520089287,0.00768725571829709,0.12120779136683
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,28774,-0.00356563542166904,0.00230144984676178,-0.00807647712132214,0.000945206277984052,0.121320709228224
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,24793,0.00636987166575521,0.0041122121365328,-0.00169006412184909,0.0144298074533595,0.121391272034887
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,-0.00853541379995128,0.00552329855892867,-0.0193610789754515,0.0022902513755489,0.122273260172127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,24101,0.0100508076816729,0.00650431810509542,-0.00269765580431409,0.02279927116766,0.122298565219822
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,24805,0.00509049473190774,0.00331034974646743,-0.00139779077116843,0.0115787802349839,0.124122189668457
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,24016,0.00739234441388492,0.00480984357365761,-0.00203494899048399,0.0168196378182538,0.124326101631914
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,24229,-0.00677515557114173,0.00444638528030519,-0.0154900707205399,0.00193975957825644,0.127585581774625
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,-0.00539778452708613,0.00354258084976906,-0.0123412429926335,0.00154567393846122,0.127597903708944
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,24938,0.00260756968753168,0.00171279416216615,-0.000749506870313975,0.00596464624537734,0.12791983815102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.00610055741412297,0.00401028610225663,-0.00175960334630003,0.013960718174546,0.128215888678691
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRTG,Protogenin,29725,-0.00266927824332749,0.00176075359866737,-0.00612035529671553,0.000781798810060546,0.129533468108931
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.00391058131106546,0.00259547035994945,-0.00117654059443546,0.00899770321656639,0.131899552777904
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,24101,0.00752242025076291,0.00499800806133877,-0.00227367554946107,0.0173185160509869,0.1323156823755
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,-0.00763626879013788,0.00507383222214561,-0.0175809799455433,0.00230844236526752,0.132329471770208
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,24101,0.0077110589613197,0.00522369346687235,-0.00252738023375011,0.0179494981563895,0.139911365236741
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,-0.00905734091166949,0.00615376471142034,-0.0211187197460534,0.00300403792271438,0.141077678350415
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,24229,-0.00315599659411255,0.00214800185966599,-0.0073660802390579,0.00105408705083279,0.141772321384005
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.00509402308094382,0.00348643490938323,-0.0119274355033349,0.00173938934144732,0.144001541866781
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,28774,-0.00308666803978596,0.0021155195350222,-0.00723308632842948,0.00105975024885755,0.14455976182888
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,24922,-0.00313630830958729,0.00215660635350458,-0.00736325676245626,0.00109064014328169,0.145881444804594
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,24845,0.00232877661152769,0.0016030371126436,-0.000813176129253754,0.00547072935230914,0.146311975437045
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,24195,-0.00364417015172422,0.00251076859191386,-0.00856527659187539,0.00127693628842696,0.146676980613513
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,23902,-0.0045327935662158,0.00312436574984154,-0.0106565504359052,0.00159096330347362,0.146851923182305
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,0.00507975989099523,0.00351691426134794,-0.00181339206124674,0.0119729118432372,0.148645225020066
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,24101,-0.00636024345160515,0.00441196462751146,-0.0150076941215276,0.00228720721831731,0.149431112265602
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,28797,-0.0105516477513544,0.0073252207463164,-0.0249090804141346,0.0038057849114257,0.149749709334798
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,28114,-0.00285467829033002,0.00198832773798842,-0.00675180065678733,0.00104244407612729,0.151093679793514
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,29478,0.0046994029608316,0.00327401295310486,-0.00171766242725392,0.0111164683489171,0.151193785097735
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,24922,-0.00270330502134129,0.00188773265365004,-0.00640326102249536,0.000996650979812787,0.152145475413892
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,24101,-0.00753929598637218,0.00533909349386806,-0.0180039192343536,0.00292532726160921,0.157935529248958
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,24922,0.0106183054454672,0.00752134495217335,-0.00412353066079257,0.0253601415517269,0.158034247997706
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,0.00337511665986968,0.00242121635026405,-0.00137046738664786,0.00812070070638723,0.163337859463531
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,0.00332977573185879,0.00239327067219834,-0.00136103478564995,0.00802058624936754,0.164145007376366
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,29566,-0.00270160234082775,0.00194771755696022,-0.00651912875246978,0.00111592407081428,0.16543373693446
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,24229,-0.00318052894830905,0.00230150369573681,-0.00769147619195321,0.0013304182953351,0.167004349446778
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,24229,0.00262221196342635,0.00190272900215707,-0.00110713688080151,0.00635156080765421,0.168175232197825
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,-0.00259765558423175,0.00188721593758419,-0.00629659882189677,0.00110128765343327,0.168695655154034
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,24867,-0.00342766977674961,0.00250661272586562,-0.00834063071944623,0.00148529116594701,0.171496389772975
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,24203,-0.00678380013984189,0.00496240586241813,-0.0165101156301814,0.00294251535049764,0.171625924807377
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,0.00640379624612372,0.00468980876501603,-0.00278822893330771,0.0155958214255551,0.172117966549287
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,24111,-0.00952329533244811,0.0069773278827434,-0.0231988579826252,0.00415226731772896,0.172299906235832
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,24195,-0.0074619105283544,0.00547394219651227,-0.0181908372335184,0.00326701617680964,0.172841819327057
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,28931,-0.00882348590653006,0.00648876333792751,-0.021541462048868,0.00389449023580785,0.173900628139573
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,24445,0.00421972468718675,0.00312441302487279,-0.00190412484156391,0.0103435742159374,0.176847142515176
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28797,-0.00483814850871552,0.00358396150954187,-0.0118627130674176,0.00218641604998655,0.177044457223556
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,28774,-0.0081185302475053,0.00602304737233629,-0.0199237030972844,0.00368664260227383,0.17769770960085
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24951,-0.00306466915839329,0.00228694107895247,-0.00754707367314014,0.00141773535635355,0.180233657258003
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,24229,-0.00469442614265403,0.00351400562511956,-0.0115818771678884,0.0021930248825803,0.181588373379941
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,23970,0.00754664291754144,0.00567690336995076,-0.00358008768756206,0.0186733735226449,0.183742197514554
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,0.00673010703551165,0.00509152855846648,-0.00324928893908264,0.0167095030101059,0.186238984656612
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,24016,0.00412341720141692,0.00312381711137211,-0.0019992643368724,0.0102460987397062,0.186849892197251
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,0.00307731700840196,0.00233563475371744,-0.00150052710888423,0.00765516112568814,0.187666658231781
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,29439,0.00549197847909102,0.00417408788927229,-0.00268923378388266,0.0136731907420647,0.188274463890349
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,24016,0.00557647737258511,0.00430980724924634,-0.00287074483593771,0.0140236995811079,0.195710990125538
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,24101,0.00680292860044986,0.0052790348583158,-0.00354397972184911,0.0171498369227488,0.197525559216231
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.00712570851056554,0.00553195612932305,-0.00371692550290763,0.0179683425240387,0.197723743995058
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,29694,0.00264685522987206,0.00205939815052517,-0.00138956514515728,0.0066832756049014,0.198712631716957
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,24445,-0.00780628951806006,0.00609509035156998,-0.0197526666071372,0.0041400875710171,0.200293502400086
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,0.00400623986012611,0.00314934019832243,-0.00216646692858586,0.0101789466488381,0.203353954533295
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCN,Decorin,28916,0.0020472416447942,0.00161838422842646,-0.00112479144292166,0.00521927473251005,0.205884717544553
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,24101,0.00554683858597341,0.00439217380447084,-0.00306182207078943,0.0141554992427362,0.206640431102618
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,24229,0.00299728497139331,0.00237420336933929,-0.0016561536325117,0.00765072357529833,0.206803317110013
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSPN,Claspin,28719,-0.00309685543574321,0.0024559069236678,-0.0079104330061321,0.00171672213464568,0.207325432515147
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,24101,-0.00516985456686948,0.0041041115302317,-0.0132139131661236,0.00287420403238466,0.207798140256588
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.00573321950587355,0.00455950774122471,-0.014669854678674,0.00320341566692689,0.208613381434956
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,24016,-0.00774286590858785,0.00621112990242965,-0.01991668051735,0.00443094870017427,0.212552151795939
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,24195,-0.00447343070688587,0.00360399509832496,-0.0115372610996028,0.00259039968583105,0.214528340513759
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,0.00279821477193361,0.00225728340505995,-0.00162606070198389,0.00722249024585111,0.215121269334368
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,29478,-0.00671645923094536,0.00544024760272449,-0.0173793445322854,0.00394642607039464,0.216994077462102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,29676,0.00377685228260029,0.00306554615739209,-0.00223161818588821,0.00978532275108879,0.21794673627112
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,0.00476700330059202,0.00387227623146339,-0.00282265811307623,0.0123566647142603,0.218312548623395
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,0.00568029138115553,0.00463171632045572,-0.00339787260693768,0.0147584553692488,0.220063870648899
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,24805,-0.0225733280272764,0.0184382450024063,-0.0587122882319928,0.01356563217744,0.220863295883473
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,24421,-0.00875076635374939,0.00715023655947185,-0.0227652300103142,0.00526369730281543,0.221023305767069
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,24951,-0.00458063380903612,0.00375293612948039,-0.0119363886228177,0.00277512100474544,0.222269238517723
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,24381,-0.00729915458444892,0.005982255914236,-0.0190243761763515,0.00442606700745364,0.222425842403709
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,24111,-0.00289427705000283,0.00237925229353,-0.00755761154532163,0.00176905744531598,0.223819765657344
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,24101,-0.00630461829917347,0.00521855056900674,-0.0165329774144267,0.00392374081607974,0.227014222652244
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,23801,0.00335036348508086,0.00278820035555661,-0.00211450921181009,0.00881523618197181,0.229521893981682
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,24016,0.00359302427468136,0.00299145944429219,-0.00227023623613133,0.00945628478549405,0.229726555483351
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,29594,0.0039014576124849,0.00324983960582426,-0.00246822801493064,0.0102711432399005,0.229951820785026
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.00290882117438073,0.00242422915409775,-0.00766031031641232,0.00184266796765085,0.230189840116056
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,0.0044609577848052,0.00372678263676838,-0.00284353618326081,0.0117654517528712,0.231318507549251
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.00546607203007413,0.00459615736309657,-0.0144745404617434,0.00354239640159515,0.234344998036214
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BSND,Barttin,24016,0.00286039222768274,0.00241166319614338,-0.00186646763675828,0.00758725209212376,0.235607893958415
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.00274105982546656,0.00232348275001002,-0.00181296636455307,0.00729508601548619,0.238120913081121
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29434,0.00292260709419911,0.00249122068847568,-0.00196018545521322,0.00780539964361144,0.240740080042169
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,0.00399086647313046,0.00340360814437561,-0.00268020548984573,0.0106619384361066,0.240991939738119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FST,Follistatin,29536,0.00418478365791374,0.00357089098610754,-0.00281416267485703,0.0111837299906845,0.241240309980604
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,24101,-0.00362488820899698,0.0031241772203674,-0.00974827556091709,0.00249849914292313,0.245950511146458
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,24101,0.0074927464057102,0.00648683746780717,-0.00522145503119185,0.0202069478426123,0.248073532887286
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,24845,-0.00566780542389546,0.0049132484321297,-0.0152977723508697,0.00396216150307874,0.248685150046526
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,24240,-0.00344128625929723,0.00298563516002313,-0.00929313117294256,0.0024105586543481,0.249080038142705
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,24407,0.0025180207895015,0.00219697175681719,-0.00178804385386019,0.00682408543286319,0.251751564270323
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,24111,0.00404142664126747,0.00352984902667708,-0.0028770774510196,0.0109599307335546,0.2522499265362
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00240564500425076,0.00211769678728643,-0.00174504069883064,0.00655633070733216,0.255977549272753
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,29123,0.00206081372571948,0.00181846464768865,-0.00150337698375027,0.00562500443518922,0.257109689992144
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,24229,-0.00462979328987426,0.00411099808398551,-0.0126873495344859,0.00342776295473734,0.260093347092277
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00434177327050071,0.00389118874874994,-0.00328495667704917,0.0119685032180506,0.264518741807054
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,24111,0.00349871620812299,0.00316663674023764,-0.00270789180274279,0.00970532421898876,0.269227738789924
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,24101,0.00739191943487618,0.00671182206040574,-0.00576325180351907,0.0205470906732714,0.270764813031532
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,0.00325435096792991,0.00296361586220323,-0.00255433612198841,0.00906303805784824,0.272171097151478
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,23970,-0.00273758469035721,0.00252548341842402,-0.00768753219046829,0.00221236280975386,0.278382613995307
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,24195,-0.00176289560717925,0.00162712562577058,-0.00495206183368959,0.00142627061933108,0.278623257864515
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,24229,0.00167075536227047,0.00155799116752456,-0.00138290732607767,0.00472441805061861,0.283560998271705
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,24016,-0.00223547725561147,0.00208684158252954,-0.00632568675736937,0.00185473224614643,0.284078962295533
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,24240,-0.00534906421255262,0.00502363745166426,-0.0151953936178146,0.00449726519270933,0.286986513011643
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,24101,0.00404810503523808,0.0038273142464287,-0.00345343088776217,0.0115496409582383,0.290208233421505
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,24445,-0.00452991984049945,0.00428299345497381,-0.0129245870122481,0.00386474733124923,0.290224237841856
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,28931,-0.00571097119065587,0.00541730031803374,-0.016328879814002,0.00490693743269025,0.291795673436305
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,-0.00464066393756621,0.00440616673498437,-0.0132767507381356,0.00399542286300316,0.292250578406724
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,28916,-0.00453446893905272,0.00430639249693566,-0.0129749982330466,0.00390606035494116,0.292367074798658
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,24445,-0.00520158713970284,0.00495841966691469,-0.0149200896868556,0.00451691540744995,0.294169476070053
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,24922,-0.00293649879003842,0.0027992519646973,-0.00842303264084513,0.00255003506076828,0.294174571523557
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,24016,-0.0039558022500879,0.00377562015820121,-0.0113560177601623,0.00344441325998647,0.294777020885448
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,24195,-0.00220033519385938,0.00211486131158398,-0.00634546336456397,0.00194479297684522,0.29815715111741
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,24445,-0.00549756270127455,0.00530830791735115,-0.0159018462192828,0.00490672081673371,0.300374510966555
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,29443,0.0024665804032994,0.00238401339776819,-0.00220608585632626,0.00713924666292506,0.300848550288721
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,29820,-0.0023194728835895,0.00224702485725907,-0.00672364160381729,0.00208469583663828,0.301967254115427
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.00265100530834003,0.00258082922550561,-0.00240741997365097,0.00770943059033103,0.304340672178692
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,-0.00307762708014263,0.00299892491570915,-0.00895551991493256,0.00280026575464731,0.304785472084259
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,24240,-0.00443841708355667,0.00434122076333357,-0.0129472097796905,0.00407037561257713,0.306606954290678
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24751,-0.00292687949622188,0.00286729516019926,-0.00854677801021243,0.00269301901776867,0.30736834372823
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,29566,0.00200679370756132,0.00197166097426903,-0.00185766180200599,0.00587124921712862,0.308772384136302
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,-0.00847795136172394,0.00833847783613784,-0.0248213679205541,0.00786546519710623,0.309292063448991
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,24016,0.0029464464452544,0.00290247487377799,-0.00274240430735045,0.00863529719785925,0.310044714772676
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,0.00182917286619631,0.00180316220086042,-0.0017050250474901,0.00536337077988273,0.310389834014027
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24445,-0.00315114191075609,0.0031079760249375,-0.00924277491963359,0.00294049109812141,0.31064588330198
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,24059,-0.00613966973312378,0.00605890246943445,-0.0180151185732153,0.00573577910696775,0.310912593957528
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,24922,-0.00248119457270961,0.00246107238828782,-0.00730489645375373,0.00234250730833452,0.31337968194044
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,24111,-0.00341652266854627,0.00340337467944987,-0.010087137040268,0.00325409170317547,0.315454626433252
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,23037,-0.00379727199429842,0.0037844344839996,-0.0112147635829376,0.00362021959434079,0.31568221763174
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",24111,-0.00282939174403083,0.00282010990361764,-0.00835680715512141,0.00269802366705974,0.31573040480183
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,24101,-0.00351229966534074,0.00350199364388237,-0.0103762072073502,0.00335160787666872,0.315898486707449
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24805,0.0104949513311601,0.010469733850675,-0.0100257270161629,0.0310156296784832,0.316156070385817
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,24867,0.00252727699007298,0.00255034430591444,-0.00247139784951932,0.00752595182966528,0.321717096636424
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,28931,-0.00302290313849065,0.00307916145810695,-0.00905805959638027,0.00301225331939897,0.326241421628388
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,-0.00472748960913617,0.00481645214924424,-0.0141677358216549,0.00471275660338255,0.326339977517917
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,-0.0086711499623205,0.00885484662512866,-0.0260266493475727,0.00868434942293167,0.327462389617545
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24793,-0.00387607929444611,0.00395974711429067,-0.0116371836384558,0.00388502504956361,0.327653569300082
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,-0.00429911103274448,0.00443068635468692,-0.0129832562879308,0.00438503422244188,0.331904641681987
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,29349,0.00280036339923527,0.002889456680512,-0.00286297169456826,0.00846369849303879,0.332470323352325
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,24938,-0.00629110677787168,0.00649167258126562,-0.0190147850371523,0.00643257148140893,0.33250263587891
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,0.00393020780567365,0.00408399189082739,-0.00407441630034803,0.0119348319116953,0.335886160580417
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,28931,-0.00441044347692058,0.004607945064427,-0.0134420158031975,0.00462112884935634,0.338505152632226
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,29594,-0.00393673766379784,0.00412978236242696,-0.0120311110941547,0.00415763576655901,0.340468432402471
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLPS,Colipase,29400,-0.00474090097402743,0.00500817828335339,-0.0145569304094001,0.00507512846134522,0.343834202312971
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,24016,-0.00527656743827259,0.00558399320567127,-0.0162211941213883,0.0056680592448431,0.344696378497099
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,24195,-0.00183228551210121,0.00194348960484537,-0.00564152513759814,0.00197695411339571,0.345802235387153
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00236868143366601,0.00251506776649908,-0.00256085138867219,0.00729821425600421,0.346306352069437
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.0037538657072339,0.003998229970215,-0.00408266503438751,0.0115903964488553,0.347800803197401
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,24111,0.0046888952113218,0.00502551283100108,-0.00516110993744031,0.0145389003600839,0.350819891491424
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,29725,-0.00193851893075169,0.00208076817147826,-0.00601682454684908,0.00213978668534569,0.351532143791361
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,29349,-0.00138457240845399,0.00148848566817239,-0.00430200431807187,0.00153285950116389,0.352281094714514
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,24195,0.0027923344532372,0.00301967021373589,-0.00312621916568514,0.00871088807215954,0.355123383301997
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,24914,0.0014827797297728,0.00160414658528306,-0.00166134757738199,0.0046269070369276,0.355317347509585
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00169058585872654,0.0018370298329955,-0.00190999261394464,0.00529116433139772,0.357434572406434
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,24101,0.00505201386390637,0.00548999934958594,-0.00570838486128208,0.0158124125890948,0.357466386478388
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,24016,0.00452145659543379,0.00492292349342384,-0.00512747345167693,0.0141703866425445,0.358392817817365
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,24111,0.0033026693865255,0.00361321863889947,-0.00377923914571746,0.0103845779187685,0.360698717212687
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24805,-0.0016411211613154,0.00182093392566014,-0.00521015165560928,0.00192790933297847,0.367462864828476
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,28334,-0.00304197281850365,0.00338791956789431,-0.0096822951715765,0.00359834953456921,0.369252818368076
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,24229,-0.00423932464402255,0.00472970273212046,-0.0135095419989787,0.00503089271093356,0.370091073846714
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,0.00388425028105998,0.0043360206663781,-0.0046143502250411,0.0123828507871611,0.370363244762455
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,24229,-0.00390809947200536,0.00436546536568061,-0.0124644115887393,0.00464821264472863,0.370672570374293
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,24381,0.00218247846340415,0.00244009439370629,-0.00260010654826018,0.00696506347506848,0.371104025470759
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,28797,-0.00196148918115438,0.00220392963037498,-0.00628119125668933,0.00235821289438058,0.3734753199739
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,24445,0.00282752243895846,0.0031817811438771,-0.00340876860304065,0.00906381348095757,0.374194447289939
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.00257688329195752,0.00290014681126209,-0.00826117104203121,0.00310740445811617,0.374261657423282
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.00249243601841394,0.00281079737198097,-0.00301672683066877,0.00800159886749665,0.375229739349638
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,24195,-0.00262975133490907,0.00297577617897439,-0.00846227264569888,0.00320276997588073,0.37685645558389
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,24445,0.00356637429026184,0.00404385809348539,-0.00435958757296954,0.0114923361534932,0.377826746611483
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,0.00392022355163339,0.00444927918884644,-0.00480036365850564,0.0126408107617724,0.378276905608612
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24805,-0.00345334029179836,0.00394747435971594,-0.0111903900368416,0.00428370945324488,0.381678843112212
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.00244894866815438,0.00281685571069534,-0.00796998586111724,0.00307208852480849,0.384641741129639
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,28774,0.0030792224095437,0.00361241974196316,-0.0040011202847041,0.0101595651037915,0.393999860050524
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,24845,0.00163490694606842,0.00192143186842063,-0.00213109951603601,0.00540091340817285,0.3948445104824
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,24195,0.00357656642332708,0.00421380759294655,-0.00468249645884815,0.0118356293055023,0.396015977890301
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,24016,-0.00441556882485353,0.00521948470117292,-0.0146457588391525,0.0058146211894454,0.39757349408375
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,24195,-0.00402031882068503,0.00475680711400808,-0.0133436607641409,0.0053030231227708,0.398023335226415
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,24111,0.0022392376938869,0.00265069429136755,-0.00295612311719349,0.00743459850496729,0.3982454051481
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00222085703760059,0.00262951449861799,-0.00737470545489185,0.00293299137969067,0.398349192220355
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.00192000352300356,0.00227710309876896,-0.00638312559659072,0.00254311855058361,0.399135836919092
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,24805,-0.0068161320541483,0.00812135603340012,-0.0227339898796125,0.00910172577131592,0.401317508335716
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,-0.00158306215217282,0.00188798113865872,-0.00528350518394392,0.00211738087959828,0.40175972872296
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,27585,-0.00290181262786543,0.0034649230667763,-0.00969306183874699,0.00388943658301612,0.402328637293001
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,24240,-0.00107148912057255,0.00128039320147427,-0.00358105979546212,0.00143808155431702,0.402688624707331
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28797,-0.00342136740461314,0.00408917149993979,-0.0114361435444951,0.00459340873526885,0.40277399379782
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,-0.0029856179163464,0.00356853404343055,-0.00997994464147027,0.00400870880877747,0.40279723055798
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,-0.00322217948128653,0.00387301989258883,-0.0108132984707606,0.00436893950818757,0.405442383587776
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,28774,0.00383311981490889,0.00462928961169319,-0.00524028782400976,0.0129065274538275,0.407669049869945
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,24101,0.0025318105207426,0.00306346053349117,-0.0034725721249001,0.0085361931663853,0.4085545459259
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,24195,0.00241573713227696,0.00293058016802857,-0.00332819999705905,0.00815967426161296,0.409765638469896
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,24101,0.00292376352778915,0.00356257547012229,-0.00405888439365054,0.00990641144922885,0.411832035127853
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,29443,-0.00208317988136786,0.00253887991785623,-0.00705938452036606,0.00289302475763035,0.411931286723239
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,24016,0.00298961533778219,0.00364598556333824,-0.00415651636636075,0.0101357470419251,0.412238763460908
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,28774,-0.00273660917820467,0.00335132545564145,-0.00930520707126191,0.00383198871485257,0.414178008930273
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,28931,0.00271578129803787,0.00333271174543518,-0.00381633372301508,0.00924789631909083,0.415144080295237
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,24101,-0.00273143699820544,0.00339945018381936,-0.00939435935849138,0.0039314853620805,0.421697332863253
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.00316598650248505,0.0039589917978289,-0.0109256104262297,0.0045936374212596,0.423895304560171
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,24016,0.00231205300590492,0.00291053849324038,-0.00339260244084623,0.00801670845265606,0.426986209365381
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,24195,0.00207000261266375,0.00260751172294409,-0.00304072036430666,0.00718072558963416,0.427283978994912
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,24016,0.00357063240493071,0.00450418002771333,-0.00525756044938743,0.0123988252592488,0.427938613846298
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,24229,0.00159388395058898,0.00201724483651461,-0.00235991592897966,0.00554768383015762,0.429460084188849
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24445,0.00468780925537609,0.00593790418703727,-0.00695048295121696,0.0163261014619691,0.429843834408015
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00256172501685309,0.00324685129862231,-0.00892555356215282,0.00380210352844664,0.430127090998857
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,24229,0.00230939738326782,0.00293034251291416,-0.00343407394204394,0.00805286870857957,0.430647037762184
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,24111,0.00316869718726352,0.00403191126271344,-0.00473384888765482,0.0110712432621819,0.431931168238146
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.0015814439048091,0.00201492537625366,-0.00553069764226626,0.00236780983264807,0.432539180984486
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24845,-0.00217182888704767,0.00278030840772535,-0.00762123336618935,0.00327757559209402,0.434723633494485
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,24922,0.00195765187313893,0.00251812241436118,-0.00297786805900899,0.00689317180528685,0.436915321041011
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.00102727688822568,0.00132672494890134,-0.00157310401162096,0.00362765778807231,0.438763520684725
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,24101,0.00270695813333399,0.00351765461039494,-0.00418764490304009,0.00960156116970807,0.44158335627823
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,29461,-0.0101810119351861,0.0132550755397153,-0.0361609599930281,0.0157989361226559,0.442443418908383
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,24445,-0.00287695498107936,0.00375368215728989,-0.0102341720093675,0.00448026204720882,0.443424666283213
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,24445,-0.00461512932358735,0.00606101682781862,-0.0164947223061118,0.00726446365893714,0.446398828853677
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,-0.00294984094102811,0.00387459677174603,-0.0105440506136503,0.00464436873159411,0.446468297027519
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,28797,-0.00297886294504109,0.00391777104353122,-0.0106576941903623,0.0046999683002801,0.447053806436211
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29402,0.00298277926278255,0.00393629086168314,-0.00473235082611641,0.0106979093516815,0.448598390792782
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,24867,-0.00201246783977986,0.00265714183817332,-0.00722046584259957,0.00319553016303986,0.448829019733231
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,24111,-0.00212728257943801,0.00283984023794918,-0.00769336944581841,0.00343880428694238,0.453813105897058
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,29581,0.00150993134884871,0.00202003721972139,-0.00244934160180521,0.00546920429950264,0.454781629245703
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.00480019934615972,0.00645542697807566,-0.00785243753086856,0.017452836223188,0.457130982025942
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,24111,0.00317673065261367,0.00431353531239136,-0.0052777985596734,0.0116312598649007,0.461460166169113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,-0.00169546825403663,0.00231385547153019,-0.00623062497823581,0.00283968847016254,0.46372051255312
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,28916,0.00276063122494139,0.00376770013398911,-0.00462406103767727,0.0101453234875601,0.463741320675972
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.00130491290549096,0.00178230705938048,-0.00218840893089477,0.00479823474187669,0.464083945310947
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,24793,-0.00412160009581923,0.00563171416524552,-0.0151597598597005,0.00691655966806199,0.464263787620835
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,24421,-0.00513337206223136,0.00701916566477579,-0.0188909367651919,0.00862419264072919,0.464580661211293
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.00255056725777402,0.00349977541873609,-0.00430899256294872,0.00941012707849677,0.466143170693231
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,24111,-0.00245973459260823,0.0033822461483589,-0.00908893704339168,0.00416946785817522,0.467080596484065
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,24229,-0.00526620744466598,0.00724498683090501,-0.0194663816332398,0.00893396674390783,0.467308913635096
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,0.00355100539519313,0.00493135606231746,-0.00611445248694909,0.0132164632773354,0.471478415146081
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.0134786393561989,0.0187743757717559,-0.0502764158688405,0.0233191371564427,0.472808956405498
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,29599,-0.00566572915768082,0.00792727727860018,-0.0212031926237372,0.00987173430837553,0.474791962026385
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,28722,-0.00270366779138971,0.00379462049423138,-0.0101411239600832,0.0047337883773038,0.476160889634086
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.00165284073181634,0.00232101219342794,-0.00289634316730243,0.00620202463093511,0.476396957046988
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.00620403423866257,0.00873325013025012,-0.0109131360166277,0.0233212044939528,0.47746661034715
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,24101,-0.00483919307707972,0.00688797111577576,-0.0183396164640002,0.00866123030984077,0.482338588901742
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEO1,Neogenin,24867,-0.001086283518805,0.00155897597538904,-0.00414187643056753,0.00196930939295753,0.485938875753703
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,24548,-0.000401638440247733,0.000577693119661341,-0.00153391695478396,0.000730640074288494,0.486908157210694
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.00215075699683998,0.00309699281778679,-0.00391934892602213,0.00822086291970209,0.487396365355226
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,24546,-0.00168895988109476,0.00243276708072356,-0.00645718335931293,0.00307926359712341,0.487529093965184
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,24101,-0.00312739934670945,0.00451354423396269,-0.0119739460452763,0.00571914735185742,0.48838391974044
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,0.00460967231120777,0.00665608682268585,-0.00843625786125649,0.017655602483672,0.488598755968083
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTTG1,Securin,24445,-0.00203393627722524,0.00294661035845585,-0.00780929257979871,0.00374142002534822,0.490035331812332
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,29694,0.00623949366103047,0.00906280862392214,-0.0115236112418569,0.0240025985639179,0.491160722155012
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,0.00216738248303113,0.00317097780434779,-0.00404773401349054,0.0083824989795528,0.494293525714611
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,0.00243925567909922,0.00358002199872006,-0.0045775874383921,0.00945609879659055,0.495655241355975
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29820,-0.000761638306537501,0.00112064172166407,-0.00295809608099908,0.00143481946792408,0.4967346806543
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",24101,-0.00401637836683063,0.0059832594538879,-0.0157435668964509,0.00771081016278965,0.502055427369402
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28931,-0.00178306491639889,0.00266175633911072,-0.0070001073410559,0.00343397750825812,0.502937823662135
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,24111,-0.00316032272581509,0.00473293320822365,-0.0124368718139334,0.00611622636230326,0.504312184741667
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,28931,-0.00229446816535736,0.00344501498387474,-0.00904669753375184,0.00445776120303712,0.505400051637881
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,24867,-0.00749662124027382,0.0112687191101291,-0.0295833106961269,0.0145900682155793,0.505890771309018
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,24229,0.00131651868051056,0.00198772178282956,-0.00257941601383539,0.0052124533748565,0.507768987260411
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,24229,-0.00225134626387327,0.00340531820592849,-0.00892576994749312,0.00442307741974658,0.508537452410791
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,28797,-0.00646826676958949,0.009812215583741,-0.0257002093137218,0.0127636757745429,0.509769070336905
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.00230855963331798,0.00350690274558267,-0.00918208901466001,0.00456496974802405,0.510357955166098
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,24229,-0.00265519377500934,0.00409826574478829,-0.0106877946347944,0.0053774070847757,0.517067231978562
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,24240,0.00287758892636574,0.00445786857557448,-0.00585983348176025,0.0116150113344917,0.518604280223121
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,29478,-0.00174603338431269,0.0027139662791707,-0.00706540729148726,0.00357334052286187,0.52000126652393
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24867,-0.00345392601103016,0.00544027069698585,-0.0141168565771224,0.00720900455506211,0.525511693092658
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,24922,0.00133035057121066,0.00210358222084604,-0.00279267058164758,0.0054533717240689,0.527117309954948
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,24016,0.00181813335835521,0.00288051146932186,-0.00382766912151563,0.00746393583822605,0.527926094994515
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,28626,-0.00299216013506944,0.00474539028120895,-0.012293125086239,0.0063088048161001,0.528346135915084
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,24938,0.00195822720074472,0.00312044666751243,-0.00415784826757965,0.00807430266906909,0.530306433053165
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,24101,-0.00267233562614197,0.00427792080723295,-0.0110570604083186,0.00571238915603463,0.532186396673208
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,-0.00182538615365787,0.00292333762949199,-0.00755512790746217,0.00390435560014643,0.532358596867982
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,0.00206679079191021,0.00336890030558695,-0.00453625380704023,0.00866983539086064,0.539557350498494
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,0.0011142165152023,0.00182516129700459,-0.0024630996269267,0.00469153265733131,0.541552361015599
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,28931,0.00210904043969277,0.00346195204238103,-0.00467638556337405,0.00889446644275959,0.542392980131083
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,0.00368003152756466,0.00605103476392893,-0.00817999660973603,0.0155400596648654,0.543082459293323
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,24845,-0.00170633694644358,0.0028520890745349,-0.00729643153253198,0.00388375763964481,0.549661126893673
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24867,-0.00142607341540005,0.00240600547646912,-0.00614184414927951,0.00328969731847942,0.553377883864294
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,24195,0.00290062688047297,0.00493663187204993,-0.00677517158874488,0.0125764253496908,0.556825066521873
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.00234013911512216,0.00402481067651554,-0.0102287680410926,0.00554848981084831,0.560957221655031
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,24101,0.00319088341184441,0.00550019143195672,-0.00758949179479076,0.0139712586184796,0.561825349258218
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24445,-0.0022222821550733,0.00384596818427374,-0.00976037979624983,0.00531581548610323,0.563390130275355
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,0.00312800474273895,0.00544729772257222,-0.00754869879350259,0.0138047082789805,0.565817014266544
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,24101,-0.00484180604098316,0.00843593907897639,-0.0213762466357769,0.0116926345538106,0.566007091592219
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29478,-0.000712421521746059,0.0012466980778804,-0.00315594975439164,0.00173110671089953,0.567701229032614
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,28797,-0.00366083541222886,0.00646877191886688,-0.0163396283732079,0.00901795754875021,0.571449633439394
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,0.00205348328377399,0.0036464507478476,-0.0050935601820073,0.00920052674955528,0.573340872168448
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,24111,0.00237040189296046,0.00420981641505462,-0.00588083828054659,0.0106216420664675,0.57339560124048
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,24229,0.00242524563426682,0.00432105994692406,-0.00604403186170434,0.010894523130238,0.574624311914065
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,24016,0.00212541811056455,0.00380976400989975,-0.00534171934883896,0.00959255556996806,0.576926699275954
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,24754,-0.00204712792263195,0.00367720904355343,-0.00925445764799668,0.00516020180273277,0.57773268625391
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,24016,0.00132264165305011,0.0023804716785316,-0.00334308283687182,0.00598836614297204,0.578474691915285
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,29169,0.00131898475239784,0.00237545851247372,-0.00333691393205066,0.00597488343684634,0.578724647580461
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,24938,-0.00202713335942911,0.00367592595595857,-0.0092319482331079,0.00517768151424968,0.581321975253369
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,28931,0.00159868469246378,0.00290885075899649,-0.00410266279516933,0.0073000321800969,0.582602645665229
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,29349,0.000741910576503665,0.00135097516121184,-0.00190600073947154,0.00338982189247887,0.582895232006066
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,28931,0.00252539487849229,0.00461505431637549,-0.00652011158160366,0.0115709013385882,0.584240028406352
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,-0.000874940994486902,0.00161059412129773,-0.00403170547223044,0.00228182348325664,0.586967886186007
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,24016,-0.00243258049879281,0.0045109565221395,-0.0112740552821862,0.0064088942846006,0.589712148143362
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,24793,-0.00101745262355834,0.00192879881650379,-0.00479789830390577,0.00276299305678909,0.597847090871718
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,-0.00181151318652596,0.00345549933164236,-0.00858429187654499,0.00496126550349306,0.60011599859781
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29820,-0.000832302796375613,0.00160781852498726,-0.00398362710535064,0.00231902151259941,0.604699587991547
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.00121950588833031,0.00236102134651604,-0.00340809595084113,0.00584710772750176,0.605497845422392
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,24016,-0.00197303420394246,0.0038480846217598,-0.00951528006259167,0.00556921165470675,0.608143869719967
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,24229,0.00108669890155215,0.0021364331960588,-0.00310071016272309,0.0052741079658274,0.611001501698617
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRN1,Neuritin,24867,-0.00128430224538876,0.00254132492685062,-0.00626529910201598,0.00369669461123845,0.613305438220848
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,24101,0.00172441688555365,0.0034282471603564,-0.0049949475487449,0.0084437813198522,0.61496711502352
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.00130551546601434,0.00260639308341118,-0.00380301497747158,0.00641404590950026,0.616453187199026
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,28931,0.00116596746444803,0.00233948755948506,-0.00341942815214269,0.00575136308103875,0.618215908256433
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,29725,0.00111629380147384,0.00224284832371313,-0.00327968891300391,0.00551227651595158,0.618690331149751
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,24111,-0.00140770675003743,0.00284652678108249,-0.00698689924095912,0.00417148574088425,0.620932995082097
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,24229,-0.000819943741707735,0.00166028887953238,-0.00407410994559119,0.00243422246217572,0.62141231038999
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",24793,-0.00151777972800145,0.00308042977027975,-0.00755542207774976,0.00451986262174686,0.622217018647975
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,-0.00101726348598389,0.00207362049050006,-0.00508155964736401,0.00304703267539622,0.623732501768843
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29581,0.000705481665256997,0.0014473037484069,-0.00213123368162052,0.00354219701213452,0.625946286668875
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,0.00217057474700797,0.00445806700596877,-0.00656723658469081,0.0109083860787068,0.62634286195518
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,0.00142750568253658,0.0029499617210451,-0.00435441929071181,0.00720943065578498,0.628456601868612
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,24229,0.00188591772652214,0.00391652335208,-0.00579046804355465,0.00956230349659893,0.63014526028798
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,24195,0.00162171825723172,0.00337687557791713,-0.00499695787548586,0.0082403943899493,0.631059506122031
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,-0.00184448035327971,0.00386932782890668,-0.00942836289793681,0.00573940219137739,0.63358528188471
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,29169,0.00155239417377171,0.00326679072311757,-0.00485051564353873,0.00795530399108215,0.634644666063536
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,24101,-0.00126931198007416,0.00267783146630075,-0.00651786165402362,0.00397923769387531,0.63549891369171
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,24195,-0.0012158275913988,0.00258068644586359,-0.00627397302529144,0.00384231784249383,0.637555255797233
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,24867,-0.00151122851255198,0.00321387262172638,-0.00781041885113569,0.00478796182603173,0.638201677394256
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,-0.00170331644365746,0.00363499434592609,-0.00882790536167258,0.00542127247435767,0.639368074930116
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,28916,0.0023582204585112,0.00504764390718744,-0.00753516159957618,0.0122516025165986,0.640365811148344
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,24111,-0.00215394837287834,0.00463839442416281,-0.0112452014442375,0.00693730469848077,0.642384225997597
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,-0.00108083594442636,0.00234696308630155,-0.00568088359357739,0.00351921170472467,0.645143329648963
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,-0.00206225411348933,0.00449211756577872,-0.0108668045424156,0.00674229631543696,0.646178759448225
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,-0.000906376128523372,0.00199817283411887,-0.00482279488339636,0.00301004262634962,0.650119041910534
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,24111,-0.00365307889228895,0.00805683666902935,-0.0194444787635865,0.0121383209790086,0.650255066163363
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,24793,0.00121944823211911,0.00269633594982731,-0.00406537022954241,0.00650426669378063,0.651084756428684
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00176977518333204,0.00391745406930817,-0.00944798515917606,0.00590843479251198,0.651441164594988
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,24111,0.00156324234046123,0.00347565941743452,-0.00524905011771042,0.00837553479863288,0.652881373701109
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,24445,0.00097436895536357,0.00218443019554044,-0.0033071142278957,0.00525585213862284,0.655563803340284
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29349,-0.000635923580115505,0.0014361560165531,-0.00345078937255958,0.00217894221232857,0.65791684353791
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,28797,-0.000999490785575449,0.0022578702857011,-0.0054249165455496,0.0034259349743987,0.65800798077407
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,28916,0.00119596475457184,0.00272517975064005,-0.00414538755668266,0.00653731706582635,0.660768291372235
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,29536,-0.0025530005213853,0.0058531219520841,-0.0140251195474701,0.00891911850469953,0.662711088534157
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,24515,0.00041600232031254,0.00096703875783566,-0.00147939364504535,0.00231139828567043,0.667067298884121
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,23603,0.0021353674347001,0.00498023982335313,-0.00762590261907204,0.0118966374884722,0.668095988934545
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,24016,-0.00126379631492153,0.00296694926291861,-0.00707901687024202,0.00455142424039895,0.670142137283741
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,24195,-0.00197213239456861,0.00468343469901752,-0.011151664404643,0.00720739961550573,0.673695463776261
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,0.00102105681439542,0.00244935334344274,-0.00377967573875235,0.00582178936754319,0.676778746483445
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,-0.00122783421927214,0.00296959264189875,-0.00704823579739369,0.00459256735884941,0.679266766150119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.00114174980511667,0.00277227633480463,-0.00429191181110041,0.00657541142133374,0.680455666630424
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,24195,0.00141393504944842,0.00343900123822179,-0.00532650737746629,0.00815437747636313,0.680968390376956
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,24229,-0.000796769536587239,0.00193798050932612,-0.00459521133486644,0.00300167226169196,0.680977972334429
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,24195,0.00110183302631912,0.00268971900223689,-0.00417001621806518,0.00637368227070343,0.682069168453239
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.00103421068232515,0.00253874123944166,-0.00394172214698051,0.00601014351163081,0.683738803778394
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,24445,-0.00153909246982256,0.00381318405118832,-0.00901293321015167,0.00593474827050654,0.686492791880255
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,24229,-0.0013285559576235,0.0033549866535164,-0.00790432979851565,0.00524721788326865,0.692112641601481
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,-0.00248153453651262,0.00629909725187006,-0.0148277651501779,0.0098646960771527,0.693620193293993
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,24938,-0.000877169206064749,0.00222813540920703,-0.00524431460811053,0.00348997619598103,0.693821717907884
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,24101,0.00195731061553191,0.0050465498718527,-0.00793392713329939,0.0118485483643632,0.698129552558338
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,0.00134569416533692,0.00347548653433489,-0.00546625944195946,0.00815764777263329,0.698614612092005
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,-0.00130082245712427,0.00336001390378049,-0.00788644970853404,0.0052848047942855,0.698649554049087
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,28931,-0.00170545857261673,0.00441169702248197,-0.0103523847366814,0.00694146759144792,0.699072572645965
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,24016,0.00256530733401027,0.00664166111145697,-0.0104523484444454,0.0155829631124659,0.699318771478158
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,24229,-0.000713686352135756,0.00186347744516871,-0.00436610214466642,0.00293872944039491,0.701733275783007
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,24016,-0.00172720689372486,0.00452315063686797,-0.0105925821419861,0.00713816835453635,0.702569150846135
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,24016,0.00148559114949447,0.00396419414522972,-0.00628422937515578,0.00925541167414472,0.707847951387379
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,24229,0.00100598935861814,0.00269109936730744,-0.00426856540130444,0.00628054411854072,0.708540794507172
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,0.00228053584902786,0.00613625522782778,-0.00974652439751459,0.0143075960955703,0.71015713778888
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,-0.0019456406349649,0.00525131785415191,-0.0122382236291026,0.00834694235917285,0.711009351772782
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,24101,0.00202923566511765,0.00550544539142534,-0.00876143730207602,0.0128199086323113,0.712438817455322
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,24016,0.00128032845646602,0.00348916669948371,-0.00555843827452204,0.00811909518745409,0.713664095152158
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27986,-0.000747712669070298,0.00206440549140663,-0.00479394743222729,0.00329852209408669,0.717210745055872
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,28931,-0.00141472575807743,0.00393324603102134,-0.00912388797887925,0.00629443646272439,0.719086067463795
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,-0.00148375316676999,0.00424431260383631,-0.00980260587028915,0.00683509953674917,0.726652316076099
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.00208192885873954,0.00597224442167695,-0.0137875279252264,0.00962367020774729,0.727392125429081
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24445,-0.00162651873992249,0.0047165638580198,-0.0108709839016413,0.00761794642179632,0.730208246128053
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,28931,-0.00115627012230631,0.00340505529373569,-0.00783017849802827,0.00551763825341565,0.734179411985779
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,24101,-0.00184871747380409,0.00545104434626949,-0.0125327643924923,0.0088353294448841,0.734500272781153
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,-0.00186991515606742,0.00556493058592814,-0.0127771791044866,0.00903734879235173,0.736860437243773
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.000642753531858796,0.00191611908114746,-0.00311283986719022,0.00439834693090781,0.737291878039165
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,28797,0.0038758967467329,0.0117167693076995,-0.0190889710963581,0.0268407645898239,0.74079864836242
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,29434,0.00130438964138723,0.00395600761890483,-0.00644938529166624,0.00905816457444069,0.741611058886123
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VIT,Vitrin,24922,-0.000876076984274375,0.0026730295555789,-0.00611521491320902,0.00436306094466027,0.743105840785972
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,29392,-0.00181545128242921,0.0055683581313912,-0.012729433219956,0.00909853065509753,0.744404050193291
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,-0.00200110650427613,0.00619649227955416,-0.0141462313722023,0.01014401836365,0.746741602585097
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,24101,-0.000789298168550659,0.00247282182538508,-0.00563602894630542,0.0040574326092041,0.749585768564281
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,-0.00113802364511842,0.00365280665151518,-0.00829752468208818,0.00602147739185134,0.75538695373768
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,24793,-0.000749200444907649,0.00244649223524297,-0.00554432522598386,0.00404592433616856,0.759428642163524
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,-0.00119620279040467,0.00393413927005331,-0.00890711575970915,0.00651471017889982,0.761086623827556
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29594,-0.000631991890579064,0.0021061539242043,-0.0047600535820195,0.00349606980086137,0.764126492468542
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,28916,-0.00225008639004046,0.00758951966931658,-0.017125544941901,0.01262537216182,0.766871142042926
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.0013762978625631,0.0046791672206907,-0.0105474656151169,0.00779486988999066,0.768658748186438
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,24445,-0.00349458972567036,0.011989379709821,-0.0269937739569196,0.0200045945055788,0.770691475106171
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,29349,-0.000537516427697772,0.00184584478114717,-0.00415537219874622,0.00308033934335068,0.77089775843678
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,24793,0.000898857750496858,0.00315603986853355,-0.0052869803918289,0.00708469589282261,0.775795480691682
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",24111,-0.00077201003464292,0.00278498190306226,-0.00623057456464494,0.0046865544953591,0.781625319309919
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,-0.000957413415912771,0.00351205476661081,-0.00784104075846995,0.00592621392664441,0.785157042898429
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,24016,0.000792698764717386,0.00291608429988261,-0.00492282646305254,0.00650822399248731,0.785749914573457
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSC1,Hamartin,24229,-0.00143855120655484,0.00533985405793015,-0.0119046651600979,0.00902756274698826,0.787624970718376
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28916,-0.00116181446924638,0.00431916218469591,-0.00962737235125036,0.0073037434127576,0.787938757647328
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24445,0.00128081130291842,0.00477238602620578,-0.00807306530844492,0.0106346879142818,0.788409366164323
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,24016,0.00222024845839236,0.00830326786150232,-0.0140541565501522,0.0184946534669369,0.789167703318943
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,24454,0.000467460008120365,0.00178518546660902,-0.0030315035064333,0.00396642352267403,0.793435325214201
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,-0.000492857556868403,0.00192562714361466,-0.00426708675835314,0.00328137164461633,0.797993902901787
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,-0.000861571845793411,0.00346287751688094,-0.00764881177888005,0.00592566808729323,0.803515842329702
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,-0.000820827529823924,0.00331987760350666,-0.00732778763269698,0.00568613257304913,0.804719307583183
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.000823208378887451,0.00333115848960066,-0.00570586226072985,0.00735227901850475,0.80481455884453
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,-0.000972491598358348,0.0039692231303031,-0.00875216893375242,0.00680718573703572,0.806452260142087
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,0.00082683802938614,0.00348611911312875,-0.00600595543234621,0.00765963149111849,0.812518732346071
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,24195,-0.000847157831019036,0.00357248050888783,-0.00784921962843918,0.00615490396640111,0.812554576311922
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,-0.00107479099111348,0.00454122175391552,-0.0099755856287879,0.00782600364656093,0.812911406534391
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,24229,0.000797582680431206,0.00339093365740269,-0.00584864728807807,0.00744381264894048,0.814047464863563
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24445,-0.0012305474088048,0.00523176539921016,-0.0114848075912567,0.00902371277364711,0.814050109099795
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,24445,-0.0009813819565298,0.00427721980076208,-0.00936473276602348,0.00740196885296388,0.818525846027376
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,28733,-0.000461704182531068,0.00202722373395362,-0.00443506270108016,0.00351165433601802,0.819840695408937
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,28931,0.000501592652838955,0.00223180285520418,-0.00387274094336124,0.00487592624903915,0.822177109634382
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.000513035074293762,0.00239560016699233,-0.0041823412530112,0.00520841140159873,0.830426207873306
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,24922,-0.000742656126452395,0.00349612591162895,-0.00759506291324514,0.00610975066034035,0.831779100671654
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,28797,-0.00129270423068283,0.00615357705474785,-0.0133537152579886,0.0107683067966229,0.833611698281336
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24404,0.000806538195498066,0.00386977697129381,-0.00677822466823781,0.00839130105923394,0.834902927256602
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,0.00096755902415105,0.00476360307500468,-0.00836910300285813,0.0103042210511602,0.839046897942376
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.000960300211865111,0.00502440780869945,-0.00888753909318581,0.010808139516916,0.848427367536285
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,24229,0.000590231275591695,0.003089289900047,-0.00546477692850043,0.00664523947968382,0.848482331073229
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,28797,0.000652976260828776,0.00346767151914948,-0.00614365991670421,0.00744961243836176,0.850639712869686
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,-0.000483775504189425,0.00259810669822459,-0.00557606463270963,0.00460851362433078,0.852287017908018
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,24793,-0.000590757525331664,0.00322807605475554,-0.00691778659265252,0.00573627154198919,0.854794749997055
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,-0.000743389022901048,0.00408515759719612,-0.00875029791340545,0.00726351986760335,0.8556053288581
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,0.00217972233958593,0.0122611913299426,-0.0218522126671016,0.0262116573462735,0.858901835478042
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,24101,0.000597246333805866,0.00336905857120113,-0.00600610846574834,0.00720060113336007,0.859294699118183
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,24445,0.000747195158241262,0.00422806030125102,-0.00753980303221074,0.00903419334869327,0.859727502328164
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,24016,0.000998301394785434,0.00565126856440303,-0.0100781849914445,0.0120747877810154,0.859784140142767
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLC,Galectin-10,29426,-0.000826748738872921,0.00469219314134758,-0.0100234472959142,0.00836994981816833,0.860140661215229
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,-0.000716608400510074,0.00411979618177922,-0.00879140891679734,0.00735819211577719,0.861911969628231
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,24240,-0.000705517892332479,0.00407572698298636,-0.00869394277898574,0.00728290699432078,0.862572429046788
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,24445,-0.000962174761675224,0.00556351941147723,-0.0118666728081706,0.00994232328482014,0.862697237161323
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.00221014879400841,0.0131161558229723,-0.0234975166190172,0.027917814207034,0.86618651521466
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,23913,0.000414180992671783,0.00246157324687046,-0.00441050257119432,0.00523886455653788,0.86638122594327
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,29349,-0.00100427911639376,0.00607552568193331,-0.0129123094529831,0.0109037512201955,0.868709681703279
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,24229,-0.00101748684083823,0.00644943126117684,-0.0136583721127448,0.0116233984310684,0.874644233231089
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,24111,-0.000477672068239338,0.00304620052301417,-0.00644822509334712,0.00549288095686844,0.875396587143834
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,28797,0.000963913417227744,0.00615513276394784,-0.01110014680011,0.0130279736345655,0.875558687745186
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,24966,0.000214285521288434,0.00137766765968776,-0.00248594309169957,0.00291451413427643,0.876395110315432
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,24845,0.00103797519830748,0.00672938159744701,-0.0121516127326886,0.0142275631293036,0.877417612251903
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,24111,0.000909413397250845,0.00594910024642342,-0.0107508230857391,0.0125696498802407,0.878505462155427
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,24195,0.000723036761961769,0.00487017999727259,-0.00882251603269251,0.010268589556616,0.881979395050748
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,-0.000605083185416398,0.00410572195635904,-0.00865229821988012,0.00744213184904732,0.882836811320251
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,24195,0.000664994937936736,0.00465653693618975,-0.00846181745699518,0.00979180733286865,0.886442294377209
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,-0.000320829178830275,0.00257327784271216,-0.0053644537505461,0.00472279539288555,0.90077994337573
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,24938,-0.000780219687265627,0.00628329048431511,-0.0130954690365232,0.011535029661992,0.90117871404493
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,28916,-0.000287048345991888,0.00231785595406006,-0.00483004601594961,0.00425594932396584,0.901441091236922
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,-0.000434770286737325,0.00354605052091146,-0.0073850293077238,0.00651548873424915,0.902419407110196
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPGN,Epigen,24793,0.000406029039337182,0.00341062559340352,-0.00627879712373372,0.00709085520240808,0.905238087427449
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,0.000669565123392944,0.00566584513146247,-0.0104354913342735,0.0117746215810594,0.905929427880383
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,24445,-0.000327343614621374,0.00285867662452072,-0.00593034979868198,0.00527566256943923,0.908835416111779
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,0.000410456324250011,0.00365081237094837,-0.0067451359228088,0.00756604857130882,0.910484382378723
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.000440516201210481,0.00393486181647738,-0.00727181295908519,0.00815284536150615,0.910862131662803
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,24016,-0.00044678328303809,0.0043013323956224,-0.00887739477845799,0.00798382821238181,0.917272665507981
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.000192458472963726,0.00185950073734871,-0.0038370799181672,0.00345216297223975,0.917566943625489
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,24101,0.000357447216466964,0.00379588257735645,-0.00708248263515167,0.0077973770680856,0.924977210168771
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,-0.000430847502800126,0.00495116715840758,-0.010135135133279,0.00927344012767873,0.930656691051657
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,24706,-0.000398099693374328,0.00511829991424495,-0.0104299675252944,0.00963376813854577,0.938003946316829
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,29434,0.000255012071081629,0.00331209407404405,-0.0062366923140447,0.00674671645620796,0.938628673556995
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,29388,0.000252915006635169,0.0034000869071369,-0.00641125533135315,0.00691708534462349,0.940704657687906
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.000102294394625758,0.00138096203053632,-0.00280897997447694,0.00260439118522543,0.940951513405365
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,24111,0.000249666085812874,0.00340141580477101,-0.0064171088915383,0.00691644106316404,0.94148792016202
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,28916,0.000127815321839464,0.0019412027183889,-0.00367694200620277,0.0039325726498817,0.947502985139502
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,24111,-0.00023863831952874,0.00433528147115475,-0.00873579000299204,0.00825851336393456,0.956102564113389
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,-0.000107188859176811,0.00194905536778939,-0.00392733738004401,0.00371295966169039,0.956142588768579
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.000115118726744637,0.00226949423557857,-0.00456332742847863,0.00433308997498936,0.959545557712579
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,28931,0.000456343541796497,0.0100469428003232,-0.019235664346837,0.0201483514304299,0.963771948991567
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,24195,-0.00018774723970159,0.00428297957116744,-0.00858238719918978,0.0082068927197866,0.96503576313395
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,24229,-0.000203058106808383,0.00493167894232429,-0.00986914883376399,0.00946303262014723,0.967157333345592
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.000101292434082703,0.00252319146922758,-0.00484416284560336,0.00504674771376877,0.967978197512371
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,24101,0.000185265351076319,0.00462016115140925,-0.00887025050568581,0.00924078120783844,0.968014270984397
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,24101,0.00011137080662426,0.00286168709551378,-0.00549753590058274,0.00572027751383126,0.968956180477154
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,24229,0.000102862128265886,0.00305921705599077,-0.00589320330147603,0.0060989275580078,0.973177518007306
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,24229,0.000105139779693236,0.00333118853462575,-0.00642398974817323,0.0066342693075597,0.9748214147754
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,-0.000136315815439099,0.00448525509421047,-0.00892741580009163,0.00865478416921343,0.975754683442667
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,24111,9.51915302451334e-05,0.00362554626353635,-0.0070108791462861,0.00720126220677637,0.979053545865459
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,28774,9.24852196079482e-05,0.00374300280436951,-0.00724380027695629,0.00742877071617219,0.980287383415219
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,29589,-5.72439999338506e-05,0.00241578465753813,-0.00479218192870858,0.00467769392884088,0.981095399585331
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,24101,0.000132877051806417,0.00603578126352474,-0.0116972542247021,0.0119630083283149,0.982436261428465
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,-5.71451585834098e-05,0.00273947794317618,-0.00542652192720872,0.0053122316100419,0.983357609617597
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,24016,-9.13352165178879e-05,0.00450950917357298,-0.00892997319672093,0.00874730276368515,0.983840986914024
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,29443,-3.20026274478286e-05,0.00170062640843096,-0.00336523038797252,0.00330122513307686,0.984986309576476
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,29288,2.94767606861492e-05,0.0015901129588762,-0.00308714463871121,0.0031460981600835,0.985210167433901
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,-9.14469513952305e-05,0.00494749760264962,-0.00978854225258848,0.00960564834979802,0.985253312344574
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,-3.69289611632091e-05,0.0022483588204747,-0.00444371224929361,0.00436985432696719,0.986895566662076
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,23975,-5.58265296208346e-05,0.00344712794508475,-0.00681219730198695,0.00670054424274528,0.987078891496064
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,8.3803496857544e-05,0.00647288383015626,-0.0126030488102487,0.0127706558039638,0.989670279610979
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,3.96602136153604e-05,0.00357850882233575,-0.00697421707816271,0.00705353750539343,0.991157407334758
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,4.074097755515e-05,0.00446776581231435,-0.00871608001458098,0.00879756196969128,0.992724358153875
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24793,1.65943810733054e-05,0.00290121113458663,-0.00566977944271649,0.0057029682048631,0.995436321571172
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,3.87467962997897e-06,0.00489756204226554,-0.00959534692321047,0.00960309628247043,0.999368764485209
